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ABSTRACT 
 
An injectable hydrogel for controlled release of methylprednisolone was designed based on the 
inflammatory response during acute spinal cord injury.  The gel is injectable through a small 
gauge needle, cross-links under physiological conditions, and releases methylprednisolone over a 
time period on the order of weeks.  Swelling properties were characterized to address potential 
safety concerns for potential clinical use.  Two studies are presented towards the development of 
a model Brown-Séquard syndrome and accompanying behavioral and pathological outcome 
measures for evaluation of biomaterials in vivo.  A modified poly(glycerol-co-sebacic acid) 
membrane was developed using electrospun poly(ε-caprolactone) nanofibers.  Retinal adhesion 
and histology was evaluated in vitro.  Membranes were evaluated in vivo for their ability to 
selectively remove photoreceptors in situ and promote survival and integration of retinal 
transplants.  Viscoelastic poly(ethylene glycol) sols were evaluated as potential vitreous 
substitutes.  Finally, a business plan outlines the strategy towards clinical trials for a hydrogel 
vitreous substitute. 
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Abstract 
Clinically available injectable hydrogels face technical challenges associated with swelling after 
injection and toxicity from unreacted constituents that impede their performance as surgical 
biomaterials.  To overcome these challenges, we developed a system where chemical gelation 
was controlled by a conjugate Michael addition between thiol and acrylate in aqueous media, 
with 97 % monomer conversion and 6 wt.% sol fraction.  The hydrogel exhibited syneresis on 
equilibration, reducing to 59.7 % of its initial volume.  It had mechanical properties similar to 
soft human tissue with an elastic modulus of 189.8 kPa.  Furthermore, a mesh size of 6.9 nm 
resulted in sustained release of methylprednisolone sodium succinate with a loading efficiency of 
2 mg/mL.  Functionalization with 50 μg/mL of an oligolysine peptide resulted in attachment of 
freshly isolated murine mesenchymal stem cells.  The rational design of the physical, chemical 
and biological properties of the hydrogel make it a potentially promising candidate for injectable 
applications. 
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Introduction 
Synthetic polymeric hydrogels represent a promising technology platform for therapeutic 
intervention in a wide range of diseases and traumatic injuries.  Comprising a three dimensional 
insoluble polymer network formed through the covalent or physical crosslinking of hydrophilic 
macromer precursors, hydrogels thermodynamically interact with aqueous media in a similar 
way to the native extracellular matrix (ECM).  Owing to their easily tunable physical and 
chemical properties, hydrogels have been explored in a variety of diverse biomedical 
applications across the domains of controlled drug delivery, in vitro disease modeling and 
regenerative medicine [1-3]. Poly(ethylene glycol) (PEG) based hydrogels are particularly 
attractive for rapid clinical translation because devices and delivery systems based on PEG 
already have FDA approval due to the characteristic properties of PEG that limit non-specific 
protein adhesion and cellular interactions [4].  To date, a wide variety of novel PEG based 
hydrogels have been fabricated using numerous covalent gelation mechanisms.  These include 
the free radical chain growth homopolymerization of activated -enes (most notably acrylates) [5]; 
free radical step growth photopolymerization of thiols and -enes [6-8], click chemistry of alkynes 
and azides [9], and conjugate Michael addition of multifunctional thiol and activated -ene 
precursors [10, 11].  Incorporation of various biological, chemical and/or mechanical cues have 
allowed these biomaterials to be applied to the study of cellular matrix interactions as well as 
disease states in vitro by recreating intricate cellular microenvironments [12].  However, the 
suitability of some of these systems for in situ gelation is limited by incomplete conversion of 
reactive functional groups and high sol fraction [2].  In addition, the use of metal catalysts, or 
photoinitiators and ultra-violet (UV) light, to initiate and propagate gelation creates 
biocompatibility concerns [9, 13].  Additional structural constraints, caused by substantial 
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network defects and problematic large equilibrium volume swelling, have also hampered in vivo 
material performance in the past.  Duraseal, a hydrogel composed of a mixture of polyethylene 
glycol (PEG) ester and trilysine amine solutions, caused spinal cord compression due to undue 
swelling and as a result induced or worsened quadriparesis requiring intervening decompression 
surgery [14, 15].  Hydrogels of co-poly(methylacrylate-hydroxyethyl acrylate) used in scleral 
buckling procedures to treat retinal detachment displayed compromised long-term performance 
attributed to undesirable swelling and also degradation [16, 17].  These cases demonstrate that 
unfavorable physical properties of injectable hydrogels can create severe post surgical 
complications.  Such limitations have been overcome by post-gelation processing prior to 
implantation, but this precludes their surgical application via a minimally invasive injection [18]. 
Hydrogels that display temperature dependent de-swelling properties have been developed 
previously through the covalent crosslinking of thermoreversible physical gels composed of 
triblock poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO) macromers.  However a 
capacity to achieve sustained release of low molecular weight molecules using this system was 
not demonstrated and photopolymerization was still required for irreversible network formation 
[19]. 
We were interested in developing a more robust hydrogel technology platform that could 
overcome the above constraints and bypass additional processing requirements through a 
capacity to safely transition from a sol precursor mixture to a gel state in situ.  Utilizing a 
rational engineering design approach, we defined performance parameters applicable to a wide 
spectrum of diseased and injured tissues prior to the selection of material constituents and a 
gelation mechanism.  These requirements included no volume increase during equilibration, 
resilient mechanical properties that match human tissues of interest, a mesh size adequate for 
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diffusion-controlled release of hydrophilic small molecule drugs, tunable gelation kinetics and 
the ability to functionalize the material with biological motifs to guide cellular interactions.  An 
injectable biomaterial displaying such properties would provide a substrate for diverse 
therapeutic interventions that could permit minimally invasive surgical application, minimal 
compressive tissue damage, reduced inflammation and risk of infection, as well as faster 
recovery for patients following surgery [20].  Given the desire to achieve rapid gelation under 
ambient conditions without use of reaction initiators or UV light, conjugate thiol-ene Michael 
addition was selected as a suitable chemical cross-linking mechanism for the injectable hydrogel 
system. This reaction involves the direct addition of a dissociated thiolate nucleophile and an 
unsaturated carbon double bond, activated by a neighboring electron withdrawing group such as 
an ester or amide [10, 11, 21, 22].  Advantageously, this mechanism has been shown to be 
applicable to a wide range of commercially available precursors, forms polymer networks with 
minimal structural deficiencies and can react completely within a surgically relevant timeframe, 
while avoiding the production of free radicals [23].  This paper describes the rational design and 
characterization of a novel PEG based hydrogel and an investigation of its applicability for drug 
release and cell adhesion in vitro. 
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Materials and methods 
Materials 
Poly(ethylene glycol) diacrylate (PEG-400-DA, Polyscience, Warrington, PA) and ethoxylated 
trimethylolpropane tri-3-mercaptopropionate (ETTMP, Thiocure 1300, Bruno Bock, Marschacht, 
Germany) were passed through a short column of activated basic aluminum oxide (Cole-Parmer 
Instrument Company, Vernon Hills, IL) to remove the radical inhibitor, hydroquinone 
monomethyl ether (MEHQ, 400ppm) prior to use.  Physiologically isotonic phosphate-buffered 
saline (PBS, pH 7.4, 1.06 mM potassium phosphate monobasic, 155.17 mM sodium chloride, 
2.97 mM sodium phosphate dibasic, Invitrogen, Carlsbad, PA), Dulbecco’s Modified Eagle 
Medium (DMEM, 1X, 4.5g/L Glucose, 4mM L-glutamine, Invitrogen, Carlsbad, PA), 
methylprednisolone sodium succinate (MPSS, CAS 2375-03-3, Sigma-Aldrich Corp., St. Louis 
MO), oligolysine peptide (14 lysine amino acid units with a cysteine at both the N and C termini, 
Applied Biosystems 430A, Biopolymers & Proteomics Core Facility, Koch Institute at  MIT, 
Cambridge MA), sodium hydroxide (NaOH, Mallinckrodt), and poly(ethylene glycol) (400 
g/mol, Fluka), acetonitrile (Chromasolv Plus, Sigma-Aldrich Corp., St. Louis MO), ddH20 
(NANOpure, Thermo Fisher Scientific, Waltham MA), and formic acid (Sigma-Aldrich Corp., 
St. Louis MO) were used as received. 
Instrumentation 
UV-vis was measured on a Spectramax Plus spectrophotometer (Molecular Devices).  pH was 
measured using a digital pH probe (Russell RL060P, Thermo Scientific).  Fourier transform 
infrared (FT-IR) spectroscopy was taken using an Alpha FT-IR with Eco ATR sampling module 
(Bruker Optics, Billerica MA).  Dynamic rheology was performed using an AR G-2 with a 40 
Doctoral Thesis A novel injectable thiol-acrylate poly(ethylene glycol) hydrogel 
Page 11 of 256 
mm diameter 2 cone and plate set-up (TA Instruments, New Castle, DE).  Specific gravity was 
measured using a kit (Mineralab, Prescott AZ).  Tensile testing was performed on a Model 5542 
(Instron, Norwood, MA).  High performance liquid chromatography (HPLC) was performed on 
an Agilent 1100 (Agilent Technologies Inc., Santa Clara CA) based on an existing procedure 
[24].  A C18 column (dC18 Atlantis 5m, 4.6 mm x 250 mm, Waters, Ireland) was used at a 
flow rate of 1 mL/min.  The mobile phase was 60:40 acetonitrile and ddH20 with 0.1% formic 
acid. Mathematica (Mathematica, Wolfram Research, Champaign IL) was employed.  
Microscopy was performed on using a Carl Zeiss microscope (MicroImaging Inc., Thornwood 
NY). 
Poly(ethylene glycol) hydrogel fabrication 
Poly(ethylene glycol) based hydrogels were formed using precursors containing multiple thiol 
and acrylate functional groups capable of reacting in an aqueous solvent to form a network 
structure (Fig. 1 and Scheme. 1).  Aqueous stock solutions of the two precursors, PEG-400-DA, 
and ETTMP, were prepared by dissolving the polymers in PBS at 4 C for 24 hours.  To 
fabricate the hydrogels, appropriate volumes of the two stock solutions resulting in an equimolar 
stoichiometric ratio of thiol and acrylate functional groups were combined, yielding a final total 
polymer concentration of 25 wt.% in a Falcon tube at 4 C.  Following a five minute incubation 
period at 4 C to increase dissolution of the precursors in the mixture, molds of a desired size 
were filled with the solution and transferred to an incubator at 37 C to complete gelation.  
Gelation occurred within 5 minutes of incubation.  However, samples produced for structural 
characterization and mechanical testing were maintained in the 37 C environment for 20 
minutes to promote complete conversion of functional groups. The gelation protocol described 
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above was applied to all hydrogels prepared in PBS.  For cell culture studies, DMEM was 
incorporated as the solvent phase in the hydrogel by incubating the cured hydrogel in the media 
for a 24 hour period, prior to cell seeding.  For MPSS encapsulation and release studies, weighed 
samples of the steroid were incorporated into the PEG-400-DA solution for a final concentration 
of 0.5, 1 or 2 mg/mL in the hydrogels.  Functionalization of the hydrogel with an oligolysine 
peptide was performed by dissolving the peptide in the PEG-400-DA in solution, prior to mixing 
with the ETTMP stock solution.  The oligolysine was reacted into the hydrogel via its thiol-
containing cysteine end residues.  Solutions were sterilized by syringe filtration through a 0.2 μm 
nylon filter.  The concentrations of oligopeptide used were 5, 50 and 500 g/mL. 
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Figure 1. Hydrogel polymer components. A: Ethoxylated trimethylolpropane tri(3-mercaptopropanoate) (ETTMP). B: Poly(ethylene 
glycol) diacrylate (PEG-400-DA). C: Oligolysine peptide with cysteine residues at N and C termini (Cys-Lys14-Cys). 
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Scheme 1. Formation of cross-linked network under physiological conditions.  In aqueous medium a thiol functional group of ETTMP 
is in equilibrium with thiolate, its conjugate base.  A 2:3 ratio of ETTMP and PEG-400-DA results in stoichiometric equivalents of 
thiol and acrylate functional groups. Due to the multi-functionality (n=3) of ETTMP, a cross-linked network is formed. The thiolate 
anion in ETTMP attacks from the unsaturated β-carbon of the acrylate in PEG-400-DA,which is activated towards nucleophiles, in a 
nucleophilic conjugate addition reaction. In a buffer, a metal cation may act as a counterion to thiolate and as a Lewis acid, 
coordinating with the ester carbonyl in PEG-400-DA to further activate it, and promote nucleophilic attack of thiolate from the 
unsaturated β-carbon. 
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Hydrogel precursors analysis 
Solubility of hydrogel precursors 
To investigate the parameters affecting solubility of ETTMP in PBS, nine standard solutions, 
with concentrations from 5 wt.% to 45 wt.%, at 5 wt.% increments, were prepared and stored at 4 
C for 24 hours.  Following vortexing, 4 x 200 L of each standard was aliquotted into a 
transparent 96-well plate and equilibrated at 4 C for 30 minutes.  The absorbance of the 
standards was then assessed spectrophotometrically at 37 C for 20 minutes (λ = 450 nm).  The 
initial absorbance and the time at which a rapid increase in absorbance occurred (represented by 
a characteristic inflection in the absorbance curve) were used as measures of solubility at 4 C 
and stability (precipitation/phase separation) at 37 C respectively.  The solubility of the PEG-
400-DA was assessed but not reported in this paper, as this polymer was soluble over the 
concentration and temperature ranges of interest.  
Measuring the pKa of ETTMP  
A 50 mL 0.1 M (0.3 N) solution of ETTMP in ddH20 was prepared in a 250 mL beaker with a 
magnetic stir bar and a digital pH probe.  A 0.1 M solution of NaOH in ddH20 was titrated in 
increments of 500 to 1200 μL into the ETTMP solution with concomitant pH measurements until 
the pH increased beyond the upper equivalence point (approximately 150 mL).  The pKa was 
determined as the pH halfway between the equivalence points. 
Gelation kinetics and mechanism 
The gelation kinetics involving sol-gel transition and chemical conversion were assessed using 
dynamic rheology and FT-IR spectroscopy respectively.  The Michael addition mechanism was 
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assessed by evaluating the gelation response as a function of buffer pH and counterion content 
using these two tests. To study the presence of radical reactions (thiyl-acrylate addition or 
acrylate homopolymerization), gelation was also performed in the presence of radical inhibitor, 
MEHQ, by not filtering PEG-400-DA prior to use. 
FT-IR analysis 
500 L hydrogel discs were cast using a 24-well tissue culture plate as a mold following the 
fabrication protocol outlined above.  Hydrogel samples were extracted from their molds after 
curing and either lyophilized for a period of 36 hours, or equilibrated by incubation at 37 ºC in a 
12-well plate (4 mL per well of PBS) for 48 hours followed by lyophilization.  FT-IR spectra 
were obtained on the dry gels by measuring attenuated total reflection.  The differences in the 
amount of unreacted acrylate and thiol constituents remaining in the two hydrogel sample groups 
(characterized by C=C stretch at 1675-1600 cm
-1
 and S-H stretch at 2550-2600 cm
-1
) were 
assessed through a quantification analysis using the OPUS software package.  Standard curves 
for the quantification analysis were constructed by diluting the precursors to known 
concentrations using poly(ethylene glycol) (400 g/mol) polymer.  Linear regression curves were 
constructed from this data and used to assess residual acrylate (R
2
 = 0.998) and thiol (R
2
 = 1.000) 
in the hydrogels. 
Dynamic rheology 
The sol-gel transition was studied in situ using dynamic rheology.  600 μL aliquots of 
precursor/PBS solution were prepared and incubated at 4 C for 5 minutes.  The solutions were 
then transferred to the rheometer.  First measurements were recorded 40 seconds after removal 
from the 4 C environment.  The dynamic evolution of the mechanical properties (storage (G’) 
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and loss (G”) moduli) was assessed at 5% strain and a frequency of 10 rad s-1 for 10 minutes. 
Separately, a frequency sweep was performed at 5% strain to verify that testing conditions were 
within the linear viscoelastic range.  The gel point was characterized as the time when tan(δ) 
=G’’/G’= 1 was observed, which was deemed a valid approximation given that the prepared 
hydrogel was stoichiometrically balanced and sufficiently far away from its glass transition 
temperature [25, 26].  The proposed mechanism of hydrogel formation via a base catalyzed 
Michael type addition reaction between thiolate anion and acrylate was studied further by 
assessing functional group conversion and gelation kinetics under varying buffer conditions.  
Potassium and sodium phosphate buffer 0.1M solutions with pH values of 6, 6.6, 7, 7.4 and 8 
were prepared by mixing and diluting appropriate quantities of 1M solutions containing their 
respective monobasic dihydrogen and dibasic monohydrogen phosphate salts.  Additional FT-IR 
and dynamic rheology experiments were performed on hydrogels using these buffer solutions as 
the solvent phase.  The extent of chemical conversion of the acrylate and thiol functional groups 
and the gel point time were characterized for each buffer solution.  For dynamic rheology testing 
of these hydrogels, the 5 minute incubation procedure at 4 C was not necessary.   
Structural and mechanical properties of the hydrogel 
Hydrogel equilibration and sol fraction  
The hydrogel equilibration behavior and sol fraction were evaluated using 500 L hydrogel discs 
prepared in a 24-well plate mold.  The wet masses of hydrogels cured and swollen for 6, 12, 24, 
48 and 72 hours were recorded before then being lyophilized to determine the mass of dry 
polymer.  To calculate the relaxed (immediately after curing) and equilibrium polymer volume 
fractions (2,r and 2,s respectively, per equations 1 and 2), the specific gravity of the hydrogel 
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(cured and equilibrated for the same above incremental time points) as well as the dry polymer 
network were measured, using a specific gravity kit and applying Archimedes’ buoyancy law 
before then being converted to volume measurements. 
Equilibrium polymer volume fraction  (1) 
Polymer volume fraction in the relaxed state  (2) 
The sol mass fraction was computed by comparing the differences in dry polymer weight 
between the cured and equilibrated samples. 
Hydrogel degradation 
Individual 500 L hydrogel discs were incubated in 4 mL PBS in 12-well plates for a period of 
12 weeks to assess hydrolytic degradation.  Masses of wet and lyophilized gels were measured in 
triplicate at 1, 2, 4, 6, and 9 weeks.  Before lyophilization, the hydrogels were washed in distilled 
water to remove any residual salt that may have built up on the surface.  The total dry polymer 
mass loss of each sample was determined through comparisons with the dry weight of cured 
(non-equilibrated) samples. 
Mechanical testing of equilibrated and cured hydrogels 
To assess the mechanical properties of the hydrogel, tensile testing was performed on cured and 
equilibrated samples.  Planar sheets of hydrogel with 3 mm uniform thickness were fabricated in 
a flat rectangular mold, with equilibrated samples incubated in PBS for 48 hours before use.  
Immediately prior to testing, ASTM 412-D type specimens were cut from the planar sheet using 
a stainless steel die and a mallet.  The final dimensions of the specimen were measured using 
Vernier calipers before being loaded into the testing jig.  Tests were performed using a 50 N 
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static load cell under a strain rate of 5 mm min
-1
.  The shear and elastic modulus was computed 
assuming incompressible neo-Hookean mechanics (Poisson’s Ratio, ~ 0.5) and assessing 
engineering stress as a function of both extension ratio and deformation factor [27, 28].  Using a 
statistical mechanics approach and applying the experimentally observed modulus value (G) (as 
calculated by fitting a linear regression for engineering stress versus deformation factor), the 
number of elastically effective chains per unit volume (e / Vo) for equilibrated hydrogels was 
determined (Equation 3).  
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 (3) 
Additional modeling of the gel structure through the application of the Miller-Macosko 
branching theory for end-linked networks was used to characterize the extent of reaction, as well 
as the ideal mechanical properties based upon the measured sol fraction [29, 30].  An 
approximate mesh size for the hydrogel in both cured and equilibrium states was also determined 
by calculating the distance between active crosslinks, μe (= 2νe/f).   
In vitro analysis 
Drug release and stability study 
The release kinetics of MPSS from hydrogels was studied as follows.  Hydrogels containing 0.5, 
1 and 2 mg/mL MPSS (dissolved in precursor solutions prior to gelation) were fabricated in 1.7 
mL Eppendorf tubes (21 x 250 L for each concentration of MPSS).  Following complete 
gelation (20 minutes at 37 ºC), 1 mL PBS was added to each tube and incubated at 37 ºC.  
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Degradation of MPSS in PBS was measured by incubating stock solutions of MPSS in PBS at 37 
ºC (500, 250 and 125 g/mL, 21 x 1 mL for each concentration).  After 6, 12, 24, 48, 96, 192 or 
384 hours the solution above the hydrogels or from stock aliquots were extracted and stored in 
Eppendorf tubes at - 80 ºC (n=3 for each concentration at each time point).  MPSS 
concentrations were analyzed using high HPLC based on an existing procedure [24]. Ultraviolet 
light absorbance was measured at 238nm.  The MPSS peak elutes at 4.864 minutes.  A standard 
curve was calculated using HPLC peak areas from six points in a series dilution from a stock 
solution (85 g/mL MPSS in PBS, diluted geometrically.  A response factor of 8.7446 mAUs 
mL g-1 was calculated with R2 of 0.9997 (linear regression with zero intercept).  Mass transfer 
coefficients for MPSS release from the hydrogel were calculated by solving a system of 
differential equations for drug release kinetics and the degradation of MPSS in PBS and fitting a 
regression of appropriate form to the data using Mathematica. 
Cell adhesion assay 
Hydrogels were prepared in PBS, with final concentrations of oligolysine peptide of 0, 5, 50 and 
500 g/mL (4 x 250 L each), in a sterile 24-well polystyrene tissue culture plate, before being 
incubated in DMEM for 24 hours to facilitate solvent exchange.  On the same plate, 4 wells were 
incubated with 200 L for 3 hours at room temperature, with 0.25 mg/mL oligolysine peptide in 
DMEM, followed by aspiration of the media.  The remaining 4 wells were left uncoated as 
positive controls.  The tissue culture plate was further sterilized in a laminar flow hood by 
ultraviolet irradiation for 15-30 minutes with the addition of excess media to the gels to maintain 
hydration.  Freshly isolated bone marrow derived murine mesenchymal stem cells (mMSC) were 
then seeded using sterile technique at a density of 10
5
 cells per well and incubated (2mL DMEM 
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per well, 37 ºC, 5% CO2).  After 24 hours, digital images of the cells were obtained from all 
wells (40x Phase 2 contrast bright field, light microscope). 
Statistics 
Throughout this paper all statistics are represented as mean ± standard deviation.  Hypothesis 
tests of comparison were performed using the student’s t-test, assuming that variances were 
unknown and not equal, with p-values of less than 0.05 taken as significant. 
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Results 
Hydrogel precursor analysis 
Solubility of ETTMP 
PEG-DA-400 was soluble in PBS over the temperature (4 to 37 ºC) and concentration (5 to 45 
wt.%) ranges of interest.  In contrast, the solubility of ETTMP in PBS changed as a function of 
concentration.  Therefore, experiments were performed to characterize the solubility of ETTMP 
in PBS at 4 ºC (Fig. 2) and stability during heating from 4 to 37 ºC (Fig. 3).  ETTMP solubility 
in PBS at 4 ºC decreased nonlinearly from 5 to 25 wt.%, determined by the increasing 
absorbance of visible light (λ = 450 nm).  The solubility of the polymer then increased again 
from 25 to 45 wt.%, exhibiting the highest solubility from 40 to 45 wt.% (Fig. 2).  The results 
were confirmed by visual inspection, where mixtures from 20 to 35 wt.% were above their cloud 
point at 4 ºC in PBS.  The stability of ETTMP in PBS when heated from 4 to 37 ºC was 
measured by dissolving ETTMP at different concentrations at 4ºC, followed by heating at 37 ºC 
for 20 minutes.  These experimental conditions were chosen to replicate the physiological 
environment under which gelation would take place in situ.  Regression of error functions (in the 
form A erf [b(t - tinf)] + d ) were applied to the temporal absorbance profiles and used to 
determine the time where the inflection in absorbance of visible light (λ = 450 nm) occurred 
(tinf), marking the maxima in rate of precipitation (Fig. 3). The precipitation time decreased from 
approximately 794 to 485 seconds between 5 and 10 wt.%.  Precipitation time increased again 
markedly from 483 to 1044 seconds to between 20 and 45 wt.%.  Based on these results, gelation 
experiments were performed with varying concentrations of ETTMP in the stock solution.  The 
concentration of the PEG-400-DA stock solution was modified accordingly to maintain a total 
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polymer concentration of 25 wt.% in the hydrogels, with no precipitation of PEG-400-DA 
observed in the stock solution over the resulting concentration range.  Higher sol fractions of the 
resulting hydrogels were observed using ETTMP stock solutions between 25 and 35 wt.% 
compared to 40 wt.%, associated with reduced ETTMP stability in solution.  Gelation did not 
readily occur using a 45 wt.% ETTMP stock solution. When the concentration was increased 
above 50 wt.%, the mixing was greatly reduced due to increased viscosity, which hindered the 
polymerization. The 40 wt.% concentration was therefore used for further experiments.
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Figure 2. Solubility of ETTMP in PBS at 4ºC. The absorbances of 200 μL standards of ETTMP 
at different concentrations in PBS were measured at a wavelength of 450 nm. The dependence of 
solubility on concentration between 5 and 45 wt.% is not monotonic, with the solubility 
minimum observed at 25 wt.%. Error bars are standard deviation, n=4. 
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Figure 3. Stability of ETTMP in PBS from 4ºC to 37ºC. The absorbances of 200 μL standards of 
ETTMP at different concentration, prepared at 4ºC, were measured at a wavelength of 450 nm at 
37ºC for 20 minutes. The graph shows the time taken for the standards to reach an inflection 
point in absorbance increase. The precipitation time is not a monotonic function of concentration 
between 5 and 45 wt.%, and is a maximum at 45 wt.%.  Error bars are standard deviation, n=4. 
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Measuring the pKa of ETTMP 
The pKa of ETTMP was measured in order to predict the extent of thiol deprotonation as a 
function of pH in aqueous media.  A titration of 0.1M ETTMP at 24 ºC with 0.1M NaOH 
resulted in a pKa for ETTMP of 9.87 (Fig. 4). 
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Figure 4. pKa of ETTMP at 24 ºC. 0.1M ETTMP (0.3N, 50 mL) at 24 ºC was titrated with 0.1M 
sodium hydroxide (NaOH) (0.1N, 200 mL).  The pKa (dashed line) of 9.87 (74.8 mL 0.1M 
NaOH) was determined as halfway between equivalence points (solid lines) at pH 5.62 (3.2 mL 
0.1M NaOH) and pH 11.23 (147.8 mL 0.1M NaOH). 
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Gelation kinetics 
Fourier transform infra-red spectroscopy 
Attenuated total reflection FT-IR was used to measure PEG-400-DA acrylate C=C stretch (1675-
1600 cm
-1
) and ETTMP S-H stretch (2550-2600 cm
-1
) (Fig. 5).  Following the reaction in PBS, 
15.0 vol.% thiol and 6.7 vol.% acrylate were detected in cured gels, after lyophilization.  8.0 
vol.% thiol and -2.7 vol.% acrylate were detected in equilibrated gels, after lyophilization.  These 
parameters were determined using the FT-IR quantification software.  The apparatus used 
appeared to have a detection limitation for low macromer concentrations, where peaks expected 
based on the values obtained could not clearly be distinguished from noise (Fig. 5C, D). 
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Figure 5. Fourier transform infrared spectroscopy (FT-IR) spectra, measured by attenuated total 
reflection through a Zinc Selenide (ZnSe) crystal, normalized by maximum and minimum 
absorbance. C=C stretch was measured at 1675-1600 cm
-1
 and S-H stretch at 2550-2600 cm
-1
. A: 
ETTMP.  There is an S-H stretch but no C=C stretch. B: PEG-400-DA.  No S-H stretch is 
present but two peaks in the C=C stretch region are visible. C: Hydrogel, cured and lyophilized.  
Following reaction of ETTMP and PEG-400-DA in PBS, both S-H stretch and C=C stretch have 
disappeared from the lyophilized network. D: Hydrogel, equilibrated for 48 hours and 
lyophilized.  Spectrum displays same characteristics as the as cured samples.   
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Dynamic rheology 
Dynamic rheology was performed to quantify the critical gelation time, defined where the 
magnitudes of the elastic (G’) and loss (G”) moduli are equivalent (Fig. 6).  Gelation times were 
measured in phosphate buffer solutions of varying pH and either Na or K cations.  The gelation 
time decreased exponentially with increasing pH, for 0.1 M phosphate buffer solution containing 
either Na or K cations (Fig. 7).  The gelation time was also weakly dependent on the cation in the 
buffer, decreasing as the ionization energy of the cation decreased from Na to K.  The gelation 
time in PBS increased with the inclusion of MEHQ, from 459.7 to 475.3 seconds (p < 0.05). 
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Figure 6. Dynamic rheology of characteristic gel point between ETTMP and PEG-400-DA in 
PBS.  Gel point can be observed by dynamic rheology as the point where the magnitude of the 
elastic modulus (G’) equals the loss modulus (G”).  Shortly before this point, G” rises as the 
molecular weight of co-polymer chains increases significantly prior to network formation, 
resulting in increased viscosity.  This is reflected in a maximum in tan(delta).  At the gel point G’ 
increases sharply as an infinite molecular weight network forms in solution.  G’ and G” reach 
asymptotes following complete conversion indicating a viscoelastic product. 
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Figure 7. Gelation kinetics as a function of pH and alkali metal cation in 0.1 M phosphate buffer 
at 25 ºC. Gel point was determined by dynamic rheology where the magnitudes of elastic (G’) 
and loss (G”) moduli are equal.  The reaction rate between ETTMP and PEG-400-DA follows an 
exponential dependence on buffer pH, and is therefore linearly proportional to thiolate 
concentration.  The reaction rate is weakly dependent on the alkali metal cation in the buffer. 
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Structural and mechanical properties of the hydrogel 
Hydrogel equilibration and sol fraction 
Equilibrium polymer volume, mass and sol fractions were measured for hydrogels cured at 37 ºC 
in different solvents.  The hydrogel exhibited syneresis during equilibration.  The polymer 
volume and mass fractions in the relaxed state were 22.1 vol.% and 26.1 wt.% immediately post 
gelation and increased to 36.7 vol.% and 39.4 wt.% after 12 hours of incubation in PBS.  This 
equilibrium value was maintained relatively constant through 48 hours (Fig. 8).  The polymer 
mass fraction followed the volume fraction profile over the 72 hour period analyzed but was 
offset by 2 to 3 % at each time point.  By comparing dry mass initially and following 
equilibration, it was determined that 93.7  1.0 wt.% and 95.4  1.4 wt.% of the polymer 
precursors were incorporated into the hydrogel network in PBS with or without MEHQ 
respectively (no statistical significance).  MEHQ did not affect the equilibrium volume or mass 
fractions.  Hydrogels prepared in ddH20 without MEHQ incorporated 64.2  5.8 wt.% of 
precursors into the gel network and had an equilibrium polymer mass fraction of 26.9  1.6 
wt.%.  Hydrogels did not form in ddH2O with MEHQ and the polymer precipitated prior to 
gelation. 
Doctoral Thesis A novel injectable thiol-acrylate poly(ethylene glycol) hydrogel 
Page 34 of 256 
 
Figure 8. Equilibrium volume and mass fractions of hydrogels in PBS (pH 7.4) at 37 ºC over a 
72 hour period.  A rapid increase from the relaxed volume fraction is observed over the first 12 
hours before a stable equilibrium volume fraction is obtained and sustained at a near constant 
value over 48 hours.  The mass fraction profile traces the volume fraction response but is offset 
by 2-3 % for each time point.  
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Degradation 
The degradation profile of hydrogels was studied by measuring mass loss of lyophilized samples 
in PBS at 37 ºC over a period of 9 weeks (Fig. 9A).  Gels reached equilibrium within 48 hours of 
incubation displaying a characteristic sol fraction of approximately 6 wt.%, similar to the value 
observed in equilibration studies.  The hydrogel degraded linearly in vitro at a rate of 2 wt.% a 
week over the 9 weeks. Furthermore, the hydrogel displayed approximately constant polymer 
mass and volume fractions over the initial 4 week period with an increased solvent uptake 
apparent from 6 weeks (Fig 9B). After 4 weeks the hydrogel exhibited a noticeable reduction in 
mechanical rigidity and could be easily compressed upon handling. 
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Figure 9. Degradation of hydrogels in PBS (pH 7.4) at 37 ºC.  The chosen buffer and temperature simulate physiological conditions 
where hydrolysis of ester bonds in the network result in gel mass loss.  A. Gels reach equilibrium within 48 hours of incubation with 
no appreciable mass loss and degrade linearly over 9 weeks in vitro.  B.  The polymer mass fraction remained approximately constant 
following equilibration for the first 4 weeks of incubation and exhibited increased solvent uptake from 6 weeks.  Error is standard 
deviation, n=3 for each time point. 
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Mechanical testing 
Tensile testing was performed on hydrogels cured at 37 ºC in their initial and equilibrium-
swollen states (Fig. 10).  From the data obtained, ultimate tensile strengths and terminal 
extensions were recorded (Table 1).  Elastomer rubber elasticity theory was applied to quantify 
the elastic modulus of the hydrogels by using the characteristic linear relationship between 
tensile stress and deformation factor over the extension ratio range of relevance [27].  For the 
equilibrated hydrogels a shear modulus of 63.26  2.13 kPa was determined, which was 
significantly greater than the modulus recorded for the cured hydrogels, calculated to be 50.98  
1.42 kPa (p<<0.001).  By assuming an isotropic material that behaves as a neo-Hookean 
incompressible solid, the elastic modulus, E was approximated to be 189.8 and 152.9 kPa for the 
equilibrated and cured gels respectively.   Through the application of equation 3 and knowledge 
of the volume fraction parameters (2,r = 0.221, 2,s = 0.376) the percentage of elastically 
effective chains was calculated to be approximately 11 % of the total number of initial chains (e 
~ 0.021 mol L
-1
) and was consistent in both the cured and equilibrium states.  The extent of 
reaction was calculated to be approximately 96.98 % based on the theory of Miller-Macosko, but 
the number of elastically effective chains was overestimated to be 0.15 mol L
-1
 using this model.  
By taking the root mean squared value of the distance between crosslinks, the mesh size of the 
system was approximated at 7 nm and 6.9 nm in the cured and equilibrium states respectively. 
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Figure 10. Tensile testing of hydrogels. Graph shows tensile stress versus extension ratio for 
cured and equilibrated hydrogels. Sample curves are shown for specimens that displayed median 
terminal elongation for each type. 
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Table 1. Mechanical properties of hydrogels.  Collated data from tensile tests on cured and equilibrated hydrogels is compared with 
calculated ideal values for Affine and Phantom network models derived from Miller-Macosko theory using the experimentally 
determined sol fraction.  Error is standard deviation, n=4 for cured gels, n=6 for swollen gels. 
Hydrogel 
Type 
Shear Modulus 
(G) [kPa] 
Elastic Modulus 
(E) [kPa] 
Ideal Shear Moduli (Affine and 
Phantom Models) [kPa] 
Ultimate Tensile 
Strength [kPa] 
Terminal Extension 
Factor (λ) 
Cured (n=4) 50.98 ± 1.42 152.9 ± 2.5 382.1 and 127.4 66.8 ± 6.9 1.637 ± 0.067 
Equilibrated 
(n=6) 
63.26 ± 2.13 189.8 ± 3.7 456.2 and 152.1 141.7 ± 21.2 2.232 ± 0.220 
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Evaluation of drug delivery and tissue engineering applications in vitro 
Release of Methylprednisolone sodium succinate from the hydrogels 
The degradation constant for MPSS in PBS was determined as 5.98  0.50 x 10-3 hour-1 by 
exponential regression (R
2
 = 0.997, Fig. 11A).  By solution of ordinary differential equations for 
mass transfer and degradation, the degradation constants in the gel and mass transfer coefficients 
were calculated by regression (Fig. 11B).  The determined mass transfer coefficient was 1.54  
0.29 x 10
-4
 hour
-1
 while the degradation constant for MPSS in the gels was 3.12  0.10 x 10-3 
hour
-1
.  Using these two coefficients, the drug release was predicted for infinite sink conditions 
(Fig. 11C). 
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Figure 11. Controlled release of Methylprednisolone Sodium Succinnate (MPSS) from 
hydrogels in PBS (pH 7.4) at 37 ºC. A. Degradation of MPSS in PBS for three concentrations 
(0.125, 0.25 and 0.5 mg/ml). B. Release profile of MPSS from hydrogels for three concentrations 
(0.5, 1, 2 mg/ml).  Graph displays experimental data for the release into PBS, including 
degradation of MPSS. n=3 for each time point and concentration. C. Predicted drug release from 
the hydrogels into an infinite sink, corrected for degradation of MPSS in PBS.
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Cell adhesion mediated by peptide functionalization 
Functionalization of hydrogels by incorporation of an oligolysine peptide (Cys-(Lys)14-Cys) was 
performed to promote cell adhesion on the hydrogels (Fig. 12).  No cell attachment was observed 
for hydrogels with zero or 5 μg/mL Cys-(Lys)14-Cys.  Attachment and process extension of 
cultured murine mesenchymal stem cells was observed for hydrogels containing 50 μg/mL, with 
a similar conformation to cells in uncoated wells.  A concentration of 500 μg/mL caused the cells 
to adhere to the gel but form spherical conformations without process extension. 
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Figure 12. Functionalization of hydrogels to promote cell adhesion.  24 well polystyrene tissue 
culture plate was coated with 200 μL 25 wt.% thiol-acrylate hydrogels cured in 1XPBS (solvent 
exchanged to 1x DMEM medium just prior to testing) containing Cys-(Lys)14-Cys at different 
concentrations (A, B, C) or wells left untreated (D). Murine mesenchymal stem cells (mMSC) 
were seeded 10
5
 cells per well. 40x Phase 2 contrast light microscope images, 24 hours post-
seeding.  Hydrogels containing 50 μg/mL promotes mMSC adhesion and process extension. n=4 
for each group. 
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Discussion 
Thermodynamic considerations of ETTMP in PBS 
Successful preparation of the hydrogels was found to be dependent on the solubility of the 
ETTMP in the solvent, which was shown to have a non-linear dependence on concentration in 
PBS at 4 ºC (Fig. 2).  In unsuccessful attempts, precipitation of the polymer at 37C occurred 
during chemical reaction, resulting in incomplete conversion and a high sol fraction.  Assessing 
the stability of ETTMP in PBS when heated from 4 to 37 ºC provided a practically relevant 
indication of solubility throughout the gelation period at physiological temperature.  It is well 
understood that polymers containing ethylene glycol units exhibit a concentration dependent 
lower critical solution temperature (LCST) [31].  Visible light absorbance data of ETTMP in 
PBS during heating was fitted to an error function, where the inflection point signifies 50 percent 
precipitation.  Therefore, a characteristic error function was observed as the cumulative function 
when a lower critical solution temperature was reached and phase separation occurs [32]. The 
solubility of ETTMP in PBS appeared to be improved upon mixing with PEG-400-DA solution 
and was maintained throughout the complete gelation process as long as the mixture was 
maintained at 4 C for the initial five minutes.   
Physical chemistry of gelation mechanism 
Understanding the timeline of hydrogel formation was of critical importance for determining its 
practical use as an injectable biomedical material.  Dynamic rheological measurements was a 
convenient means of assessing the gelation kinetics of the hydrogel system and provided insight 
into the mechanism of gelation through the control of various gelation parameters such as pH, 
temperature and macromer stoichiometry [25, 33]. The characteristic hydrogel formation 
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response of the current system, as depicted in Figure 6, can be described by standard branch 
gelation theory developed by Flory and Stockmayer [27, 34].   
The data presented in Figure 7 provides support for a conjugate Michael addition reaction 
mechanism between a thiolate and the activated unsaturated carbon double-bond of the acrylate.  
The gelation time, or reaction rate, was linearly dependent on the concentration of protons and 
corresponding thiolate anions in solution.  While a pKa of 9.87 indicates that a small proportion 
of thiol groups in ETTMP are dissociated in pH 7.4 PBS, thiolate anions will continue to be 
produced under rapid equilibration with their rate of consumption according to Le Châtelier's 
principle.  The small variation in gelation time and physical properties with the inclusion of a 
radical inhibitor MEHQ in PBS indicated that a radical thiyl-acrylate reaction mechanism was 
not kinetically competitive with the addition mechanism.  This is advantageous in the 
minimization of transient free radical production in situ, compared to approaches using 
photoinitiators and UV light. 
Mechanical properties 
The PEG-400-DA/ETTMP hydrogel exhibited a de-swelling property during equilibration at 37 
ºC.  This can be attributed to the LCST of the PEG based precursors.  In addition, a relief of 
tension was observed, as the hydrogels were separated from the walls of their molds during 
removal, indicating residual tensile stress after curing.  This characteristic makes it a candidate 
material for applications where pressure exerted by hydrogel swelling may cause severe nerve 
damage [14-17]. 
Biomaterials often require a resorbable capacity in vivo following the completion of their desired 
function so as to minimize the extent of the induced foreign body response.  Poly(-hydroxy 
esters) have been incorporated into the PEG based system to increase the rate of hydrolytic 
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degradation [35].  The PEG-DA-400/ETTMP system contains ester bonds, allowing the material 
to resorb within an estimated 12-months in vitro.  However, the in vitro experiment does not 
account for many factors in vivo such as enzymatic and phagocytic activity as well as mechanical 
loading, which may increase the degradation rate.  Due to the hydrophilic nature of PEG, bulk 
degradation is the predominate mechanism [36].  The linear profile of the macroscopic 
degradation curve for the hydrogel as depicted in Figure 9, may be attributed to the net result of 
two competing processes, namely first order hydrolysis and crosslink density reduction, which is 
stochastic in nature [37]. 
The mechanical properties of biomaterials can influence the phenotype and activity of local and 
systemic cells, dictating foreign body and wound healing responses.  The developed hydrogel 
displays a modulus of elasticity of 189.8 kPa that is comparable, in magnitude, to a range of soft 
human tissues.  It is important to note that the material failed to obtain mechanical properties 
close to the affine or phantom values predicted by the Miller-Macosko model (Table 1).  This 
was attributed to a significant difference in the number of elastically active chains actually 
incorporated (11% of the initial chains, e = 0.021 mol L
-1
) compared to that the model 
prediction (82%, a = 0.15 mol L
-1
).  However, this is to be expected due to a number of factors 
such as low volume fraction of polymer during curing, the use of low molecular weight 
macromers and the possibility of intramolecular reactions, which may all contribute to non-ideal 
network formation. 
Sustained drug release 
MPSS is a glucocorticoid prodrug, with anti-inflammatory and immunosuppressant properties, 
that is currently a clinical treatment option for acute traumatic spinal cord injury [38].  However, 
high-dose intravenous administration immediately post-injury is being widely abandoned by 
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neurosurgeons due to complications associated with systemic immunosuppression, including 
increased risk of pneumonia and sepsis [39].  MPSS has a half-life of 109 hours in PBS at 37ºC.  
In aqueous media, the ester bond between the methylprednisolone and succinate hydrolyses, 
yielding free methylprednisolone (MP) which has limited solubility in PBS due to its 
hydrophobic nature.  MP was likely not detected by HPLC for this reason in drug release 
experiments.  In future experiments, it may be possible to measure MP by extraction with 
organic solvents.  The drug release experiment was modeled using a system of ordinary 
differential equations to include rates of mass transfer, proportional to the MPSS concentration 
difference between the hydrogel and the PBS, and drug degradation in both the hydrogel and 
PBS. Experimental data were fitted to the solutions to determine the mass transfer coefficient 
and degradation constants. The degradation rates of MPSS in the PBS and hydrogel were 
modeled separately in the differential equations to assess whether encapsulation had a stabilizing 
effect on the active life of the drug.  Regression analysis using the solution to the system of 
equations identified a lower degradation constant for MPSS in the hydrogel, suggesting that the 
material may create a protective environment that transiently impedes drug degradation.  To 
predict the actual release profile of methylprednisolone in vivo, the equations were modified for 
an infinite sink and resolved using the determined constants.  In reality, the sink conditions in 
vivo will deviate from this infinite sink approximation.  A more accurate mathematical 
description would need to consider further the spatial dimensions of the system, account for 
interstitial diffusion and convection, as well as make concession for receptor binding and other 
biological processes.  The hydrolysis of MPSS to MP once it has been released from the 
hydrogel is of little concern for local release systems as MP is the active form of the steroid and 
the limited aqueous solubility will not hinder activity.  A key feature of the MPSS release profile 
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from the current system is that the release time period is independent of the initial concentration 
in the hydrogel.  For biomedical applications, this means that the drug dosage could be tailored 
to individual patients without increasing the volume of the drug depot required to administer it 
locally over a precise period of time.   
Functionalization and cell adhesion 
Whilst PEG is generally favored in biomedical applications because of limited protein 
adsorption, this can result in limited interaction with cells.  To improve cell interactions, the 
hydrogel can be functionalized with peptides.  One advantage of the PEG-DA-400/ETTMP 
hydrogel is that it involves thiol chemistry, which can be exploited to attach almost any 
compound with a thiol group, including any peptide containing cysteine to promote a specific 
cell response.  Incorporation of an oligolysine peptide into the hydrogel promoted surface 
attachment of mMSCs in a concentration dependent manner in vitro.  Polylysine was chosen as 
an initial proof of concept as it generally promotes cell adhesion, and in fact is used to promote 
neural stem cell attachment to culture plates [40, 41].  Others have shown that cell attachment on 
PEG based hydrogels can also be achieved using short peptide sequences from extracellular 
matrix proteins [42, 43].  The current nanoscale mesh size of the hydrogel (~6.9 nm) was too 
small for cellular ingrowth into the material.  However, the small mesh size is advantageous for 
the characteristic de-swelling and drug release properties.   Furthermore, a small mesh size may 
be useful to isolate encapsulated cells from a host immune system to prevent rejection.  Recently, 
others have demonstrated incorporation of macroscopic pores or channels into similar hydrogels 
for cell ingrowth using sacrificial substrates of fibrin or poly(-hydroxy esters) [44, 45].  
However, utilizing these approaches would not preserve injectability.  Future work towards use 
of this hydrogel in regenerative medicine will therefore focus on the development of procedures 
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to create macroporous structures with controlled architecture in situ following injection and 
gelation. 
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Conclusion 
This paper presents the rational design of a hydrogel, seeking to address the engineering 
challenges associated with clinical translation of injectable in situ gelling biomaterials.  This 
poly(ethylene glycol) based hydrogel cross-linked in aqueous media via conjugate Michael 
addition reaction of thiol and acrylate groups, resulting in nearly complete conversion and 
minimal sol fraction.  By selecting low molecular weights macromer precursors with favorable 
solvent interactions the hydrogel exhibited syneresis under simulated physiological conditions in 
vitro.  The suitability of the material for sustained release of a hydrophilic small molecule drug, 
methylprednisolone sodium succinate, was demonstrated with high encapsulation efficiency and 
programmable dosage which facilitated release over a concentration independent timeline.  
Furthermore, incorporation of an oligolysine peptide promoted concentration dependent adhesion 
of murine mesenchymal stem cells in vitro. 
Doctoral Thesis A novel injectable thiol-acrylate poly(ethylene glycol) hydrogel 
Page 51 of 256 
Acknowledgements 
We thank Dr. Arthur J. Coury (Boston, MA) for reviewing the manuscript and engaging in 
discussions.  C.D.P. was supported by the MIT/CIMIT Medical Engineering Fellowship.  T.M.O 
was supported by the General Sir John Monash Award.  This research was sponsored by a gift to 
MIT by InVivo Therapeutics Corporation.  This research was sponsored by the Armed Forces 
Institute of Regenerative Medicine award number W81XWH-08-2-0034.  The U.S. Army 
Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the 
awarding and administering acquisition office.  The content of the manuscript does not 
necessarily reflect the position or the policy of the Government, and no official endorsement 
should be inferred. 
Doctoral Thesis A novel injectable thiol-acrylate poly(ethylene glycol) hydrogel 
Page 52 of 256 
Role of the funding source 
InVivo Therapeutics Corporation provided assistance determining the general design of this 
study to develop a novel injectable hydrogel. 
 
Doctoral Thesis A novel injectable thiol-acrylate poly(ethylene glycol) hydrogel 
Page 53 of 256 
References 
1. Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and 
applications. Biomaterials 2003;24(24):4337-4351. 
2. Lin C-C, Anseth K. PEG Hydrogels for the Controlled Release of Biomolecules in 
Regenerative Medicine. Pharm Res 2009;26(3):631-643. 
3. Slaughter BV, Khurshid SS, Omar ZF, Khademhosseini A, Peppas NA. Hydrogels in 
Regenerative Medicine. Adv Mater 2009;21(32-33):3307-3329. 
4. Chapman RG, Ostuni E, Liang MN, Meluleni G, Kim E, Yan L, et al. Polymeric Thin 
Films That Resist the Adsorption of Proteins and the Adhesion of Bacteria. Langmuir 
2001;17(4):1225-1233. 
5. Pathak CP, Sawhney AS, Hubbell JA. Rapid photopolymerization of immunoprotective 
gels in contact with cells and tissue. J Am Chem Soc 1992;114(21):8311-8312. 
6. Salinas CN, Anseth KS. Mixed Mode Thiol‚àíAcrylate Photopolymerizations for the 
Synthesis of PEG‚àíPeptide Hydrogels. Macromolecules 2008;41(16):6019-6026. 
7. Rydholm AE, Bowman CN, Anseth KS. Degradable thiol-acrylate photopolymers: 
polymerization and degradation behavior of an in situ forming biomaterial. Biomaterials 
2005;26(22):4495-4506. 
8. Lee TY, Roper TM, Jonsson ESn, Guymon CA, Hoyle CE. Thiol-Ene 
Photopolymerization Kinetics of Vinyl Acrylate/Multifunctional Thiol Mixtures. 
Macromolecules 2004;37(10):3606-3613. 
9. DeForest CA, Polizzotti BD, Anseth KS. Sequential click reactions for synthesizing and 
patterning three-dimensional cell microenvironments. Nat Mater 2009;8:659 - 664. 
10. Lutolf MP, Hubbell JA. Synthesis and Physicochemical Characterization of End-Linked 
Poly(ethylene glycol)-co-peptide Hydrogels Formed by Michael-Type Addition. 
Biomacromolecules 2003;4(3):713-722. 
11. Elbert DL, Pratt AB, Lutolf MP, Halstenberg S, Hubbell JA. Protein delivery from 
materials formed by self-selective conjugate addition reactions. J Control Release 
2001;76(1-2):11-25. 
12. Cushing MC, Anseth KS. MATERIALS SCIENCE: Hydrogel Cell Cultures. Science 
2007;316(5828):1133-1134. 
13. Sawhney AS, Pathak CP, Hubbell JA. Bioerodible hydrogels based on photopolymerized 
poly(ethylene glycol)-co-poly(.alpha.-hydroxy acid) diacrylate macromers. 
Macromolecules 1993;26(4):581-587. 
14. Thavarajah DM, De Lacy PM, Hussain RM, Redfern RMF. Postoperative Cervical Cord 
Compression Induced by Hydrogel (DuraSeal): A Possible Complication. Spine;35(1):E25-
E26. 
15. Blackburn Sl, Smyth MD. Hydrogel-induced cervicomedullary compression after posterior 
fossa decompression for Chiari malformation. J Neurosurg Pediatr 2007;106(4):302-304. 
Doctoral Thesis A novel injectable thiol-acrylate poly(ethylene glycol) hydrogel 
Page 54 of 256 
16. Roldan-Pallares M, del Castillo Sanz JL, Awad-El Susi S, Refojo MF. Long-term 
Complications of Silicone and Hydrogel Explants in Retinal Reattachment Surgery. Arch 
Ophthalmol 1999;117(2):197-201. 
17. Hwang KI, Lim JI. Hydrogel Exoplant Fragmentation 10 Years After Scleral Buckling 
Surgery. Arch Ophthalmol 1997;115(9):1205-1206. 
18. Bakshi A, Fisher O, Dagci T, Himes BT, Fischer I, Lowman A. Mechanically engineered 
hydrogel scaffolds for axonal growth and angiogenesis after transplantation in spinal cord 
injury. J Neurosurg Spine 2009;1(3):322-329. 
19. Pathak CP, Barman SP, Philbrook MC, Sawhney AS, Coury AJ, Avila LZ, et al. 
Multiblock biodegradable hydrogels for drug delivery and tissue treatment. US Patent No. 
0072961, 2001. 
20. Klimo P, Jr., Khalil A, Slotkin JR, Smith ER, Scott RM, Goumnerova LC. Wound 
Complications Associated With the Use of Bovine Serum Albumin-Glutaraldehyde 
Surgical Adhesive in Pediatric Patients. Neurosurgery 2007;60(4):305-309.  
21. Metters A, Hubbell J. Network Formation and Degradation Behavior of Hydrogels Formed 
by Michael-Type Addition Reactions. Biomacromolecules 2004;6(1):290-301. 
22. Lowe AB. Thiol-ene "click" reactions and recent applications in polymer and materials 
synthesis. Polym Chem 2010;1:17-36. 
23. Mather BD, Viswanathan K, Miller KM, Long TE. Michael addition reactions in 
macromolecular design for emerging technologies. Prog Polym Sci 2006;31(5):487-531. 
24. Smith MD. High-performance liquid chromatographic determination of hydrocortisone and 
methylprednisolone and their hemisuccinate esters in human serum. J Chromatogr B 
1979;164(2):129-137. 
25. Chambon F, Winter HH. Linear Viscoelasticity at the Gel Point of a Crosslinking PDMS 
with Imbalanced Stoichiometry. J Rheol 1987;31(8):683-697. 
26. Winter HH. Can the gel point of a cross-linking polymer be detected by the G' - G" 
crossover? Polym Eng Sci 1987;27(22):1698-1702. 
27. Flory PJ. Principles of polymer chemistry. Ithaca, N.Y.: Cornell University Press, 1953. 
28. Treloar LRG. The physics of rubber elasticity. 2d ed. Oxford,: Clarendon Press, 1958. 
29. Gnanou Y, Hild G, Rempp P. Molecular structure and elastic behavior of poly(ethylene 
oxide) networks swollen to equilibrium. Macromolecules 1987;20(7):1662-1671. 
30. Miller DR, Macosko CW. A New Derivation of Post Gel Properties of Network Polymers. 
Macromolecules 1976;9(2):206-211. 
31. Kjellander R, Florin E. Water structure and changes in thermal stability of the system 
poly(ethylene oxide)–water. J Chem Soc Farad T 1 1981;77(9). 
32. Barnes MD, Ng KC, Fukui K, Sumpter BG, Noid DW. Probing Phase-Separation Behavior 
in Polymer-Blend Microparticles: Effects of Particle Size and Polymer Mobility. 
Macromolecules 1999;32(21):7183-7189. 
Doctoral Thesis A novel injectable thiol-acrylate poly(ethylene glycol) hydrogel 
Page 55 of 256 
33. Chiou B-S, English RJ, Khan SA. Rheology and Photo-Cross-Linking of Thiol-ene 
Polymers. Macromolecules 1996;29(16):5368-5374. 
34. Stockmayer WH. Theory of Molecular Size Distribution and Gel Formation in Branched-
Chain Polymers. J Chem Phys 1943;11(2):45-55. 
35. West JL, Hubbell JA. Photopolymerized hydrogel materials for drug delivery applications. 
React Polym 1995;25(2-3):139-147. 
36. Sawhney AS, Pathak CP, Hubbell JA. Bioerodible hydrogels based on photopolymerized 
poly(ethylene glycol)-co-poly(α-hydroxy acid) diacrylate macromers. Macromolecules 
1993;26(4):581-587. 
37. Metters AT, Anseth KS, Bowman CN. Fundamental studies of a novel, biodegradable 
PEG-b-PLA hydrogel. Polymer 2000;41(11):3993-4004. 
38. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, et al. A 
randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute 
spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl 
J Med 1990;322(20):1405-1411. 
39. Hugenholtz H. Methylprednisolone for acute spinal cord injury: not a standard of care. C 
Med Assoc J 2003;168(9):1145-1146. 
40. Yavin E, Yavin Z. Attachment and culture of dissociated cells from rat embryo cerebral 
hemispheres on polylysine-coated surface. J Cell Biol 1974;62(2):540-546. 
41. Banker GA, Cowan WM. Rat hippocampal neurons in dispersed cell culture. Brain Res 
1977;126(3):397-425. 
42. Burdick JA, Anseth KS. Photoencapsulation of osteoblasts in injectable RGD-modified 
PEG hydrogels for bone tissue engineering. Biomaterials 2002;23(22):4315-4323. 
43. Lutolf MP, Lauer-Fields JL, Schmoekel HG, Metters AT, Weber FE, Fields GB, et al. 
Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue 
regeneration: Engineering cell-invasion characteristics. P Natl Acad Sci USA 
2003;100(9):5413-5418. 
44. Ford MC, Bertram JP, Hynes SR, Michaud M, Li Q, Young M, et al. A macroporous 
hydrogel for the coculture of neural progenitor and endothelial cells to form functional 
vascular networks invivo. P Natl Acad Sci USA 2006;103(8):2512-2517. 
45. Namba RM, Cole AA, Bjugstad KB, Mahoney MJ. Development of porous PEG hydrogels 
that enable efficient, uniform cell-seeding and permit early neural process extension. Acta 
Biomater 2009;5(6):1884-1897. 
 
Doctoral Thesis Establishing a model SCI in the African green monkey 
Page 56 of 256 
II.  
Establishing a model spinal cord injury in the African green 
monkey for the preclinical evaluation of biodegradable 
polymer scaffolds seeded with human neural stem cells 
Christopher D Pritchard (1), Jonathan R Slotkin (2), Dou Yu (3), Haining Dai (4), Matthew S 
Lawrence (5), Roderick T Bronson (6), Francis M Reynolds (7), Yang D Teng (3), Eric J 
Woodard (8), Robert S Langer (1) 
 
(1) Department of Chemical Engineering 
Massachusetts Institute of Technology, Cambridge, MA 02139 
(2) Department of Neurosurgery 
The Washington Brain and Spine Institute, Washington, DC 20010 
(3) Department of Neurosurgery 
Brigham and Women’s Hospital, Boston, MA 
(4) Department of Neuroscience 
Georgetown University Medical Center, Washington, DC 
(5) RxGen, Inc., Hamden, CT 
(6) 6 Department of Pathology 
Harvard Medical School, Boston, MA 
(7) InVivo Therapeutics Corporation 
Cambridge, MA 02141 
(8) Department of Neurosurgery 
New England Baptist Hospital, Cambridge, MA 02120 
 
Reprinted with permissions from Elsevier: J Neurosci Methods. 2010 May 15;188(2):258-69. 
Doctoral Thesis Establishing a model SCI in the African green monkey 
Page 57 of 256 
Abstract 
Given the involvement of post-mitotic neurons, long axonal tracts and incompletely elucidated 
injury and repair pathways, spinal cord injury (SCI) presents a particular challenge for the 
creation of preclinical models to robustly evaluate longitudinal changes in neuromotor function 
in the setting in the presence and absence of intervention.  Whilst rodent models exhibit high 
degrees of spontaneous recovery from SCI injury, animal care concerns preclude complete cord 
transsections in nonhuman primates and other larger vertebrate models.  To overcome such 
limitations a segmental thoracic (T9-T10) spinal cord hemisection was created and characterized 
in the African green monkey.  Physiological tolerance of the model permitted behavioral 
analyses for a prolonged period post-injury, extending to predefined study termination points at 
which histological and immunohistochemical analyses were performed.  Four monkeys were 
evaluated (one receiving no implant at the lesion site, one receiving a poly(lactide-co-glycolide) 
(PLGA) scaffold, and two receiving PLGA scaffolds seeded with human neural stem cells 
(hNSC)).  All subjects exhibited Brown-Séquard syndrome two days post-injury consisting of 
ipsilateral hindlimb paralysis and contralateral hindlimb hypesthesia with preservation of bowel 
and bladder function.  A 20-point observational behavioral scoring system allowed quantitative 
characterization of the levels of functional recovery.  Histological endpoints including silver 
degenerative staining and Iba1 immunohistochemistry, for microglial and macrophage 
activation, were determined to reliably define lesion extent and correlate with neurobehavioral 
data, and justify invasive telemetered electromyographic and kinematic studies to more 
definitively address efficacy and mechanism. 
Doctoral Thesis Establishing a model SCI in the African green monkey 
Page 58 of 256 
Introduction 
Spinal cord injury (SCI) results from penetrating or compressive traumatic injury to the spine or 
from compressive lesions associated with neoplastic growth or vertebral dislocation.  Neuronal 
injury and recovery is critically guided and impacted by the surrounding cells and extracellular 
environment within the spinal cord and adjacent tissues, reducing the utility of in vitro assays, 
and necessitating the study of injury mechanisms and spinal cord physiology in in vivo vertebrate 
models (Feringa et al., 1975; Hall and Springer, 2004; Jones et al., 2005; Liverman et al., 2005; 
Thuret et al, 2006; Baptiste and Fehlings, 2007; Rossignol et al. 2007).  A recent review of data 
derived from the extensive literature related to the modeling of SCI to better understand 
mechanisms of injury and repair has highlighted the greater relevance and utility of nonhuman 
primate models relative to rodents and other vertebrate species in the preclinical investigation of 
therapeutic interventions (Courtine et al., 2007).  Rodents may over-predict the efficacy of 
interventions given high rates of spontaneous recovery from induced spinal cord injury, even 
following profound lesions.  The spinal cord anatomy and physiology of old world monkeys are 
more similar to humans, particularly with respect to the position and function of corticospinal 
tracts (Courtine et al., 2007).  This permits a more critical evaluation of results from preclinical 
studies, facilitating translation to humans.  Here we report the development of a surgical model 
of acute SCI in the African green monkey (chlorocebus sabaeus) for the evaluation of 
biomaterial implants as a translational interval between rodent and clinical investigations. 
Poly(lactide-co-glycolide) (PLGA) biocompatible and biodegradable porous scaffolds seeded 
with neural stem cells (NSC) have demonstrated potential as a strategy for the treatment of 
central nervous system lesions (Flax et al., 1998; Park et al., 2002).  A PLGA scaffold seeded 
with murine NSC (mNSC) promoted long-term functional improvements in an adult rat 
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hemisection model of SCI as compared to controls (Teng et al., 2002).  70 days post-injury, 
treated animals exhibited coordinated, weight-bearing hindlimb stepping.  Histological and 
immunocytochemical analysis suggested the recovery may have been associated with a reduction 
in tissue loss, possibly resulting from modulation of secondary injury mechanisms and reduced 
astrogliosis. 
To establish an SCI model in which this possibility might be critically evaluated, a lateral 
hemisection at level T9-10 in the thoracic spine was created in the monkey, with removal of the 
ipsilateral T9-T10 segment.  This approach bears some similarity to previously published 
models, where ipsilateral tracts were transected without removal of a full segment or only 
particular tracts (lateral corticospinal efferents, dorsal funiculus afferents) were targeted (Crowe 
et al., 1997; Babu et al., 2000; Edgerton et al., 2004).  The lesion was designed to result in 
Brown-Séquard syndrome, characterized in humans at comparable cord levels by paralysis of the 
ispilateral leg, loss of ipsilateral muscle tone in the lower abdomen (innervated by T9-L1), loss 
of vibration and position sensation in the ipsilateral hindlimb, loss of thermal and mechanical 
pain sensation in the contralateral leg, lumbar and sacral dermatomes and ipsilateral lower 
thoracic dermatomes, and spastic paresis in the ipsilateral leg resulting in increased knee and 
ankle jerk reflexes with retention of monosynaptic reflexes involving the lower motor neurons 
(Brown-Séquard, 1851).  Importantly, a unilateral restriction of the lesion was implemented with 
the additional aim of sparing bladder function and anal muscle tone by allowing compensatory 
innervation by retained contralateral corticospinal efferents.  Evaluation of loss and recovery of 
these multiple lower extremity functions may permit objective measures of the efficacy of the 
therapeutic intervention with minimal post-operative complications. 
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In addition to establishing methodologies for the generation of a discrete unilateral cord lesion 
designed to minimize special animal care requirements, behavioral and histological endpoints 
were evaluated for their utility in differentiating treatment outcomes.   Neuromotor and 
histopathological endpoints were assessed across multiple time points following introduction of a 
PLGA scaffold, PLGA scaffold seeded with hNSC, or no implant. 
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Materials and methods 
Hemisection model 
Four juvenile male African Green monkeys ranging in weight from 2.3 to 2.7 kg were employed 
in the study.  Subjects were between 1.8 to 2.0 years old.  Baseline clinical and neurological 
exams confirmed good health and suitability for study enrollment.  Treatment allocation was 
performed arbitrarily with respect to weight.  All experimental and surgical procedures were 
carried out in accordance with the Guide for the Care and Use of Laboratory Animals (National 
Academy Press, revised 1996) and the Institutional Animal Care and Use Committee (IACUC) 
of the St. Kitts Biomedical Research Foundation, where the study was conducted. 
To perform the hemisection lesion, monkeys were sedated with ketamine/xylazine i.m., and kept 
on a 0.9% saline drip.  Isoflourane anesthesia was applied with depth of anesthesia monitored 
throughout the study. Deep-dermal or subcutaneous bleeding was controlled using electrocautery 
following skin incision.  The laminectomy was performed by an en-bloc, lateral lamina cut 
method.  Following bone removal, the dural opening was performed with a #15 surgical blade.  
Dural edges were tacked to the surrounding ligaments or musculature with 4.0 non-absorbable 
sutures.  The midline of the spinal cord was carefully assessed with the visualization of anatomic 
landmarks.  At all times, spinal cord veins and surface vessels were spared unless it was 
absolutely necessary that they be controlled.  The segmental hemisection lesion was 
microscopically performed with the use of microneurosurgical dissection instruments and micro-
suction aspiration. A transverse incision extending to the midline was made at the caudal point of 
the intersection of the T9 dorsal root with the cord and at the rostral point of the intersection of 
the T10 dorsal root with the cord, followed by a midline incision extending between those levels.  
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Hemi-cord parenchyma resection to these defined boundaries ensured complete transection to the 
anatomic midline in a lesion extending 10mm in length, without damage to the contralateral 
hemi-cord.  At this point in the procedure, if designated, a scaffold was implanted (Figure 1). 
The scaffold was sized to fill the hemisection cavity, without exerting pressure on the 
surrounding host tissue during or following insertion.  When this process was complete, the dural 
tack-up sutures were removed, and the dura was closed with a 4.0 non-absorbable single running 
suture.  Fibrin tissue sealant was applied to the dural suture line.  The fascia was then closed with 
interrupted 3.0 absorbable sutures. After this layer was closed, the subcutaneous layers were re-
approximated with 3.0 absorbable sutures. Then, the deep dermal layer was brought together 
with interrupted 3.0 absorbable sutures. After successful extubation and recovery from 
anesthesia, a neurologic examination was performed.  Vital signs were monitored in a manner 
consistent with standard human post-anesthesia care.  Following recovery from anesthesia the 
monkeys were returned to their cage with a mattress placed on the floor to minimize pressure 
sore risk.  Monkeys were observed twice daily to assess skin integrity and exclude the possibility 
of autophagy, which can be observed in the setting of limb denervation.  All monkeys 
additionally received a pre and postoperative course of immunosuppressants, consisting of 
cyclosporine (0.6 mg/kg), prednisolone (0.3 mg/kg) and azathioprine (0.5 mg/kg) i.m. BID 
starting 3 days before implantation and continuing until sacrifice to prevent hNSC rejection.  
Though this immunosuppressant regimen had been previously established to be well tolerated, 
additional attention and vigilance was maintained to prevent opportunistic infections. 
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Figure 1. Photograph through surgical microscope of scaffold implanted into T9-T10 
hemisection lesion. Arrow indicated scaffold position. Scale bar = 10 mm. 
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Neuromotor video recordings 
Video recordings of quadrupedal locomotion were generated for qualitative and quantitative 
assessment of gait and posture deficiencies associated with motor impairment of the ipsilateral 
hindlimb.  To document locomotion, the monkeys were placed in an 8 by 2.5 by 2 foot 
ambulation chamber.  One long side of the chamber was made of Plexiglas
TM
 to allow 
visualization of the monkey as it navigated the enclosure.  Movements were recorded by video 
continuously for a four-minute period with the entire width of the enclosure captured in the 
camera’s field of view under optimized illumination.  At the end of the four-minute video 
segment a food reward was introduced to the chamber through an aperture in the ceiling to 
promote and document upright standing, after which another 4 minutes of close-up video of the 
monkey was obtained.  Video sessions were conducted prior to surgery, postoperative days 2, 3, 
4, 6 and 10 and then weekly for 6 weeks and prior to sacrifice. 
Video data were reviewed and rated by a blinded reviewer, not involved in the in vivo execution 
of the study.  Ratings for each video session were based on review of the combined four-minute 
video segments collected during the wide field and close-up recordings.  Ratings generated an 
overall observational neuromotor score for the ipsilateral and contralateral hindlimbs (Table 1).  
The rating scale incorporates the components derived from the spectrum of behaviors and 
motions observed in healthy African green monkeys and was based on previously established 
methods for observational scoring (Basso et al., 1996; Babu et al., 2000). 
Doctoral Thesis Establishing a model SCI in the African green monkey 
Page 65 of 256 
Table 1. Ambulation chamber video observational neuromotor score. 
Scale Description 
0 no voluntary function 
1 slight one or two joints movement 
2 active one or two joints, slight movement others 
3 active movement of all three joints, no weight bearing 
4 slight weight bearing, consistent dorsal stepping (no plantar stepping) 
5 slight weight bearing, occasional plantar stepping 
6 frequent plantar stepping, occasional weight bearing, hops with partial weight support 
7 frequent plantar stepping and weight bearing, occasional FL-HL coordination, 
8 consistent plantar stepping and partial weight supported steps, occasional FL-HL coordination 
9 frequent partial weight supported steps, occasional FL-HL coordination 
10 
occasional partial weight supported steps, frequent foot drop and/or drag, run with partial 
weight support 
11 occasional partial weight supported steps, frequent FL-HL coordination 
12 
slight partial weight supported steps, frequent FL-HL coordination,stands up HL with partial 
weight support 
13 
slight partial weight supported steps, consistent FL-HL coordination, frequent foot drop and/or 
drag 
14 
full weight supported steps and consistent FL-HL coordination, occasional foot drop and/or 
drag 
15 occasional foot drop and/or drag, stand up HL with full weight support 
16 slight foot drop and/or drag, no toe clearance 
17 no foot drop and/or drag, no toe clearance 
18 occasional toe clearance 
19 frequent toe clearance 
20 normal 
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Histology & immunohistochemistry 
On the study day indicated in Table 2, the monkeys were euthanized with intravenous sodium 
pentobarbital followed by whole body perfusion fixation with 4% paraformaldehyde.  Animals 
were examined carefully for external abnormalities including hair loss or decubitus ulcers at 
bony prominences, palpable masses, and abnormalities in the abdominal, thoracic, and cranial 
cavities.  The sciatic nerves, spinal cord and brain were dissected en masse and fixed overnight 
in 4% paraformaldehyde, following which specimens were transferred to phosphate buffered 
saline. 
The fixed tissue was treated overnight with 20 % glycerol and 2 % dimethylsulfoxide and 
embedded in a gelatin matrix using MultiBrain
TM
 (NeuroScience Associates, Knoxville, TN).  
After curing in weak formaldehyde solution, the block was rapidly frozen by immersion in 2-
methyl butane chilled to -70 °C with crushed dry ice and mounted on an A860 sliding 
microtome.  The block was sectioned to generate alternating 40 µm sagittal and coronal sections 
spanning the lesion site as well as cervical, thoracic and lumbar regions rostral and caudal to the 
lesion.  For each stain, every 24
th
 section at 720 µm intervals was mounted and processed, 
yielding approximately 20 individual sections mounted on 10 slides.  For ionized calcium-
binding adapter molecule (Iba1) staining, sections were stained free-floating.  Sections were 
treated with hydrogen peroxide and blocking serum, and immunostained with a 1:15,000 dilution 
of primary polyclonal rabbit anti-Iba1 antibody (#01973, WAKO, wakousa.com), a goat anti-
rabbit secondary antibody, and an avidin-biotin-HRP complex (Vectastain ABC kit, Vector, 
Burlingame, CA).  Incubation times were 24 hours (4 °C) for the primary antibody, 30 minutes 
(room temperature) for the secondary antibody, and 1 hour (room temperature) for the avidin-
biotin-HRP complex.  Sections were subsequently treated with diaminobenzidine 
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tetrahydrochloride (DAB) and mounted on gelatinized (subbed) glass slides.  Amino cupric 
silver staining was performed as described previously (de Olmos et al., 1994). 
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Table 2. Study animal summary. 
Monkey 
Weight 
(kg) 
Sex 
Treatment 
group 
Surgery 
date 
Sacrifice 
date 
Sacrifice 
day 
Y464 2.80 M Scaffold alone 4/19/08 7/11/08 83 
X992 2.74 M Scaffold+hNSC 4/19/08 5/29/08 40 
Y156 2.34 M Control 4/20/08 8/8/08 111 
Y430 2.79 M Scaffold+hNSC 4/20/08 7/11/08 82 
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Adobe Photoshop Creative Suite 4 Extended was used for cord image compilation and analysis. 
For each cord, the original 8-10 microscopic images of the sections containing the lesions were 
consolidated using Photomerge in the reposition layout, shown in Figure 9. Guidelines for cord 
lengths and widths were formulated using the straight line tool, and their pixel measurements 
were taken using Ruler tool. For lesion areas, original cord border was approximated with the 
outline of the spared portion as a reference with the help of the magnetic lasso under 10% 
contrast settings and the brush. Area measurements with square pixel units were taken using the 
magnetic lasso and record measurements with area data points. 
Due to the curvature of both X992 and Y156, the cord images were straightened out to obtain 
more realistic data for quantification of lesion dimensions. While keeping cord width constant 
between the original and modified images, warp was used to straighten out the image and 
prepare it for measurements. 
All data was converted from pixel units to metric units using measurements recorded from the 
original cord samples. Cord widths were then normalized to 6 mm for all samples, to enable 
comparison and remove histological artifact.  Linear and area dimensions were adjusted 
accordingly and summarized in Table 3. 
Poly(lactide-co-glycolide) implants 
Poly(lactide-co-glycolide) (PLGA) polymer porous scaffolds were prepared in a similar manner 
to previously published protocols (Mikos et al., 1992; Lavik et al., 2002; Teng et al., 2002).  The 
implant was sized to precisely fit the spinal cord cavity, created by the segmental hemisection 
surgical resection.  The size of the lesion was determined prior to live surgery by measurement 
of the spinal cord of a cadaver African Green monkey, of similar weight to the enrolled subjects.  
The ratio of lactic to glycolic acids units in the PLGA was chosen in order for the scaffold to 
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degrade over a period of four to eight weeks in vivo (Sung et al., 2004).  PLGA with a 
lactide/glycolide ratio of 50:50 and intrinsic viscosity 0.55-0.75 dL/g was obtained from Lactel 
(Durect, Pelham, AL).  Thin polymer foams were fabricated by solvent casting/particulate 
leaching. PLGA was dissolved in chloroform (Sigma, St. Louis, MO) to obtain a 5 % wt./vol. 
stock solution. The stock solution was mixed with sodium chloride (particle size 180-450 µm by 
sieving; Sigma) in a 1:1.67 ratio (3 mL / 5 g) and poured into a 5.5 cm diameter Teflon
TM
 mold. 
After chloroform was evaporated in a fume hood for 48 hours, the salt particles were leached out 
by immersion in distilled water for 48 hours at room temperature. The water was changed every 
4-8 hours during the leaching period.  Subsequently, PLGA foam disks were dried on blotting 
paper and lyophilized overnight to remove residual water.  The process yielded highly porous 
foam with a thickness of 1 mm. The foams were cut into segments (5 cm by 2 cm) with a 
surgical razor blade (VWR, West Chester, PA) and stored in 50 mL polypropylene Falcon test 
tubes (BD Biosciences, San Jose, CA) in a secondary container over anhydrous calcium sulfate 
(Drierite, Xenia, OH) at -20 °C until use. 
Cell seeding on poly(lactide-co-glyolide) scaffolds 
Scaffolds were trimmed to 5 mm by 12 mm by 1 mm, prior to seeding.  As PLGA is 
hydrophobic, the scaffolds were immersed in 70% ethanol for 30 minutes on an orbital shaker at 
room temperature (Daigger, Vernon Hills, IL), for the purpose of removing air inside the pores, 
sterilizing the accessible surface for cell attachment, and pre-wetting the scaffolds prior to 
immersion in aqueous media (Mikos et al., 1992).  The excess ethanol was then removed and the 
scaffolds were washed 3 times for 10 minutes in sterile phosphate buffered saline (PBS, pH 7.4, 
Invitrogen, Carlsbad, CA) solutions and transferred individually to sterile 2 mL Eppendorf™ 
centrifuge tubes (Daigger) containing 1.5 mL sterile PBS solutions with extracellular matrix 
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(ECM) adhesion molecules (10 µg/mL): poly-D-lysine (Sigma, St Louis, MO), laminin (BD 
Biosciences, San Jose, CA), and fibronectin (Sigma, St Louis, MO).  Scaffolds were left 
overnight on a sterilized orbital shaker platform to ensure sufficient adsorption of the adhesion 
proteins on the accessible scaffold surface, as well as full hydration inside the scaffold pores.  
The following day, supernatant was removed, and the scaffolds were transferred to a 6 well 
culture plate (Falcon
TM
, BD Biosciences, San Jose, CA), followed by two 5 minute rinses in 
fresh Neurobasal
TM
 medium (with B27-A supplement, Invitrogen, Carlsbad, CA) on an orbital 
shaker (45 rpm). 
Human neural stem cells (hNSC, clone HFB2050) were maintained in Falcon
TM
 culture flasks in 
modified Neurobasal
TM 
cell culture medium (with B27 supplements, antibiotics, heparin, and L-
glutamine) in a humid incubator (37 °C, 5% CO2) (Flax et al., 1998).  Prior to seeding, cells were 
lifted from the flasks using Accutase
TM
 (Innovative Cell Technologies, San Diego, CA), and 
concentrated to 5x10
5
 per mL to 1x10
6
 per mL via a series of centrifugation, cell counting, and 
re-suspension in fresh medium.  The first time the scaffolds were seeded with hNSC is 
considered an acclimation seeding.  For the acclimation seeding, 2 mL of 5x10
5
 per mL hNSC 
were used in each well in a 6 well plate.  The plates were gently rotated in a sterilized humid 
chamber on an orbital shaker at 37 °C for 30 minutes (40 rpm).  For subsequent cell seedings, 2 
mL of 1x10
6
 per mL hNSC were used. Following the rotations, 3 mL of fresh modified 
Neurobasal
TM
 medium were added to each well, and growth factors (20 ng/mL, basic fibroblast 
growth factor, bFGF, Calbiochem, San Diego, CA; 10 ng/mL, leukemia inhibitory factor, LIF, 
Chemicon, Temecula, CA; 20 ng/mL, epidermal growth factor, EGF, Invitrogen, Carlsbad, CA), 
and the plates were maintained in the incubator.  The plates were observed under sterilized light 
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microscope twice daily, and 2.5 mL of the 5 mL total culture medium in each well was replaced 
with fresh medium and new growth factors every 3 days.  The seedings were repeated at total of 
4 times (including the acclimation seeding) with an average interval of 1 week in between each 
seeding.  Films of PLGA approximately 200 microns thick were sterilized in 70% ethanol and 
maintained in serum containing medium for one week. 
At the end of the scaffold seeding period, light-field microscopy was carried out on scaffolds in 
the culture plates, and images of attached hNSC inside the scaffold pores were captured using an 
AxioCam
TM
 MRc on an AxioVert
TM
 S100 inverted microscope (Carl Zeiss Microimaging, 
Thornwood, NY).  Representative scaffolds were then fixed in 4% paraformaldehyde at 4 °C 
overnight (on the same day as the surgeries were carried out using scaffolds from the same 
seeding wells), cryoprotected in 30% sucrose solution, embedded in OCT
TM
 compound (Sakura 
Finetek, Torrance, CA), and cut into 20 µm thick serial sections for immunocytochemical (ICC) 
analysis. The scaffolds were oriented in the embedding compound in such a way that the sections 
are across the width (5 mm side) of the scaffold. 
Microslides with scaffold sections were coverslipped with Fluorescent Mounting Medium with 
DAPI (Vector Labs, Burlingame, CA), and fluorescent images were captured via an AxioCam
TM
 
MRm on an AxioVert
TM
 S100 inverted microscope (Carl Zeiss Microimaging) with a DAPI-
specific color filter.  Montage images of the entire cross section were created from multiple shots 
at 10 x magnification, which show clear identification of the nucleus of each attached hNSC.  
Occasionally, higher magnification images were captured in areas where too many cells cluster.  
The images were then printed inverted with high resolution so that each nucleus appears as a 
black dot.  The total numbers of nuclei stained in each cross section were counted, and sections 
from the ends and the center of the scaffolds were used for this practice.  The average cell 
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numbers (n) in each cross section (20µm) were used to estimate the total number (N) of hNSC 
seeded in each scaffold (N = n x scaffold length / 20µm). The cell nucleus counting follows the 
principle of conservative counting, by which only the clearly distinguishable nuclei were 
counted.  Given the fact that some cells are washed off during the staining process, and some 
nuclei were not visible if they were behind others, the total N estimates derived from this 
counting method represent a somewhat deflated version of the true cell numbers.  
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Results 
Implants 
The implant was designed as a porous PLGA scaffold to support seeded hNSC and permit in-
growth of endogenous cells in vivo, as well as facilitating nutrient and waste transport.  The 
pores were approximately 300 microns in diameter (Figure 2).  To facilitate cell seeding, cells 
were seeded on scaffold layers, 1 millimeter in thickness, which were subsequently sutured 
together with an outer layer to yield a three-dimensional hemi-cylindrical structure (Figure 3).  
The outer layer of the implant was designed to emulate the spinal cord dura, to inhibit infiltration 
of meningeal cells into the scaffold in case the dura was not completely resealed post-surgery.  
The outer layer consisted of a solid PLGA sheet, approximately 200 microns in thickness. 
The seeding protocol lead to scaffolds with hNSC attached to the outer surface, as well as the 
inner walls of the pores inside the scaffolds (Figure 4). Based on 6 sections from 2 scaffolds, the 
average number of hNSC attached in each 20 µm scaffold section n=4922, which translates to 
approximately 2.5 million hNSC in a 10 mm x 5 mm x 1mm scaffold.  Therefore, there were an 
estimated 5 million hNSC on assembled scaffolds. 
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Figure 2. Scanning electron microscope image of scaffold architecture. 
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Figure 3. Composite scaffold design. 
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Figure 4. Seeding of hNSC on PLGA scaffolds. A: Microscope image of Toluidine Blue 
staining of a cross section of a PLGA scaffold seeded with hNSCs (purple dots). B: Montage of 
multiple microscope images of the different areas of the same scaffold cross section; inverted 
greyscale image of DAPI fluorescence (black dots are hNSC nuclei stained for DAPI). Scale bar 
= 500 microns. 
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Neuromotor outcomes 
Monkeys were enrolled in the study according to the treatment schedule indicated in Table 2.  
The spinal cord hemisection procedure and placement of the scaffold or scaffold seeded with 
hNSC (scaffold+hNSC) was well tolerated in all subjects.  Throughout the duration of the study 
the monkeys remained in good health. The T9-T10 hemisection resulted in Brown-Séquard 
syndrome with paralysis of the ispilateral leg, slight reduction in ipsilateral muscle tone in the 
lower abdomen, loss of pain sensation in the contralateral leg, and spastic paresis in the 
ipsilateral leg with increased knee and ankle jerk reflexes.  There was a preservation of bladder 
and bowel tone, including in the acute setting, and no evidence of joint contractures in the paretic 
limb.  Induced neuromotor deficits were observed in the immediate post-operative setting.  One 
monkey (Y430) developed a sore on the dorsal surface of the ipsilateral (left) foot two weeks 
post-injury, as a result of loss of dorsiflexion.  The wound improved with routine wound care. 
Video recordings of quadrupedal locomotion and object retrieval in the ambulation chamber 
permitted an assessment of gait and posture deficits and improvements over time.  Application 
by a trained observer of the specified video scoring procedure (Table 1) to recorded video 
segments provided a reproducible measure of leg, foot and toe positioning and movements, 
postural changes and overall neuromotor changes.  Changes in the video based neuromotor score 
were defined for the in the ipsilateral (left) and contralateral (right) side of each monkey (Figure 
5). 
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Figure 5. Temporal profile of functional recovery post-injury. A: Video neuromotor scores in 
ipsilateral (left) hindlimb. B:. Video neuromotor scores in contralateral (right) hindlimb. 
Designations are as follows: Scaffold+hNSC: mean and standard deviation for Y430 and X992; 
n=2 except for day 1 and day 44 where n=1 due to sacrifice of X992 at 40 days post-injury.  
Scaffold alone: Y464.  Control (no treatment): Y156. 
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Histopathology and Immunohistochemistry 
Hematoxylin and eosin (H&E) stained cross-sections in the thoracic region rostral and caudal to 
the injury center were examined, showing clear anatomic evidence for the observed Brown-
Séquard syndrome in all subjects.  In rostral sections, there was severe degeneration of ipsilateral 
dorsal funiculus afferent tracts, as confirmed by the presence of swollen axons, necrosis and 
lymphocyte and macrophage invasion.  Severe ipsilateral degeneration of lateral and ventral 
corticospinal tract efferents was also observed.  In caudal sections, there was bilateral 
preservation of dorsal funiculi afferents.  The degree of lymphocyte recruitment to afferent and 
efferent tracts, rostral and caudal to the injury site respectively, varied between subjects.   
H&E staining revealed small amounts persisting polymer debris in the scaffold+hNSC subject 
sacrificed at 40 days post-injury (Figure 6 A, B).  There was minimal evidence of persisting 
polymer in the scaffold+hNSC sacrificed at 82 days post-injury, suggesting complete 
degradation and clearance of the scaffold within this time frame in vivo (Figure 6 C, D). 
H&E staining revealed evidence of fibrous matter around the lesion in two subjects, namely the 
scaffold treated subject sacrificed at 83 days post-injury (Y464) and the scaffold+hNSC treated 
subject sacrificed at 82 days post-injury (Y430).  This was observed as birefringence using a 
polarizing filter under an optical microscope, often an indication of collagen deposition.  It is 
possible that, in these subjects, the resealed dura did not remain completely intact following 
surgery, permitting infiltration of fibroblasts into the injury site.  As the influx of meningeal cells 
could play a significant role in the pathological profile of the lesion, the consistency of dural 
integrity is important across subjects in the development of a central nervous system injury 
model. 
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H&E staining also revealed lines of hemocynanin deposition, demarking severed blood vessels 
within the spinal cord.  Blood flowing under pressure from severed blood vessels, in particular 
arterial vessels, is a possible source of mechanical insult to nervous system tissue surrounding 
the lesion.  In addition, damaged blood vessels result in local ischemia.  The presence of 
multinucleated giant cells around the lesion site was observed in all subjects, and it is unclear to 
what extent, if at all, these were specifically present in response to foreign polymer materials and 
allogeneic hNSC. 
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Figure 6. Hematoxylin and eosin staining of lesion margins. A-B: Rostral (A) and caudal (B) 
lesion margins of scaffold+hNSC treated animal 40 days post-injury (X992). Arrows indicate 
preserved polymer matrix. C-D: Rostral (C) and caudal (D) lesion margins of scaffold+hNSC 
treated animal 82 days post-injury (Y430). There was no appreciated polymer matrix, indicating 
substantial degradation and clearance of the scaffold within 82 days in vivo. Glial cell 
proliferation and mononuclear cell infiltration adjacent to the lesion margin is visible in both 
subjects (A-D). Magnification = 40x. 
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Silver degenerative staining of cross-sections rostral and caudal to the lesion provided an 
indication of the extent of axonal disruption.  The lesions remained unilateral in the lateral 
regions, with severe degeneration of ipsilateral lateral corticospinal tract (CST) efferents (Figure 
7).  Some degree of variability between subjects exists at the midline in dorsal funiculus afferents 
(Figure 8 A, C, E, G).  In all animals, longitudinal sections through the lesion site showed clear 
evidence that, at the time of analysis, the lesion had crossed the cord midline, resulting in loss of 
grey matter on the contralateral side (Figure 9), further studied by quantification of lesion 
dimensions (Table 3).  Axonal damage was observed both ipsilaterally and contralaterally in 
ventral-medial tracts (Figure 10).  The small sample size, however, was not intended to 
distinguish the degree to which these differences were due to variations in the surgical lesion and 
individual responses to trauma compared to secondary injury and wound healing processes that 
may hypothetically be influenced by implantation of scaffolds and hNSC (Teng et al., 2002). 
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Figure 7. Silver staining for axonal degeneration of lateral corticospinal tracts (CST) in thoracic 
cross-sections caudal to the injury site. A-B: Ipsilateral (A) and contralateral (B) images of 
control subject 111 days post-injury. C-D: Ipsilateral (C) and contralateral (D) images of 
scaffold treated subject 83 days post-injury. E-H: Ipsilateral (E, G) and contralateral (F, H) 
images of scaffold+hNSC treated subjects 40 (E, F) and 82 (G, H) days post-injury. The lesion 
is unilateral with respect to degeneration of axons in the CST. Dors = dorsal. Vent = ventral. 
Magnification = 10x. 
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Figure 8. Silver staining and Iba1 staining of the dorsal funiculus in thoracic cross-sections 
rostral to the injury site. A-B: Silver (A) and Iba1 (B) staining of control subject 111 days post-
injury. The lesion crosses the midline slightly in the control subject in the dorsal funiculus. C-D: 
Silver (C) and Iba1 (D) staining of scaffold treated subject 83 days post-injury. The images show 
total bilateral damage to the dorsal funiculus in the scaffold treated subject. E-H: Silver (E, G) 
and Iba1 (F, H) staining of scaffold+hNSC treated subjects 40 (E, F) and 82 (G, H) days post-
injury. The lesion is predominately unilateral, with some axonal degeneration of contralateral 
dorsal funiculus afferents with spatially correlating microglial and macrophage activation. Dors 
= dorsal. Vent = ventral. Magnification = 10x. 
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Figure 9. Silver staining for axonal degeneration of in thoracic sagittal sections through the 
hemisection lesions. Sections shown are closest to the middle of the cord in the rostral-caudal 
direction. A: Control subject 111 days post-injury. B: Scaffold treated subject 83 days post-
injury. C-D: Scaffold+hNSC treated subjects 40 (C) and 82 (D) days post-injury. The lesion 
crosses the midline, in reference to the central canal where present, into the contralateral gray 
matter. In these sections the contralateral lateral funiculi appear to be preserved from the surgical 
lesion in all subjects. However, some degenerative staining is visible in contralateral efferents. 
Ipsi = ipsilateral lesioned side. Contra = contralateral unlesioned side. The cords are oriented 
rostral to caudal from left to right. Scale bar = 1 mm. 
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Table 3. Quantification of lesion dimensions.  All cord widths were normalized to 0.60 cm.  All 
units in cm unless otherwise noted. 
Monkey Treatment group Sacrifice day Lesion area (cm
2
) Maximum lesion width 
X992 Scaffold+hNSC 40 0.24 0.36 
Y430 Scaffold+hNSC 82 0.26 0.28 
Y464 Scaffold alone 83 0.26 0.24 
Y156 Control 111 0.31 0.29 
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Figure 10. Silver staining for axonal degeneration of ventral funiculus tracts in thoracic cross-
sections caudal to the injury site. A: Control subject 111 days post-injury. B: Scaffold treated 
subject 83 days post-injury. C-D: Scaffold+hNSC treated subjects 40 (C) and 82 (D) days post-
injury. The lesion is bilateral with respect to degeneration of axons in the ventral-medial tracts. 
Dors = dorsal. Vent = ventral. Magnification = 10x. 
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Iba1 immunohistochemistry provided an indication of reactive microglial and macrophage 
abundance and distribution, providing a further measure of the degree to which the impact of the 
hemisection remained unilateral weeks post-injury.  The lesions remained unilateral in the lateral 
regions, with substantial Iba1 immunoreactivity around ipsilateral lateral CST efferents (Figure 
11).  A similar degree of variability as observed by silver staining was observed using Iba1 
immunohistochemistry in the dorsal funiculus rostral to the injury site (Figure 8 B, D, F, H). 
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Figure 11. Iba1 staining for microglial and macrophage activation around lateral corticospinal 
tracts (CST) in thoracic cross-sections caudal to the injury site. A-B: Ipsilateral (A) and 
contralateral (B) images of control subject 111 days post-injury. C-D: Ipsilateral (C) and 
contralateral (D) images of scaffold treated subject 83 days post-injury. E-H: Ipsilateral (E, G) 
and contralateral (F, H) images of scaffold+hNSC treated subjects 40 (E, F) and 82 (G, H) days 
post-injury. The lesion is unilateral with respect to microglial and macrophage activation in the 
cord around the CST. Dors = dorsal. Vent = ventral. Magnification = 10x. 
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Discussion 
Creation of a hemisection in the thoracic spine at the T9-T10 level in the African green monkey 
resulted in paralysis of the ipsilateral hindlimb, with concomitant sparing of bladder and rectal 
function and retention of sufficient overall motor function and mobility to allowed the 
continuation of feeding, grooming and other healthy activities without supplementary veterinary 
care.  Behavioral evaluations confirmed improvement in post-operative paralysis over time, but 
improvement was gradual with sufficient remaining deficit to allow definition of recovery rate 
and distinction within subjects between phases of recovery and between subjects exhibiting 
different degrees of impairment.  As such, this African green model of SCI may represent a 
means by which the safety and efficacy of therapeutic SCI interventions in a clinically relevant 
species could be assessed humanely. 
This study was primarily designed to evaluate the feasibility of implementing a lateral 
hemisection model of SCI in a non-human primate, and to identify the specific clinically relevant 
behavioral and pathological endpoints that could be reproducibly obtained.  Coupled kinematic 
and electromyographic measures in previous primate studies have demonstrated the feasibility of 
obtaining these critical endpoints (Courtine et al., 2005).  The associated telemetry and surgical 
interventions, however, are, in themselves, a significant research investment and variable 
impacting animal wellbeing, with the established need for prolonged postoperative care.  The 
more critical question addressed in this study was the consequence and tolerance of a T9-10 
hemisection lesion, and a characterization of the overall neuromotor phenotype and its evolution 
over time such that more definitive efficacy and mechanism studies could be rationally and 
humanely designed.  Therefore, the sizes of the treatment groups in the present study were 
limited and not designed to provide statistical evaluation of the therapeutic efficacy of the 
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implanted PLGA scaffold PLGA scaffold seeded with hNSC at the lesion site.  All subjects 
exhibited a return toward baseline neuromotor scores in the ipsilateral hindlimb, which exhibited 
complete post-operative paralysis following the T9-T10 lesion.  This indicates a degree of 
recovery and neural plasticity consistent with reported findings in other primate SCI models 
(Edgerton et al., 2004).  This observation encourages additional application of the model for 
more definitive preclinical studies in a larger study cohort to evaluate the therapeutic efficacy of 
PLGA scaffolds and human neural stem cells in the promotion of SCI recovery and repair. 
Video capture of neuromotor behavior in the ambulation chamber provided a means of 
documenting and scoring neuromotor deficits and improvement over time.  An observation based 
scoring system, however, may be inadequate to give precise information of neuromotor 
performance, due to the potential for the contralateral side to compensate for any loss of weight 
bearing ability and posture resulting from a unilateral interruption of motor and sensory 
pathways to the injured hindlimb.  The application of kinematics, electromyography and evoked 
potentials would contribute to improved measures of neurologic function and quantification of 
ipsilateral and contralateral deficit and recovery (Courtine et al., 2009). 
Histological analysis confirmed creation of a thoracic lesion in all study monkeys.  Hematoxylin 
and eosin staining provided a definition of the extent of the lesion and degree of injury associated 
lymphocyte invasion, axonal swelling and macrophage infiltration, as well as a circumscribed 
degree of hemorrhage and gross necrosis.  Silver staining revealed clear degenerative changes 
consistent with interruption of ipsilateral efferent lateral corticospinal tracts at the thoracic level 
caudal to the lesion and sensory afferents rostral to the lesion.  It was noted that the ventral-
medial region of the cord, which contains both important sensory and motor tracts, may be 
particularly sensitive to different degrees of bilateral surgical injury among subjects.  Iba1 
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immunohistochemistry, exhibited a distribution that paralleled the degenerative findings 
highlighted by the silver staining.  As such, Iba1 constituted an additional measure of the degree 
of injury and repair.   
Histological evaluations confirmed the creation of a lesion with severe degeneration of ipsilateral 
motor and sensory axons.  In no animals were the degenerative changes entirely unilateral. While 
contralateral corticospinal tracts were extensively preserved in all subjects, in addition to the 
majority of the dorsal horn in most subjects, contralateral damage was observed in the ventral-
medial region in all subjects.  Contralateral damage is most due to surgical variability, which will 
be improved in future, more sophisticated, investigations. 
The persistence of the PLGA scaffold for at least 40 days, and degradation and clearance from 
the spinal cord within 82 days post-implantation was observed. Two important changes were 
made to the neural stem cells seeded PLGA scaffold used in this study, in comparison with a 
similar rodent study (Teng et al., 2002).  Firstly, human neural stem cells (hNSC) were used 
instead of murine neural stem cells.  Secondly, the PLGA scaffold was redesigned in response to 
observations made in the rodent study (Teng et al., 2002).  The relative volume of the inner 
scaffold was increased to accommodate more hNSC.  It was postulated that a major mechanism 
of action of the implanted cells may be due to trophic support rather than neuronal replacement.  
Therefore, it was hypothesized that a larger number of hNSC could increase any therapeutic 
effect.  It was also proposed that the ‘outer scaffold’ in the rodent study, consisting of 
longitudinally oriented channels intended to permit axon in-growth, may have also served to 
prevent meningeal inflammatory cell infiltration.  Unpublished in vitro data showed that the 
channels were impermeable to fibroblasts.  To maximize the size of the inner scaffold, while 
providing a physical barrier to meningeal cell infiltration, the outer scaffold was constructed as a 
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200 micron thin, flexible sheet of PLGA.  The observed tolerance of the current implant will 
guide implant design for further studies. 
The ability to model spinal cord injury by lateral, segmental hemisection in African Green 
monkeys with limited impact on overall well-being presents a useful model for the assessment of 
spinal cord injury repair and response to intervention.  Greater sensitivity and specificity to 
treatment effects could be achieved through expanded samples sizes to address lesion variability 
and application of coupled kinematic and electromyographic analyses, as well as further 
histological markers to identify specific mechanisms involved in secondary injury, repair and 
regeneration. 
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Abstract 
A porous poly(lactide-co-glycolide)-co-poly(L-lysine) (PLGA-PLL) scaffold was implanted into 
a non-human primate model (Rhesus Macaque) of experimental acute spinal cord injury (SCI) to 
assess of safety and efficacy of the medical device.  A thoracic lateral hemisection was 
performed on three subjects followed by histological analysis 12 weeks post-injury.  One subject 
received a customized PLGA-PLL scaffold immediately after surgical spinal cord resection.  No 
adverse events were observed as a result of the biomaterial implants.  In addition, a reduction in 
scarring around the lesion was observed in the primate treated with the scaffold.  This result 
provides a promising preliminary indication of the effect of the scaffold in reducing the degree of 
secondary injury, measured as astrogliosis, in a model surgical hemisection SCI. 
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Materials and methods 
Synthesis of poly(lactide-co-glycolide)-co-poly(L-lysine) 
Poly(lactide-co-glycolide)-co-poly(L-lysine) (PLGA-PLL) was synthesized according to 
previously published methods (Fig. 1) [1].  Briefly, poly(D,L-lactic-co-glycolic acid) (RG502H, 
50:50 ratio; Resomer 502 H, Mn ~ 12,500; Boeringer Ingelheim KG) and poly(ε-carbobenzoxy-
L-lysine) (PLL, MW 6300 by LALLS; Sigma) were stored in a desiccator at --20 °C until use. 
Dimethylaminopyridine (DMAP) and dicyclohexyl carbodiimide (DCC), anhydrous 
dimethlyformamide (DMF), and hydrogen bromide, 30 wt% in acetic acid, (HBr/HOAc), were 
from Aldrich and used as received.  RG502H and PLL were loaded into a flask in dissolved in 
DMF under Argon. Two molar equivalents (with respect to the estimated number of carboxylic 
acid groups present in the PLGA based on molecular weight) of DCC and 0.1 molar equivalents 
of DMAP were loaded into a separate flask and dissolved under argon.  The DCC solution was 
then added to the polymer solution and the reaction was allowed to run for 48 h under argon at 0 
°C in an ice bath.  The solution was diluted by the addition of chloroform and filtered to remove 
the DCU, an insoluble product of the reaction. The polymer product was precipitated in 
methanol, isolated by vacuum filtration, washed three times in ether, and dried under vacuum for 
at least 48 h.  For deprotection, approximately 1.5 g of the protected polymer was placed in a 100 
mL round bottomed flask and purged under argon for 15 min. 10 mL of HBr/HOAc was added 
via syringe to the polymer under argon to form a slurry and was allowed to stir for 90 min. The 
polymer was precipitated with ether, separated by vacuum filtration, and washed several times 
with ether until the polymer took on an off-white color and went from being a sticky mass to a 
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crumbly powder. The product was then redissolved in chloroform, precipitated in ether, 
separated by vacuum filtration, and dried under vacuum for at least 48 h. 
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Figure 1. Poly(lactide-co-glycolide)-co-poly(L-lysine).  The poly(lactide-co-glycolide) is 
depicted here as an alternating block copolymer showing only one monomer of lactic acid and 
glycolic acid for illustrative simplification.  Characteristing groups are labeled: a. methyl in 
lactic acid monomer. b. ester in glycolic acid monomer. c. amide in poly(L-lysine). d. primary 
amine on lysine residue side chain. 
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Characterization of poly(lactide-co-glycolide)-co-poly(L-lysine) 
The lysine content in the resulting PLGA-PLL was assessed by amino acid analysis (AAA 
Laboratory, Mercer Island, WA).  A sample was hydrolyzed for 20 hours in 6N hydrochloric 
acid (HCl) with 0.05% mercaptoethanol and 0.02% phenol at 115 ºC and analyzed by liquid 
chromatography.  Fourier transform infrared (FT-IR) spectroscopy was taken using an Alpha FT-
IR with Eco ATR sampling module (Bruker Optics, Billerica MA).  FT-IR spectra were obtained 
on the dried powder by measuring attenuated total reflection. 
Scaffold fabrication 
Porous polymer scaffolds were prepared in a similar manner to a previously published protocol 
[2].  Poly(lactide-co-glycolide) (PLGA) with a lactide/glycolide ratio of 50:50 and intrinsic 
viscosity 0.55-0.75 dl/g was obtained from Lactel (Durect Corp., Pelham, AL).  Polymer 
scaffolds were fabricated by solvent casting/particulate leaching.  A blend of PLGA and 
synthesized PLGA-PLL (1:1) was dissolved in chloroform (Sigma, St. Louis, MO) to obtain a 5 
wt % stock solution.  The stock solution was mixed with sodium chloride (particle size 180-450 
µm by sieving; Sigma) in a 1:1.67 ratio (3 mL / 5 g) and poured into an elliptical aluminum mold 
with dimensions 5 x 3 x 20 mm. After chloroform was evaporated in a fume hood and rotovap 
(Büchl, Germany) for 48 hours, the salt particles were leached out by immersion in distilled 
water for 48 h at room temperature. The water was changed every 4-8 h during the leaching 
period.  Subsequently, the scaffolds were dried on blotting paper and lyophilized overnight to 
remove residual water.  The process yielded a highly porous scaffold with dimensions matching 
the spinal cord of the African green monkey.  The scaffolds were stored in Eppendorf tubes 
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(Daigger) and Tyvek™ packaging (3 tubes per package) in a secondary container with desiccant 
(Drierite) at -20 ºC until use. 
Scanning electron microscopy 
Lyophilized scaffolds were air dried for 24 hours, mounted on aluminum stubs and sputter 
coated with gold, and imaged using a JEOL 6400 Scanning Electron Microscope with Orion 
image processing (JEOL, Tokyo, Japan). 
Scaffold testing with neuroblastoma cells 
Adhesion of neuronal cells on the scaffolds was assessed using neuronal cells (N18RE105 cell 
line).  This cell line is a somatic cell hybrid from the fusion of dissociated embryonic rat neural 
retina cells with the neuroblastoma cell line N18-TG2.  Cells (approx. 300,000) were cultured in 
T75 flasks (Corning, Midland, MI) an incubator at 37ºC with 5% CO2 in 15 mL Dulbecco’s 
Modified Eagle Medium (DMEM, Gibco #430-2100) with 4500 mg / L D-glucose and L-
glutamine.  Medium was replaced twice weekly.  Cells were split once a week using a phosphate 
buffered saline wash (PBS, 10 mL, Invitrogen) followed by trypsin (5 mL, Gibco, 5 minutes at 
room temperature), addition of 10 mL DMEM, centrifugation at 1000 r.p.m. (5 minutes) and 
resuspension (10 mL). 
Electron beam sterilization validation and procedure 
Sterilization testing was conducted using spore strips (Bacillus pumilus, 10
6
 per strip, STP-06, 
NAMSA, Northwood, OH) in closed Eppendorf™ tubes and packaging (Tyvek™) (one wrapped 
spore per tube, one tube per package.  Sterilization was performed by electron beam sterilization 
(Electron Technologies Corp., South Windsor, CT) at 3, 5 and 10 mRad.  Sterilized spore strips 
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and an unsterilized control were removed from tubes and cultured in soybean casein digest broth 
in test tubes overnight at 35 ºC under vigorous shaking.  Optical density was measured at a 
wavelength of 600 nm in a cuvette with a pathlength of 1 cm on a Spectramax Plus 
spectrophotometer (Molecular Devices).  Scaffolds were sterilized in closed Eppendorf™ tubes 
and packaging (Tyvek™) in (one scaffold per tube, 3 tubes per package) by electron beam 
sterilization (Electron Technologies Corp., South Windsor, CT) at 3 mRad. 
Scaffold hydration 
Prior to seeding or implantation scaffolds were placed in 0.2 μm filtered ethanol (2 mL) for 5 
minutes in a sterile polystyrene 6-well culture plate (Corning) in a laminar flow hood, followed 
by rinsing in PBS (3 x 2 mL).  Scaffolds were transferred to the operating room with minimal 
excess PBS inside sterile polystyrene test tubes (VWR). 
Animal selection and protocol approval 
3 female rhesus macaques that had been previously ovariectomized were selected based on 
normal health examinations by Oregon National Primate Research Center (ONPRC) Division of 
Animal Resources (DAR) veterinary staff and following hematological and blood chemistry 
analyses.  The Oregon Health & Science University (OHSU) Institutional Animal Care and Use 
Committee gave permission to conduct the overall study (protocol #0840) on January 2, 2009 in 
accordance with federal and state laws regarding the use of animals in biomedical research. 
Approval was granted based on a pilot study performed using African Green Monkeys 
demonstrating minimal post‐surgical animal care.  Permission to utilize these animals for a 
second major surgical procedure (spinal cord hemisection; animals had already been 
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ovariectomized) was granted by the USDA on January 20, 2009.  Animals were housed in 
standard caging, lined with soft toweling following spinal cord hemisection surgeries. 
Spinal cord hemisection surgeries 
T10 hemisections were performed as indicated (Table 1) as described previously [3].  The 
scaffolds was implanted in #21948 within five minutes of hemisection.  The length of 
hemisection was measured using a sterile plastic 15 mm ruler, and the scaffold was customized 
using a surgical blade.  All animals were awake and moving in their cages within a few hours 
post‐ surgery and were monitored closely by surgical and veterinary staff during the recovery 
period.  Cases #21948 and #24841 experienced urinary retention.  These subjects were 
catheterized and shown to be carrying urine volumes of approximately 150 ml. In these subjects, 
the bladder was flaccid and could not be expressed manually. This is consistent with a 
neurological insult resulting in loss of reflexive bladder control, and catheterization was 
performed on a regular basis.  Reflexive bladder control was fully regained within 72 hours post‐
surgery. 
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Table 1. Animal assignments. 
Animal# Age (years) EMG Surgery date Treatment 
21948 9 OK 2/27/09 Scaffold 
24841 9 OK 2/28/09 Lesion only 
22747 7 OK 2/28/09 Lesion only 
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Results 
Scaffold characterization 
The poly(lactide-co-glycolide)-co-poly(L-lysine) had a lysine content of 3.09 wt.% by amino 
acid analysis.  Lysine presence was further confirmed by FT-IR spectroscopy (Fig. 2). 
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Figure 2. FTIR spectroscopy of PLGA-PLL. Components were identified by peaks at the 
following wavenumbers: a. methyl C-H stretch at 2870 cm
−1
 and 2960 cm
−1
.b. ester C=O stretch 
at 1735 cm
−1
. c. amide C=O stretch at 1650 cm
−1
. d. primary amine stretch at 1560-1640 cm
-1
. 
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Sterilization 
Table 2 shows results of electron beam sterilization at increasing dosages.  All three dosages 
were successful in sterilizing the spore strips.  To minimize polymer degradation, a dosage of 3 
mRad was selected for scaffold sterilization. 
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Table 2. Optical density measurements of soybean broth supernatant for spore strips sterilized at 
increasing radiation dosages, compared to an unsterilized spore strip control.  Absorbance values 
were obtained at a wavelength of 600 nm and a 1 cm path length. 
mRad OD600 
3 0.042 
5 0.043 
10 0.042 
0 (control) 1.206 
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Scaffold characterization and intraoperative customization 
The solvent casting / salt leaching procedure resulted in hemi elliptical scaffolds with a porous 
interconnected architecture on the order hundred of microns (Fig. 3 A).  Once hydrated, the 
scaffold could be easily customized intraoperatively using a surgical blade (Fig. 3 B).  Poly(L-
lysine) is well known to promote cell adhesion to scaffolds and cell culture plates [4].  Combined 
with the porous scaffold architecture, this led to structure highly seeded with neuronal cells in 
vitro (Fig. 3 C, D). 
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Figure 3. A. Scanning electron microscope image of scaffold. B. Intraoperative customization of 
scaffold. C-D. Light microscope (C) and DAPI (blue) fluorescence (D) image of neuroblastoma 
cells seeded on scaffold. 
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PLGA-PLL scaffold reduced astrogliosis following T10 lateral hemisection SCI 
Glial scarring and astrogliosis were assessed by glial fibrillary acidic protein (GFAP) 
immunolabeling.  Both control primates, numbered 24841 (Fig. 4 A, B) and 22747 (not shown), 
had extensive GFAP immunoreactivity both surrounding and distant from the lesion.  The 
scaffold-treated primate,numbered 21948 (Fig 4 C, D), had reduced contralateral GFAP 
immunoreactivity that was restricted to lesion borders. 
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Figure 4. GFAP (red) and neurofilament (green) immunoreactivity in cross-sections of Macaca 
Mulatta monkey spinal cords near the lesion center following hemi-section surgical injuries.  
Cell nuclei were labeled with DAPI (blue).  A: Ventral-lateral spinal cord region in a control 
subject. B: Extensive astrogliosis (red) throughout the tissue near the midline in a control 
subject.  The central canal was preserved (blue).  C-D: Dorsal and medial portions of the lesion 
in the scaffold-treated primate, showing reduced contralateral gliosis compared to controls 
restricted to lesion border. 
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Extent of lesion 
Overall lesion volume, including areas of secondary injury, was estimated by measuring the 
longitudinal distance from the lesion with high GFAP immunoreactivity in labeled cross-sections 
(Table 3).  The scaffold treated primate exhibited an approximately 56 percent shorter 
longitudinal distance of glial scarring, or astrocyte activation, rostal and caudal to the lesion 12 
weeks post-injury compared to the two controls. 
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Table 1. Lesion volume, including secondary injury, as measured by elevation of glial fibrillary 
acidic protein (GFAP). 
Treatment group (number) Rostral-caudal distance of elevated GFAP (mm) 
Controls (2 primates) 10.5 ± 0.7* 
Scaffold (1 primate) 5 
* mean ± standard deviation from two primates 
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Abstract 
Retinal transplantation experiments have advanced considerably during recent years, but 
remaining diseased photoreceptor cells in the host retina and inner retinal cells in the transplant 
physically obstruct the development of graft-host neuronal contacts which are required for 
vision.  Recently, we developed methods for the isolation of donor photoreceptor layers in vitro, 
and the selective removal of host photoreceptors in vivo using biodegradable elastomeric 
membranes composed of poly(glycerol-co-sebacic acid) (PGS).  Here, we report the surface 
modification of PGS membranes to promote the attachment of photoreceptor layers, allowing the 
resulting composite to be handled surgically as a single entity.  PGS membranes were chemically 
modified with peptides containing an arginine-glycine-aspartic acid (RGD) extracellular matrix 
ligand sequence.  PGS membranes were also coated with electrospun nanofiber meshes, 
containing laminin and poly(epsilon-caprolactone) (PCL).  Following in vitro co-culture of 
biomaterial membranes with isolated embryonic retinal tissue, composites were tested for 
surgical handling and examined with hematoxylin and eosin staining and immunohistochemical 
markers.  Electrospun nanofibers composed of laminin and PCL promoted sufficient cell 
adhesion for simultaneous transplantation of isolated photoreceptor layers and PGS membranes.  
Composites developed large populations of recoverin and rhodopsin labeled photoreceptors.  
Furthermore, ganglion cells, rod bipolar cells and AII amacrine cells were absent in co-cultured 
retinas as observed by neurofilament, PKC and parvalbumin labeling respectively.  These results 
facilitate retinal transplantation experiments in which a composite graft composed of a 
biodegradable membrane adhered to an immature retina dominated by photoreceptor cells may 
be delivered in a single surgery, with the possibility of improving graft-host neuronal 
connections. 
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Introduction 
Retinal degenerative disease currently afflicts over 30 million patients worldwide [1].  This 
number is expected to increase in coming years, due not only to population growth but also the 
effect of aging populations, especially in developed countries.  Age-related macular 
degeneration, hereditary retinal degeneration and retinal detachment involving the macula all 
lead to loss of photoreceptor function. The photoreceptor cells, located in the outer layer of the 
retina, are responsible for the transduction of light into electrical impulses.  These signals are 
transmitted via neuronal connections through the inner retinal layers to the optic nerve and 
ultimately to the brain, resulting in a visual image.  Therefore, retinal degenerative diseases lead 
to significant visual impairment and blindness. 
When diseased photoreceptors are still present, but dysfunctional, current treatments may slow 
the progress of retinal degeneration [2] [3]. At this stage of disease, gene therapy may also 
provide alleviation of symptoms [4]. However, there are currently no therapies that regenerate 
lost photoreceptors. 
The prospect of retinal transplantation offers the possibility of replacing photoreceptors lost by 
degenerative disease. Experiments have been ongoing for more than two decades in a multitude 
of animal models, but to date, retinal transplantation is not available as a clinical treatment [5] 
[6] [7]. 
A critical issue remaining before clinical trials using retinal transplantation can be attempted is to 
increase the ability of graft and host retinal neurons to form functional connective neuronal 
networks. Graft-host neuronal connections have been shown to occur to some extent in rabbit 
models [8] but not in porcine models, which have a retinal vasculature that is more akin to the 
human eye [9].  In the porcine model, integration is hampered by the presence of two cell layers, 
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namely remaining inner retinal cells in the transplant and diseased host photoreceptors [6].  In 
order to improve the probability of functional connection between host and graft retina, it is 
hypothesized that these two physical barriers must be removed. 
A recent development, in this field of study, involves the removal of host photoreceptors by the 
insertion of a thin biodegradable elastomeric membrane between the retinal pigment epithelium 
and the outer nuclear layer [10]. The membrane, made from poly(glycerol-co-sebacic acid) 
(PGS) [11] disrupts blood supply from the choroid to the retina leading to selective removal of 
the photoreceptor layer. In vivo, the membrane degrades completely within 14 days, leaving a 
host retina composed of isolated inner retinal layers prepared to receive a complementary 
photoreceptor transplant. 
In the current study, we aimed to combine the PGS membrane with donor retinal tissue, to create 
a composite graft that can be transplanted into the subretinal space in a single surgery.  The 
creation of such a composite graft composed of a biodegradable membrane adhered to a retina 
dominated by photoreceptor cells may in future experiments enhance neuronal integration by 
providing close contact of grafted photoreceptors with host inner retinal cells.  PGS membranes 
were chemically modified with peptides containing an arginine-glycine-aspartic acid (RGD) 
extracellular matrix ligand sequence [12].  Additionally, nanofiber meshes, composed of laminin, 
poly(epsilon-caprolactone) (PCL) or a blend of laminin and PCL, were electrospun onto PGS 
membranes. 
The biomaterial membrane is intended ultimately to serve as a clinical paradigm that can be 
modified further to incorporate drugs or proteins with the aim of enhancing synaptic connections 
between grafts and the host nervous system.  For example, neurotrophic factors such as brain 
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derived neurotrophic factor (BDNF) or glial cell derived neurotrophic factor (GDNF) have the 
ability to stimulate neuron growth [13] and may promote neurite sprouting from the transplant. 
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Materials and Methods 
All compounds and solvents were obtained from Sigma-Aldrich, St. Louis, MO, USA unless 
otherwise stated. 
Preparation of poly(glycerol-co-sebacic acid) Membranes 
Poly(glycerol-co-sebacic acid) (PGS) branched polymer was prepared by poly-condensation as 
previously described [11].  Briefly, equimolar amounts (0.989 mol) of re-crystallized sebacic 
acid and anhydrous glycerol were charged to an oven-dried round bottom flask and reacted with 
stirring at 120°C under argon.  After 21 hours, vacuum was applied and the mixture was reacted 
for another 64 hours.  The resulting material formed a white wax at room temperature. 
Cross-linking of the PGS to an elastomer was carried out in a class 10,000 clean room.  A 10:1 
prepolymer:hardener mixture of poly(dimethylsiloxane) (PDMS) (Sylgard 184, Dow Corning, 
Midland, MI) was outgassed under vacuum and cured in a 10 cm Petri dish for 1 hour at 60°C.  
The resulting 10 cm diameter PDMS slab was plasma oxidized for 1 minute to create a 
hydrophilic surface.  The top surface was spin coated at 3000 rpm for 30 seconds with a 61.5 wt. 
% aqueous sucrose solution (saturated at room temperature and 0.45 µm syringe filtered).  The 
sucrose-coated PDMS was subsequently baked at 130 °C for 10 min and transferred to a hotplate 
at 120°C.  Molten PGS wax (120 °C) was poured onto the sucrose-coated PDMS slab, covering 
the entire surface, and subsequently cured at 120 °C under a 15 millitorr vacuum until the PGS 
lost any adhesiveness to a stainless steel spatula. 
Subsequently, the mold was submerged in 18 MOhm water overnight and the PGS was peeled 
from the PDMS underwater.  The resultant PGS disk was approximately 3 mm thick. 
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The PGS disk was cut into 5 x 5 x 3 mm blocks, embedded in Tissue-Tek OCT compound 
(Sakura, Torrance, CA) and rapidly frozen by immersion in ethanol cooled with dry ice.  Frozen 
PGS was cryo-sectioned into 30 µm membranes at -30˚C with a Shur/Sharp Heavy Duty razor 
blade (TBS, Durham, NC).  Thicker blades (0.5 mm or greater) and slow sectioning speeds were 
necessary to reduce vibration and warming of the blade from friction.  Membrane thickness and 
uniformity was confirmed by scanning electron microscopy. 
PGS – Peptide coupling 
Membrane activation 
PGS samples (5 mm x 5 mm) were individually treated in a 0.1 w/v % solution of 1-(3-
dimethylaminopropyl)-3-ethylcarbodiimide (EDC; 0.1 g) in 0.1 N (2-(N-morpholino)-
ethanesulfonic acid (MES; 2.13 g) buffer in 18 MOhm water (100 mL, pH 3.5).  Each sample 
was immersed in 1.5 mL of the EDC solution in 1.7 mL Eppendorf tubes at room temperature for 
1 hour, whilst shaking with a vortex mixer.  The samples were washed in MES buffer (1 x 10 
minutes; 1.5 mL / sample), and then in 18 MOhm water (2 x 10 minutes; 2 x 1.5 mL / sample).  
The activated PGS samples were directly used in the coupling reactions. 
Membrane coupling to peptide GRGDS 
The activated PGS sample (5 mm x 5 mm) was immersed into a 1 mM solution of the peptide 
sequence GRDGS (Anaspec, Freemont, CA) in phosphate buffered saline (PBS; pH 7.3) (1.5 
mL) during 2 hours at room temperature, under shaking.  The sample was rinsed 3 times for 10 
minutes with 1 mL PBS and then with 1 mL 18 MOhm water for 10 minutes. 
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X-ray photoelectron spectroscopy analysis of peptide modified membranes 
The surface chemical composition of the sample was determined by X-ray photoelectron 
spectroscopy (XPS) using a Surface Science Instruments SSX-100, equipped with a 
monochromatic aluminum X-ray source at 1486.8 eV.  Charge neutralization was achieved using 
an electron flood gun.  The vacuum in the analysis chamber was less than 2x10
-9
 torr during 
analysis.  Photoelectrons were collected at an angle of 55 ° from the surface normal.  A 
hemispherical analyzer was used with a pass energy of 150 eV for surveys and 50 eV for high-
resolution scans.  The peak areas were determined using Shirley background subtraction.  The 
intensity ratios were converted into atomic concentration ratios using CasaXPS processing 
software (Casa Software Ltd., Cheshire, UK), which takes into account the instrument 
transmission function and provides a standard library of empirically-determined relative 
sensitivity factors. 
Fabrication of electrospun nanofibers 
Nanofibers consisting of poly(epsilon-caprolactone) (PCL) laminin and a blend of 10 wt. % 
laminin in PCL of approximately 100 nanometers were electrospun onto 30 micron PGS sheets 
to create a bi-layer biomaterial membrane.  Neuroretinal explants were subsequently cultured on 
a culture membrane with the outer layers facing downward and the PGS-nanofiber membranes 
on top, with the nanofiber side of the PGS sheet facing downward.  Type 1 Laminin was isolated 
from murine Englebreth-Swarm-Holme tumor as previously described [14].  The laminin was 
provided as a gift by Stemgent, Inc. (Cambridge, MA).  Electrospinning followed previously 
described protocols [15].  For laminin nanofibers, lyophilized laminin was dissolved in 
1,1,1,3,3,3-hexafluoro-2-propanol (HFP) at 3 w/v % at 4 °C overnight. The solution was then 
mounted into an Aladdin syringe pump (World Precision Instruments, Sarasota, FL) using a 
Doctoral Thesis The use of surface modified poly(glycerol-co-sebacic acid) in retinal transplantation 
Page 128 of 256 
disposable syringe and 18 gauge needle. PGS sheets mounted on glass cover slips were placed on 
the collector plate, and the laminin solution was dispensed at a flow rate of 1 mL/hr and driving 
voltage of 15 kV across a 15 cm vertical gap onto the grounded copper collector, and hence onto 
the PGS sheets. Samples were dried completely and stored in dessicant at -20 °C.  Laminin-PCL 
blend nanofibers were electrospun in a similar manner. A solution consisting of 10 wt. % laminin 
and 90 wt. % PCL with 8 w/v % total polymer dissolved in HFP was used as the initial solution. 
The same procedure as for laminin was used to electrospin the blend onto PGS sheets, though the 
driving voltage was increased to 20 kV to compensate for the higher viscosity of this solution.  
18 wt. % PCL was dissolved in 1:1 THF:DMF and electrospun at 20 kV in the same manner to 
fabricate PCL nanofibers. 
Characterization of electrospun nanofibers 
Samples were air dried for 24 hours, mounted on aluminum stubs, and coated with a thin layer of 
carbon for scanning electron microscopy.  A JSM-5910 General Purpose Scanning Electron 
Microscope(JEOL, Tokyo, Japan) was used to image the samples.  To study the effect of 
hydration, samples were air dried after 5 days in culture medium.  For scanning electron 
microscopy, samples were mounted on aluminum stubs and sputter coated with gold, and imaged 
using a JEOL 6400 Scanning Electron Microscope with Orion image processing (JEOL, Tokyo, 
Japan).  Diameter measurements were made using the measure tool in Image J (NIH, Bethesda, 
MD), with at least 50 measurements per sample. 
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Culture procedure 
Porcine tissue isolation 
Eyes from Yorkshire/Hampshire pigs (gestational age of 114 days) were obtained from a local 
breeder (Lund, Sweden) and used for all experiments. Retinal tissue from E45 (45 days after 
conception) and E49-50 was used for culturing experiments, and E60 and E70 specimens were 
obtained as in vivo controls. The pregnant sow was euthanized by means of captive bolt and 
incision of the carotid arteries.  The fetuses were collected by caesarean section and euthanized 
by decapitation.  Both eyes were enucleated and immediately immersed in ice-cold CO2-
independent medium. The neuroretinas were carefully dissected free from the retinal pigment 
epithelium (RPE) and hyaloid vascular system with fine forceps. The optic nerve was thereafter 
cut with micro-scissors and neuroretinal pieces measuring approximately 4x4 mm were 
explanted on Millicell®-HA 0.45- µm culture plate inserts with the photoreceptor layer towards 
the membrane. All neuroretinas were put in culture within 240 minutes. 
Explants were cultured in 1.2 mL Gibco D-MEM F12 medium –L-Glutamine (Gibco, Paisley, 
UK) supplemented with 10 vol. % fetal calf serum. A cocktail containing 2 mM L-glutamine, 
100 U/mL penicillin and 100 ng/mL streptomycin was added, and the retinas were maintained at 
37 °C with 95 % humidity and 5 % CO2. 
Co-culture of retinal layers with biomaterial membranes 
After two days, PCL-PGS and Laminin-PCL-PGS membranes measuring 2x3 mm were added to 
the explanted retinal specimens (12 each) while another 12 pieces were kept in culture without 
the addition of a membrane as in vitro controls.  At this time half of the culture medium was 
Doctoral Thesis The use of surface modified poly(glycerol-co-sebacic acid) in retinal transplantation 
Page 130 of 256 
exchanged, and this procedure was then repeated every second day.  Specimens were kept under 
culture conditions for either 1 or 2 weeks (7-9 or 14-16 days). 
All proceedings and treatment of animals were in accordance with the guidelines and 
requirements of the Government Committee on Animal Experimentation at Lund University and 
with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. 
Histology 
For histologic examination, the explants were fixed for 1 hour in 4% formalin, pH 7.3 in a 0.1 M 
Sørensen’s phosphate buffer (PB).  After fixation, the specimens were washed with 0.1 M 
Sørensen’s PB, and then washed again using the same solution containing sucrose of rising 
concentrations (5-25%).  They were then sectioned at 12 µm on a cryostat, and each 10th slide 
was stained with hematoxylin and eosin according to standard procedures. 
For immunohistochemical staining, sections were incubated at room temperature with phosphate 
buffered saline (PBS) containing 0.25 % Triton X-100 and 1 % bovine serum albumin for 30 
minutes.  This was followed by incubation of the slides overnight with primary antibodies (Table 
1).  After incubation, the slides were rinsed in PBS and incubated with Texas-red-conjugated 
secondary antibodies (Jackson Immunoresearch, West Grove, PA, USA) for 50 minutes. in room 
temperature and thereafter rinsed again and finally mounted in custom made Vectashield 
mounting media containing DAPI (4´,6-diaminidin-2-phenylindoldihydrochloride; Vector 
laboratories, California, USA). 
For recoverin and vimentin double-labeling, the tissue was incubated with recoverin and 
vimentin antibodies for 18 to 20 hours and rinsed in PBS-Triton.  Subsequently, the tissue was 
incubated for 45 minutes in darkness with a mixture of the secondary antibodies conjugated with 
two fluorophores: anti-rabbit fluorescein isothiocyanate (FITC; Southern Biotechnology; 
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Birmingham, AL, USA) and anti-mouse Texas red. The dilution of each secondary antibody was 
1:200. 
Neuroretinas derived from E60 and E70 eyes were used to compare cultured specimens with the 
corresponding in vivo counterparts.  Sections from adult porcine retinas were used as positive 
controls.  Negative controls were obtained by performing the complete labeling procedure 
without primary antibody on retinal sections from adult pigs.  Photographs were obtained with a 
digital camera system (Olympus, Tokyo, Japan).  Photographs were adjusted for brightness and 
contrast digitally. 
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Table 1. Specification of immounohistochemical markers. 
Antigen 
Antibody 
name 
Target cell Species Dilution Source 
Neurofilame
nt 160 KDa 
Anti-
neurofilament 
160 clone 
NN18 
Ganglion cells 
(Horizontal 
cells) 
Mouse 
monoclon
al 
1:500 
Sigma, St 
Louis, MO, 
USA 
Recoverin Anti-recoverin 
Rod and cone 
photoreceptors 
Rabbit 
polyclonal 
1:10000 
Chemicon 
International, 
Ca, USA 
Vimentin 
Mouse anti-
vimentin 
Müller cells 
Mouse 
monoclon
al 
1:500 
Chemicon 
International, 
Ca, USA 
Rhodopsin Rho4D2 
Rod 
photoreceptor 
Mouse 
monoclon
al 
1:100 
Kind gift of 
Prof. RS 
Molday, 
Vancouver, 
Canada 
Parvalbumin 
Mouse anti-
Parvalbumin 
AII amacrine 
cells 
Mouse 
monoclon
al 
1:1000 
Sigma, St 
Louis, MO, 
USA 
PKC 
Phospho-PKC 
(pan) 
Rod bipolar cells 
(Photoreceptor 
outer segments) 
Rabbit 
polyclonal 
1:200 
Cell Signaling, 
Beverly, MA, 
USA 
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Results 
Membrane properties 
PGS sheets 
A variety of approaches for the fabrication of PGS membranes were attempted.  A microtome 
was used with and without the PGS embedded in paraffin.  The microtome was unable to cut 
PGS, and the material compressed at the point of contact with the microtome blade.  
Subsequently, a cryo-sectioning technique employed to fabricate PGS sheets was able to create 
30µm thick membranes (Fig. 1A). A slightly wavy surface was produced due to blade vibrations, 
as seen in the image by light and dark contours on the membrane surface.  Compared to the edge 
of the membrane, which was cut by a standard laboratory razor blade, the cryo-sectioning 
technique created a smooth surface.  To optimize the cryo-sectioning technique, the type of 
blade, temperature of the instrument, temperature of the frozen block, size of the frozen block 
and surface area of the PGS pieces were varied to identify conditions that would allow 
sectioning.  After suitable parameters were obtained, we investigated how thin the PGS could be 
sectioned.  A thickness of 30 µm was found to be the limit, as 20 µm sections were too fragile 
and readily folded upon themselves. 
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Figure 1. Scanning electron microscope images of membranes. A: 30 µm PGS sheet. Edge view 
at 60°. B-D: Nanofibers electrospun onto PGS sheets (B: PCL, C: Laminin, D: Laminin-PCL 
nanofibers). Top view. 
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GRGDS peptide modification of PGS sheets 
Analysis by XPS gave: C1s: 284.526 eV (98.56 %); N1s: 399.335 eV (1.44 %).  Considering the 
theoretical monomer unit ((PGS)y+(PGS-GRGDS)x), i.e. ((C13H22O5)y+(C30H52N8O13)x), 
where x + y = 1, we calculated the  atomic ratios as: N/C = 8x/(30x+13(1-x)) and O/C = 
(13x+5(1-x))/(30x+13(1-x)).  From the experimental value (N/C = 0.0146), we found x = 0.0245, 
i.e. approximately 2.45 % surface functionalization. 
Characterization of electrospun nanofibers on PGS sheets 
A thin-layered random network of PCL nanofibers was created on top of the PGS sheets (Fig. 
1B).  While some bead defects are visible, the overall morphology remains fibrous in structure.  
The laminin-PCL blended nanofibers created a denser network with fewer bead defects and 
visibly thicker fibers than PCL alone (Fig. 1D).  Electrospinning of laminin alone also created a 
dense network with few defects, but markedly finer nanofibers than PCL and laminin-PCL 
blends (Fig. 1C).  Table 2 reports the diameters of the three meshes.  The mean diameters for dry 
nanofibers increased significantly with decreasing concentration of laminin from 65.38 nm for 
pure laminin to 101.50 nm for laminin-PCL blends to 175.12 nm for pure PCL.  A one-way 
ANOVA showed significance for differences among groups (p < 0.01). Following hydration in 
culture medium, the mean diameter of the laminin-PCL blended nanofibers almost doubled to 
199.21 nm, indicating that the networks are prone to swelling under aqueous conditions; 
however, the fibrous morphology of the mesh was retained (image not shown).  Furthermore all 
of the networks possess a significant distribution of nanofiber size as evidenced by the standard 
deviations. 
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Table 2. Measurements of diameters of nanofibers electrospun onto PGS membranes. ANOVA 
shows significant difference between all groups (p < 0.01). 
 Nanofiber material 
Size (nm) PCL Laminin Laminin-PCL Laminin-PCL (hydrated) 
Mean 175.12 65.38 101.50 199.21 
Minimum 93.04 15.74 22.26 62.50 
Maximum 294.22 140.81 267.41 447.43 
St.Dev. 39.70 23.34 49.09 90.59 
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Surgical handling results 
Table 3 shows the results of mechanical integrity of the co-cultured membranes during 
loading/unloading into the transplantation instrument for a variety of biomaterial membranes and 
retinas. The PGS membranes without chemical or physical modifications cultured for 7 to 14 
days with E40 porcine retinas demonstrated insufficient adherence between the biomaterial and 
retina during transplantation. 
By contrast, the RGD peptide modified membranes (RGD-PGS), as well as the PGS membrane 
coated with pure laminin nanofibers (Laminin-PGS), demonstrated improved adherence over 
PGS. However, the membrane and retina dissociated after the composite was pushed out of the 
transplantation device, rendering the RGD-PGS and Laminin-PGS membranes unsuitable for in 
vivo transplantation in pig models. 
Two of the nanofiber mesh coated PGS membranes (PCL-PGS and Laminin-PCL-PGS) seemed 
to integrate quite well with the porcine retinas.  It was possible to dissect these composites from 
the culture membrane, place them in the transplantation device, and eject them without the two 
components dissociating. 
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Table 3. Surgical handling results. Letter N represents no attachment. Letter A represents 
attachment, but insufficient for surgical application. Letter Y represents sufficient attachment for 
retinal transplantation. 
 Membrane type 
Retina type PGS RGD-PGS PCL-PGS Laminin-PGS 
Laminin-PCL-
PGS 
Pig (E40-50) N A Y A Y 
Pig (E99)   Y  Y 
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Histology and immunohistochemistry 
Histological sections showed that some porcine retinal explants were double folded, whether or 
not they were co-cultured with biomaterial membranes.  This was probably due to the fact that 
some of the vitreous membrane remained in place during isolation of the retinal layer.  The 
vitreous membrane should ideally be completely removed prior to transplantation.  PGS 
membranes co-cultured for 7 to 14 days with E40 porcine retinas developed photoreceptors 
(images not shown).  The cells in the retinas co-cultured with PGS were somewhat less 
organized than in vitro controls (images not shown).  However, the controls were more folded, 
indicating that the addition of PGS membranes flattened the retinal cultures.  In retinas co-
cultured with RGD-PGS sheets, processes extending from retinal cultures towards the RGD-PGS 
sheets were observed in some sections (images not shown). 
Neurofilament staining in retinas co-cultured in vitro with PCL-PGS or Laminin-PCL-PGS 
membranes for 9 or 16 days demonstrated an absence of ganglion cells in these retinas (Fig. 2A-
D).  Neurofilament labeling was evident in the ganglion cell layer for E49 in vitro controls 
cultured for 7 days (Fig. 2E), but eventually disappeared from the nerve fiber layer (NFL) after 
14 days (Fig. 2F).  By comparison, neurofilament positive axons were intensely labeled in the 
NFL of in vivo controls (Fig. 2G, H). 
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Figure 2. Neurofilament staining of fetal porcine retina. A-D: E50 retinas co-cultured for 9 (A, 
C) and 16 (B, D) days in vitro with PGS membranes coated with PCL (A, B) or laminin-PCL 
blend (C, D) nanofibers. Neurofilament staining is absent in the retinas co-cultured with 
nanofiber coated PGS membranes. E-F: E49 retinas cultured for 7 (E) and 14 (F) days in vitro. 
Neurofilament positive ganglion cells are visible in the ganglion cell layer (E). However, 
neurofilament staining is less evident following longer culture in vitro (F). G-H: E60 (G) and 
E70 (H) in vivo retina specimens. Neurofilament positive axons are visible in the nerve fiber 
layer (G). Intensely labeled neurofilament positive axons in the nerve fiber layer are visible, and 
horizontal cells in the outer part of the INL are also labeled (H). Neurofilament staining is less 
pronounced in in vitro specimens (E-F) compared to in vivo specimens (G-H). VITR, vitreal 
(inner) aspect, SCL, sclera (outer) aspect. Scale bar = 50 microns. 
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PKC labeled rod bipolar cells and parvalbumin labeled AII amacrine cells were not evident in 
retinas co-cultured with biomaterial membranes or in in vitro controls (Fig. 3A-F).  Tube-like 
structures appeared as rosettes in some sections (indicated by arrows in Fig. 3B, C).  In E70 in 
vivo controls, PKC labeled rod bipolar cells were visible in the inner nuclear layer (INL) and 
ganglion cell layer (GCL).  Neurites were intensely labeled with PKC in the inner plexiform 
layer (IPL) (Fig. 3G).  Parvalbumin labeled amacrine cells were present in the GCL (Fig. 3H). 
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Figure 3. PKC (left column) and parvalbumin (right column) staining of fetal porcine retina. A-
D: E50 retinas co-cultured for 16 days in vitro with PGS membranes coated with PCL (A, B) or 
laminin-PCL blend (C, D) nanofibers. Rosettes (arrows) are present in some sections (B, C). E-
F: E49 retinas cultured for 14 days in vitro. PKC labeled rod bipolar cells and parvalbumin 
labeled amacrine cells are not abundant in any retinas cultured in vitro (A-F). G-H: E70 in vivo 
retina specimens. PKC labeled rod bipolar cells are seen in the inner part of the INL and in the 
GCL with intense labeling of neurites in the IPL (G). Parvalbumin labeled amacrine cell bodies 
are found in the GCL (H). VITR, vitreal (inner) aspect, SCL, sclera (outer) aspect. Scale bar = 50 
microns. 
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Large populations of recoverin labeled photoreceptors were present in all retinas co-cultured 
with biomaterial membranes (Fig. 4A-D).  Recoverin labeled photoreceptors were located 
predominately in the outer retinal layers of in vitro controls (Fig. 4E, F), and in the outer nuclear 
layer (ONL) of in vivo controls (Fig. 4G, H). 
Vimentin labeled Müller cells were well organized in retinas co-cultured with biomaterial 
membranes, with processes apparently extending into the nanofiber networks (Fig. 4A-D).  
Vertically arranged vimentin labeled fibers were present in inner retinal layers of in vitro and in 
vivo controls (Fig. 4E-H).  The retinas co-cultured with membranes did not express vimentin at 
the same intensity as the controls. 
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Figure 4. Recoverin (red) and vimentin (green) double-labeling of fetal porcine retina. A-D: E50 
retinas co-cultured for 9 (A, C) and 16 (B, D) days in vitro with PGS membranes coated with 
PCL (A, B) or laminin-PCL blend (C, D) nanofibers. Müller cells are well organized, large 
populations of recoverin labeled photoreceptors are visible, and vimentin labeled processes 
extend into the nanofiber network. E-F: E49 retinas cultured for 7 (E) and 14 (F) days in vitro. 
Recoverin labeled photoreceptors are found mainly in outer retinal layers, and vertically 
arranged vimentin labeled fibers are visible with strong intensity corresponding to inner retinal 
layers. G-H: E60 (G) and E70 (H) in vivo retina specimens. Recoverin labeled photoreceptors 
are visible with highest intensity in the outer retinal layers, and vertically arranged vimentin 
labeled fibers are visible (G). Recoverin labeled photoreceptor cells are seen in the entire ONL, 
and Müller cell processes display vimentin labeling throughout the retina with strong intensity 
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corresponding to the inner retinal layers (H). Vimentin labeling of Müller cells is less intense in 
retinas co-cultured with PGS-nanofiber membranes (A-D) compared to controls (E-H). VITR, 
vitreal (inner) aspect, SCL, sclera (outer) aspect. Scale bar = 50 microns. 
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Rhodopsin labeling revealed an abundance of rod photoreceptors in outer nuclear layer (ONL) of 
retinas co-cultures with biomaterial membranes (Fig. 5A-D).  Rhodopsin labeled rods were also 
present in in vitro and in vivo controls (Fig. 5E-H). 
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Figure 5. Rhodopsin staining of fetal porcine retina. A-D: E50 retinas co-cultured for 9 (A, C) 
and 16 (B, D) days in vitro with PGS membranes coated with PCL (A, B) or laminin-PCL blend 
(C, D) nanofibers. Rhodopsin labeled rod photoreceptors are visible in the outer nuclear layers of 
retinas, and survive at least 16 days in co-culture with PGS-nanofiber membranes. E-F: E49 
retinas cultured for 7 (E) and 14 (F) days in vitro. Rhodopsin labeled rod photoreceptors are 
visible in the outer nuclear layer. G-H: E60 (G) and E70 (H) in vivo retina specimens. 
Rhodopsin labeled rod photoreceptors with neurites extending inwards as well as outwards to the 
margin of the retina are visible (G). Rhodopsin labeled rod photoreceptors are visible in the outer 
nuclear layer (H). VITR, vitreal (inner) aspect, SCL, sclera (outer) aspect. Scale bar = 50 
microns. 
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Discussion 
In a previous study, 45 µm thick membranes were implanted into the subretinal space of rabbits, 
with one case of mechanical noncompliance resulting in damage to the RPE and choroid [10].  In 
this study, we were able to fabricate 30 µm membranes using a cryo-sectioning technique.  By 
making the membranes thinner, they also became more flexible.  Therefore mechanical 
disruption of the retina during and following implantation, as well as subretinal gliosis, may be 
reduced by using 30 µm membranes.  PGS membranes without modification did not adhere 
firmly to the cultured retinas.  However, the controls were more folded, indicating that the 
addition of PGS membranes flattened the retinal cultures.  This is considered desirable, as it may 
help preserve the laminated morphology of the photoreceptor layer following transplantation. 
A nanofiber architecture was necessary to provide sufficient attachment of porcine retinal layers 
for surgical handling and transplantation.  Nanofibers have been demonstrated to be effective at 
providing a bridge within peripheral nerve tubes for axonal regeneration both in vitro and in vivo 
[16] [17] [18].  Polymeric nanofibers have also exhibited nerve guidance capabilities in the 
central nervous system.  Structure and geometry have been shown to play very significant roles 
in cell adhesion and guidance.  For example, smaller diameter nanofibers appear to yield longer 
and faster outgrowth of neurites than larger diameter nanofibers [19].  The paper also reports 
significantly longer outgrowth of neurites occurred on laminin coated fibers compared to 
fibronectin fibers with fibers of the same diameter.  In another study, collagen-functionalized 
nanofibers improved cell adhesion and migration compared to non-functionalized nanofibers 
[20].  The authors suggested that functionalizing nanofibers with fibronectin or laminin may 
potentially have a greater effect than collagen by stimulating integrin binding through peptide 
sequences such as RGD, IKVAV and YISGR.  The addition of laminin to the nanofibers coating 
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the PGS sheets was to promote neurite in-growth into the membrane and to facilitate neuronal 
connection between graft and host following degradation of the biomaterial by orienting graft 
neurites towards host inner nuclear layers.  However, no evidence of neurite in-growth into the 
nanofiber mesh was observed in vitro in this study. Furthermore, based on the antibodies tested 
in this study, no differences were detected between membranes with PCL nanofibers and 
membranes with PCL and laminin blended fibers.  The structural arrangement and bioactivity of 
the laminin following electrospinning warrants further investigation. 
In some histological sections of retinas co-cultured with nanofiber coated membranes, it 
appeared as though some tissue elements have penetrated the fiber network showing promising 
in-growth (images not shown).  These processes label for vimentin and are thus at least partly of 
Müller origin.  Comparing retinas co-cultured with membranes to in vitro controls it was 
observed that the retinas with membranes do not express vimentin in Müller cells at the same 
intensity as controls.  Low vimentin expression in Müller cells is difficult to interpret.  The cells 
display a normal structure, but the membrane may influence nutrition. 
Persisting inner nuclear cells in the donor tissue are thought to inhibit integration of donor 
photoreceptors with the host inner nuclear layers.  Therefore, the removal of these cells prior to 
transplantation may be favourable for neuronal connection of the co-cultured retinal layer upon 
degradation of the biomaterial.  Neurofilament remains for some time in E49 in vitro controls 
cultured for 7 days (E49-7DIV), but not in the PCL-PGS or Laminin-PCL-PGS cultured 
specimens.  This removal of ganglion cells may be due to retrograde degeneration as the optic 
nerve is cut, enhanced by the ischemia induced by the sectioning of retinal vessels as well as 
placing the biomaterial membranes on top of the retinal layers in vitro.  Even in E60 in vivo 
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controls, PKC (rod bipolars) and parvalbumin (amacrine cells) are not abundant, indicating that 
retinal tissue isolated prior to 60 days post-embryogenesis is ideal for transplantation. 
In a prior study, the 45 µm PGS membranes degraded within 28 days in the subretinal space in 
rabbits [10].  This duration was sufficiently long enough for the selective removal of host 
photoreceptors in rabbit eyes.  Whilst the 30 µm PGS membranes will degrade more rapidly, 
PCL is likely to degrade over a longer period of time in vivo than PGS.  Therefore, the 
nanofibers may persist for longer than the PGS membrane.  This may or may not be 
advantageous. Pig photoreceptors are likely to be more resilient to ischemic trauma than rabbits, 
and may require a longer separation time from the retinal pigment epithelium (RPE).  On the 
other hand, a prolonged separation between donor photoreceptors and the host inner nuclear 
layer (INL) may lead to undesired subretinal gliosis. 
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Conclusion 
We have shown that electrospun nanofibers composed of laminin and PCL promoted sufficient 
cell adhesion for simultaneous transplantation of isolated photoreceptor layers and PGS 
membranes.  Composites developed large populations of recoverin and rhodopsin labeled 
photoreceptors.  Furthermore, ganglion cells, rod bipolar cells and AII amacrine cells were 
absent in co-cultured retinas as observed by neurofilament, PKC and parvalbumin labeling 
respectively.  It may now be possible to conduct retinal transplantation experiments in which a 
composite graft composed of a biodegradable membrane adhered to an immature retina 
dominated by photoreceptor cells are delivered in a single surgery.  By selective removal of host 
photoreceptors and delivery of a photoreceptor transplant without inner retinal cells, this 
approach may improve graft-host neuronal connections. 
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Abstract 
In retinal transplantation experiments it is hypothesized that remaining diseased photoreceptor 
cells in the host retina and inner retinal cells in transplants physically obstruct the development 
of graft-host neuronal contacts which are required for vision. Recently, we developed methods 
for the isolation of donor photoreceptor layers in vitro, and the selective removal of host 
photoreceptors in vivo using biodegradable elastomeric membranes composed of poly(glycerol-
co-sebacic acid) (PGS). We also coated PGS membranes with electrospun nanofibers, composed 
of laminin and poly(epsilon-caprolactone) (PCL), to promote attachment of embryonic retinal 
explants, allowing the resulting composites to be handled surgically as a single entity. Here, we 
report subretinal transplantation of these composites into adult porcine eyes. In hematoxylin and 
eosin stained sections of composite explants after 5-7 days in vitro, excellent fusion of retinas 
and biomaterial membranes was noted, with the immature retinal components showing laminated 
as well as folded and rosetted areas. The composite grafts could be transplanted in all cases and, 
3 months after surgery, eyes displayed clear media, attached retinas and the grafts located 
subretinally. Histological examination revealed that the biomaterial membrane had degraded 
without any signs of inflammation. Transplanted retinas displayed areas of rosettes as well as 
normal lamination. In most cases inner retinal layers were present in the grafts. Laminated areas 
displayed well developed photoreceptors adjacent to an intact host retinal pigment epithelium 
and degeneration of the host outer nuclear layer (ONL) was often observed together with 
occasional fusion of graft and host inner layers. 
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Introduction 
Retinal transplantation experiments have the common goal of alleviating symptoms in patients 
suffering from retinal degeneration by replacing diseased photoreceptors with healthy cells. In 
the past two decades, a multitude of experimental approaches involving many different animal 
models have been explored but, to date, retinal transplantation is not available as a clinical 
treatment. 
To transfer the retinal transplantation paradigm from the laboratory to the clinic, several key 
requirements must first be demonstrated. First, photoreceptors must survive the transplantation 
procedure and avoid rejection in the foreign host. Once in place, grafted cells have to organize 
properly and display structural properties as well as biochemical machinery compatible with 
phototransduction. Finally, the transduced signal must be transferred from the grafted cells to 
host neurons in a manner which allows visual perception. 
Early protocols of retinal transplantation involved enzymatically and mechanically disrupted 
donor tissue in soluble form which, with comparatively little surgical effort, could be transferred 
to the confined subretinal space of the host eye. These experiments, as well as more recent ones 
built on the concept of cell-suspensions of retinal, progenitor or stem cells, have shown that 
disruption of the donor tissue may not be beneficial for graft survival, development, organization 
and integration [1-4]. 
To improve graft survival and organization, transplantation of non-disrupted tissue in the form of 
full-thickness retina has been explored by a few groups [5-8]. The rationale of the full-thickness 
paradigm is to limit antigen exposure to the host immune system, and retain the laminated 
organization of the donor retina with its delicate intrinsic microcircuitry. From experiments in 
large-eye animal models, the surgical procedure for full-thickness transplantation has been 
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shown to be safe and relatively atraumatic to the eye in both normal and diseased eyes. Further, 
full-thickness grafts develop and retain morphologically normal photoreceptors for extended 
time periods in the foreign environment. In accordance with the initial hypothesis, these grafts 
elicit almost no immune response, as long as the graft is kept intact in both allogeneic as well as 
xenogeneic donor tissue paradigms [9-11]. 
The remaining issue that needs to be resolved pending clinical trials is the formation of 
functional connective neuronal networks so that transduced signals from grafted photoreceptors 
can be transferred to the host CNS. Graft-host neuronal connections have been demonstrated to 
some extent in the rabbit model [12-13] but not in the more relevant porcine one, in which 
integration of the two entities is hampered by the presence of remaining inner retinal cells in the 
transplant and remaining photoreceptors in the host [14]. To enhance the chance of useful 
integration of host and graft retina, these physical barriers should ideally be removed. 
We have previously described the creation of a graft retina composed of isolated photoreceptors 
supported by Müller cells in an in vitro rodent model [15]. This was accomplished by separating 
immature full-thickness retinas from their inherent retinal circulation which, in combination with 
optic nerve transection, caused regression of inner retinal layer development. Next, we were able 
to remove photoreceptor cells from a defined area in adult rabbit eyes without damaging 
remaining inner retinal cells [16]. The photoreceptor cells are dependent on nutritive support 
from the choroid and, by implanting a 50 μm thick biodegradable PGS elastomer in the 
subretinal space of normal rabbits, selective outer retinal ischemia was accomplished. 
Implantation of the PGS membrane, however, did inflict damage on the retinal pigment 
epithelium. To limit the risk of this and other complications, transplantation of the neuroretinal 
tissue and implantation of the PGS membrane in the same session would be preferable. To this 
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end, we constructed a composite graft consisting of an immature porcine full-thickness retina 
fused with a degradable PGS membrane [17]. We found that the PGS membranes coated with 
electrospun nanofibers adhered very well to the retina after 7 days of co-culture in vitro, and did 
not separate after placement and ejection from the transplantation instrument. The addition of the 
PGS membrane had no observed adverse effects on the developing donor tissue. 
In the present study, we explore transplantation of the PGS-retina composite graft. We 
hypothesize that a graft composed of well-organized photoreceptors within a Müller glia cell 
scaffold fused with a biodegradable membrane will have an increased likelihood of recreating 
the complete retina with outer layers derived from the graft and inner retinal layers from the host 
(Fig. 1). 
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Figure 1. Illustration of the composite retinal graft model. Top: The in vivo host retina is 
dependent on a dual blood supply. The choroid supplies the photoreceptors in the outer nuclear 
layer (ONL) while the retinal vessels supply the inner retinal cells in the inner nuclear and 
ganglion cell layer (INL and GCL). Middle: When the composite graft, consisting of 
photoreceptors in a transplant outer nuclear layer (tONL) fused with a PGS membrane, is placed 
in the subretinal space, the membrane blocks the nutritive support to the host ONL which 
induces ischemia and removes host photoreceptors. Bottom: Following PGS membrane 
degradation, the remaining inner retina of the host integrates with the transplanted 
photoreceptors (tONL) creating a new retina with all normal layers. 
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Materials and methods 
All compounds and solvents were obtained from Sigma-Aldrich, St. Louis, MO, USA, unless 
otherwise stated. 
Preparation of poly(glycerol-co-sebacic acid) membranes 
Poly(glycerol-co-sebacic acid) (PGS) branched polymer was prepared by poly-condensation as 
previously described [18]. Briefly, equimolar amounts (0.989 mol) of re-crystallized sebacic acid 
and anhydrous glycerol were charged to an oven-dried round bottom flask and reacted with 
stirring at 120°C under argon. After 21 hours, vacuum was applied and the mixture was reacted 
for another 64 hours. The resulting material formed a white wax at room temperature. 
Cross-linking of the PGS to an elastomer was carried out in a class 10,000 clean room [19],[16]. 
A 10:1 prepolymer:hardener mixture of poly(dimethylsiloxane) (PDMS) (Sylgard 184, Dow 
Corning, Midland, MI) was degassed under vacuum and cured in a 10 cm Petri dish for 1 hour at 
60°C. The resulting 10 cm diameter PDMS slab was plasma oxidized for 1 minute to create a 
hydrophilic surface. The top surface was spin coated at 3000 rpm for 30 seconds with a 61.5 wt. 
% aqueous sucrose solution (saturated at room temperature and 0.45 µm syringe filtered). The 
sucrose-coated PDMS was subsequently baked at 130 °C for 10 minutes and transferred to a 
hotplate at 120°C. Molten PGS wax (120 °C) was poured onto the sucrose-coated PDMS slab, 
covering the entire surface, and subsequently cured at 120 °C under a 15 millitorr vacuum until 
the PGS lost any adhesiveness to a stainless steel spatula. 
Subsequently, the mold was submerged in 18 MOhm water overnight and the PGS was peeled 
from the PDMS underwater. The resultant PGS disk was approximately 3 mm thick. 
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The PGS disk was cut into 5 x 5 x 3 mm blocks, embedded in Tissue-Tek OCT compound 
(Sakura, Torrance, CA) and rapidly frozen by immersion in ethanol cooled with dry ice [17]. 
Frozen PGS was cryo-sectioned into 30 µm membranes at -30˚C with a Shur/Sharp Heavy Duty 
razor blade (TBS, Durham, NC). Thicker blades (0.5 mm or greater) and slow sectioning speeds 
were necessary to reduce vibration and warming of the blade from friction. Membrane thickness 
and uniformity was confirmed by scanning electron microscopy. 
Fabrication of electrospun nanofibers 
Nanofibers consisting of poly(epsilon-caprolactone) (PCL) laminin and a blend of 10 wt. % 
laminin in PCL of approximately 100 nanometers were electrospun onto 30 micron PGS sheets 
to create a bi-layer biomaterial membrane. Neuroretinal explants were subsequently placed on a 
culture membrane with the outer layers facing downward and the PGS-nanofiber membranes on 
top, with the nanofiber side of the PGS sheet placed onto the inner layers of the explant. Type 1 
Laminin was isolated from murine Englebreth-Swarm-Holme tumor as previously described 
[20]. The laminin was provided as a gift by Stemgent, Inc. (Cambridge, MA). Electrospinning 
followed previously described protocols [21],[17]. For laminin nanofibers, lyophilized laminin 
was dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol (HFP) at 3 w/v % at 4 °C overnight. The 
solution was then mounted into an Aladdin syringe pump (World Precision Instruments, 
Sarasota, FL) using a disposable syringe and a 18 gauge needle. PGS sheets mounted on glass 
cover slips were placed on the collector plate, and the laminin solution was dispensed at a flow 
rate of 1 mL/hr and driving voltage of 15 kV across a 15 cm vertical gap onto the grounded 
copper collector, and hence onto the PGS sheets. Samples were dried completely and stored in 
dessicant at -20 °C. Laminin-PCL blend nanofibers were electrospun in a similar manner. A 
solution consisting of 10 wt. % laminin and 90 wt. % PCL with 8 w/v % total polymer dissolved 
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in HFP was used as the initial solution. The same procedure as for laminin was used to 
electrospin the blend onto PGS sheets, though the driving voltage was increased to 20 kV to 
compensate for the higher viscosity of this solution. 18 wt. % PCL was dissolved in 1:1 
THF:DMF and electrospun at 20 kV in the same manner to fabricate PCL nanofibers. 
Porcine tissue isolation 
Eyes from Yorkshire/Hampshire pigs (gestational age of 114 days) were obtained from a local 
breeder (Lund, Sweden) and used for all experiments. Retinal tissue from E40 (40 days after 
conception) was used for culturing experiments. The pregnant sow was euthanized by means of 
captive bolt and incision of the carotid arteries. The fetuses were collected by caesarean section 
and euthanized by decapitation. Both eyes were enucleated and immediately immersed in ice-
cold CO2-independent medium. The neuroretinas were carefully dissected free from the retinal 
pigment epithelium (RPE) and hyaloid vascular system with fine forceps. The optic nerve was 
thereafter cut with micro-scissors and neuroretinal pieces measuring approximately 3x4 mm 
were explanted on Millicell®-HA 0.45- μm culture plate inserts with the photoreceptor layer 
towards the membrane. All neuroretinas were put in culture within 240 minutes of euthanasia. 
Explants were cultured in 1.2 mL Gibco D-MEM F12 medium –L-Glutamine (Gibco, Paisley, 
UK) supplemented with 10 vol. % fetal calf serum. A cocktail containing 2 mM L-glutamine, 
100 U/mL penicillin and 100 ng/mL streptomycin was added and the retinas were maintained at 
37 °C with 95 % humidity and 5 % CO2. 
All proceedings and treatment of animals were in accordance with the guidelines and 
requirements of the Government Committee on Animal Experimentation at Lund University and 
with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. 
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Co-culture of retinal layers with biomaterial membranes 
After two days in vitro, PCL-PGS and Laminin-PCL-PGS membranes measuring 3x4 mm were 
added to the explanted retinal specimens, while remaining pieces were kept in culture without 
the addition of a membrane as controls. At this time, half of the culture medium was exchanged, 
and this procedure was then repeated every second day. The composite explants were kept for 5-
7 days in vitro. At the end of the culture period, the PGS membrane had attached firmly to the 
neuroretina. 
To establish the fate of the composite explants prior to transplantation, neuroretinal explants with 
and without PGS membranes were fixed and prepared for histology at the end of the culture 
period. For these experiments, culture plate inserts were fixed in 4% paraformaldehyde in 0.1 M 
phosphate buffer (PB), pH 7.2, for 4 h at 4°C. Several rinses in PB followed, and then the 
specimens were infiltrated with 0.1 M PB containing sucrose in increasing concentrations, and 
finally embedded for cryosectioning. After serial sectioning on a cryostat, every 10th slide was 
stained with hematoxylin and eosin. Photographs were obtained with a digital camera system 
(Olympus, Tokyo, Japan) and were adjusted for brightness and contrast digitally. 
Surgery 
Twelve normal Yorkshire/Hampshire pigs, aged 3 months were used as hosts and received one 
PGS-retina composite graft in the right eye (PCL-PGS n=5, and Laminin-PCL-PGS n=7). The 
surgical procedure for full-thickness transplantation has been described in detail in previous 
articles [14]. In summary, a two-port central vitrectomy, including a posterior vitreous 
detachment, was performed, after which a local retinal bleb was created in a vessel-free area 2–3 
mm superior and nasal to the optic nerve by infusing Ames´ medium subretinally (Fig. 2). A 
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second retinotomy was then made to provide a valve. The compound graft, consisting of PGS 
membrane and neuroretina was transferred from the culture system to an embryonic cryodish 
filled with Ames´ solution. The Ames´ solution was exchanged several times, to ensure that no 
culture medium remained with the explants. The graft was drawn into a polyethylene tube 
(Becton Dickinson and company, MD, USA) attached to a syringe filled with Ames´ solution. 
The polyethylene tube had an original inner diameter of 1.4 mm and an outer diameter of 1.9 
mm, and was flattened mechanically to accommodate the flat PGS-retina graft. The tube was 
introduced into the eye, and advanced until its tip was adjacent to the first retinotomy. The graft 
was then eased out, into the subretinal space. Eyes from the first and second day of surgery 
received a 3x4 mm graft, and in these eyes, some bleeding from the retinotomy was evident. On 
the second day of surgery, smaller (2x3 mm) grafts were used which reduced the incidence of 
retinal hemorrhage. 
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Figure 2. Intra-operative photographs, demonstrating the formation of a subretinal bleb (A and 
B) and introduction of the graft into the subretinal space (C and D). 
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Postoperative management and follow-up 
No postoperative treatment was given. Eyes were examined externally daily for the first week. 
An ophthalmoscopic examination was performed on one occasion, 4-6 days postoperatively. At 
the end of the follow-up period, animals were euthanized by means of captive bolt and incision 
of the carotid arteries. The eyes were enucleated, a cut made at the pars plana, and the eyes were 
fixed in 4% paraformaldehyde in 0.1 M PB, pH 7.2, for 30 minutes. The anterior segment was 
then removed and the posterior eyecup was fixed in the same solution for 4 hours. After fixation, 
the specimens were handled in the same way as the explants fixed directly after culture (see 
above). 
All procedures and animal treatment were in accordance with the guidelines and requirements of 
the Government Committee on Animal Experimentation at Lund University and with the ARVO 
Statement for the Use of Animals in Ophthalmic and Vision Research. 
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Results 
Macroscopic findings 
At ophthalmoscopic examination, most eyes displayed clear media with the graft placed flat in 
the subretinal space. One pig showed signs of infection (blepharitis and slight opacification of 
the cornea) and was terminated 5 days postoperatively. At dissection, the interior of this eye was 
clear, and the graft was found in place in the subretinal space. Remaining eyes were followed for 
3 months. At dissection, these eyes displayed clear media, an attached retina with no signs of 
inflammation. In most cases, the graft was visible in the subretinal space as a rectangular gray 
tissue (Fig. 3). 
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Figure 3. Dissected eyecup 3 months after transplantation of a PGS-Retina explant. The graft is 
present as a gray rectangular shape under the folded host retina. 
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Histology 
PGS-retina explants 
In hematoxylin and eosin stained sections, explants cultured for a total of 7-9 days displayed 
areas of laminated retina as well as areas with folded retina and rosettes (Fig. 4). Retinal explants 
without addition of PGS membrane (n=7) displayed minimal folding/rosettes in one case, mixed 
rosettes and lamination in 4 cases, and in 2 cases mostly rosettes. Laminin-PCL-PGS explants 
(n=5) displayed minimal folding/rosettes in 2 cases, mixed rosettes and lamination in one case, 
and in 2 cases mostly rosettes. PCL-PGS explants (n=6) had minimal folding/rosettes in 3 cases, 
mixed rosettes and lamination in 2 cases, and in one case mostly rosettes. Laminated areas of 
explants without PGS membrane displayed a neuroblastic cell layer (NBL) consisting of multiple 
rows of undifferentiated cells, a thin inner plexiform layer (IPL), a ganglion cell layer (GCL) 
with one row of cells and a nerve fiber layer (NFL) in the innermost part (Fig.4A). In composite 
explants, the PGS membrane could be seen well-attached to the inner surface of the immature 
neuroretina (Fig. 4C-E). Laminated areas were thinner compared to specimens without PGS 
membrane and consisted of a NBL, a thin IPL and GCL and no discernible NFL (Fig. 4D). 
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Figure 4. Donor tissue after 7-9 days in vitro. Hematoxylin and eosin staining. A - B: E40 
neuroretinal explants without addition of PGS membrane. In A, a well laminated explant is seen 
with a neuroblastic cell layer (NBL) consisting of multiple rows of undifferentiated cells, a thin 
inner plexiform layer (IPL), a ganglion cell layer (GCL) with 1 row of cells and a nerve fiber 
layer NFL in the innermost part. In B severe folding of the retinal architecture is seen in another 
explant. 
C - E:  PGS-Retina explants: In C, the full extent of the composite explant with the Laminin-
PCL-PGS membrane (between arrows) attached to the inner retina can be seen. D: Detail. The 
explanted retina displays a NBL and rudimentary inner layers. E: Rosetted explant without any 
apparent lamination. 
Scale bar = 50 µm (A-B and D-E) and 500 µm (C) 
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Transplanted eyes 
In hematoxylin and eosin stained sections, the one eye with a PCL-PGS composite graft 
terminated on postoperative day 5 displayed the graft upside down in the subretinal space, with 
the membrane adjacent to the host retinal pigment epithelium (RPE), and the grafted neuroretina 
severely degenerated (Fig. 5A). The host retina had an epiretinal hemorrhage in the 
transplantation area and the outer nuclear layer (ONL) was thinner than normal. 
In transplanted eyes 3 months postoperatively, grafts were found in all 11 eyes which had 
received a PGS-retina composite graft (Fig. 5B-E). Eyes with Laminin-PCL-PGS composite 
grafts (n=7) displayed a laminated retina with minimal folding/rosettes in one case, mixed 
rosettes and lamination in 2 cases and mostly rosettes in 4 cases. Eyes with PCL-PGS composite 
grafts (n=4) displayed a laminated retina with minimal folding/rosettes in one case, with the 
remaining 3 consisting mostly of rosettes. Laminated areas of 3-month composite grafts 
displayed outer segments apposed to the host RPE, inner segments, a well developed ONL, an 
outer plexiform layer (OPL), INL, thin IPL and cells with small perikarya in the GCL. The host 
RPE was found to be continuous in all areas where a laminated graft was found. In rosetted 
areas, the RPE was occasionally discontinuous, and in one case, an invasion of cells from the 
choroid was evident. No other signs of inflammation were seen. The host retina appeared normal 
in all eyes, except for the part covering the transplant. Here, the photoreceptors in the ONL had 
degenerated to varying degrees. In some sections no ONL was found, while in others 3 to 4 rows 
of cells without outer segments remained. The inner retinal layers were preserved in most cases 
but occasionally disruption of the INL was evident. The PGS membrane could not be identified 
in any 3-month specimen. However, between graft and host, especially in areas of rosette 
formation, yellowish deposits were found in 5 specimens (4 Lam-PCL-PGS and 1 PCL-PGS), 
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and reddish material in one case, suggestive of remnants of foreign material possibly derived 
from the degraded biomaterial membrane (Fig. 5D-E).  Occasionally fusion of graft and host 
retina was seen and the innermost layers of the graft had integrated with the host INL. 
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Figure 5. PGS-Retina transplants. Hematoxylin and eosin staining. A: PCL-PGS composite graft 
5 days postoperatively. The transplant (T) is upside down in the subretinal space with the 
membrane (PGS) adjacent to the host Retinal Pigment Epithelium (RPE). The grafted 
neuroretina in severely degenerated. The host retina (H) has an epiretinal hemorrhage and the 
outer nuclear (ONL) is thinner than normal. B - D: 3-month transplants (T). B - D shows 
laminated areas where the graft consists of outer segments (OS) apposed to the host retinal 
pigment epithelium (RPE), inner segments (IS), outer nuclear layer (ONL), outer plexiform layer 
(OPL), inner nuclear layer (INL), inner plexiform layer (IPL), and cells with small perikarya in 
the ganglion cell layer (GCL). In the host retina (H), the ONL is absent in B and D and severely 
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reduced in C. Fusion of the graft with the inner nuclear layer is evident in B and D while the two 
entities remain separate in C. E and F shows rosetted transplants areas with yellowish and 
reddish material between the host and graft (arrows). 
Scale bar = 200 µm (A), and 100 µm (B - F). 
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Discussion 
Surgical considerations 
In the present paper we have explored the concept of retinal transplantation in combination with 
a degradable membrane for the purpose of enhancing graft-host neuronal integration. Eyes 
transplanted with the PGS-retina graft fared well postoperatively, displaying clear media, 
attached retina, and the graft securely in place in the subretinal space, suggesting that the surgical 
procedure for composite graft transplantation works efficiently. 
Transplantation of full-thickness retina has been reported in several animal models previously [6-
8],[14]. In earlier work in pig and rabbit eyes, we used a siliconized glass cannula for 
transplantation in which the elastic retinal graft adopted a rolled-up shape. This allowed us to use 
a relatively small sclerotomy and retinotomy. In the present study, the added PGS membrane 
made the composite graft less flexible, requiring a different approach using a wider device in 
which the graft could be kept flat. This, in turn, necessitated a wider sclerotomy and retinotomy, 
which was associated with some degree of retinal hemorrhage. We are currently developing a 
more flexible biomaterial membrane, with a lower elastic modulus, to reduce the risk of 
complications. This may be accomplished by changing the curing time of PGS to reduce the 
degree of cross-linking, or the selection of different monomer precursors [22-23]. 
Transplanted retina 
Surviving grafts were found in all transplanted eyes confirming the low degree of antigenicity of 
full-thickness retina. This also suggests that the addition of PGS membrane does not provoke 
immune rejection. Laminated areas of the grafts displayed well-developed photoreceptors 
organized in an outer nuclear layer comparable in size to the one found in the normal adult 
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porcine retina. However, somewhat surprisingly, inner layers also developed and were retained, 
which hampered neuronal contacts between grafted photoreceptors and the host inner retina. In a 
previously published paper where E45-E50 porcine retina cultures were explored, we found that 
addition of PGS membrane drastically suppressed inner retinal cell development while 
photoreceptors were unaffected [17]. Except for the use of E40 instead of E45-50 porcine retina, 
the same culturing protocol as in our previous work was used in the present work. In spite of 
several steps which should theoretically ensure photoreceptor isolation (optic nerve transection, 
separation from the developing retinal circulation, and placement of  PGS membrane on the 
inner part of the explants), inner layers were observed consistently in transplanted eyes. Cell type 
differentiation in the porcine retina commences at approximately E39-40 with a large population 
of cells still retained in an undifferentiated state [24]. The relative immaturity of the E40 
specimens may thus account for a seemingly normal inner retinal development in spite of the 
culturing process. The results suggest that, to obtain photoreceptor isolation in the graft, more 
mature donor tissue should be used. 
The PGS-retina composite grafts all displayed areas of rosette formation. Rosettes are an 
abnormal form of retinal development where the retina forms folds and then rolls of retinal 
tissue. The phenomenon has been attributed to abnormal development, and is not seen in the 
adult retina, even after trauma [25]. The exact origin of rosettes has not been established but they 
were first described in tumors (retinoblastoma) and later in retinal cultures, as well as in 
fragmented retinal transplants. Rosettes have been described in full-thickness retinal transplants 
but, in our previous work, laminated areas have invariably dominated the more atypical rosetted 
architecture [14]. Photoreceptors in rosettes display short or absent outer segments due to lack of 
proper contact with the RPE. In addition, visual processing in the retina is completely dependent 
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on a precise organization of the retinal subtypes for transduction, as well as visual processing, 
and it is unlikely for rosetted grafts to result in functional restoration of vision. A strong 
association between Müller cell trauma and rosette formation in the developing retina has been 
postulated [25]. In the present work, the E40 retinal explants with or without added PGS 
membrane displayed a considerable degree of folding and rosette formation, indicating that the 
culturing procedure prior to transplantation induces abnormal retinal development. In our 
previous paper on E45-E50 porcine retina cultures, we found only minimal folding [17]. Further, 
the addition of PGS membrane attenuated this phenomenon. As mentioned above, E39-40 is a 
critical time-point in porcine retinal development and it is possible that disturbance of early cell 
type differentiation disrupts retinal lamination [24]. Again, this indicates that the use of more 
mature donor tissue may be favorable. 
Host retina 
One of the main aims of the present work was to eliminate host photoreceptors without 
disturbing the inner retinal architecture. In all specimens, the ONL was reduced in the part 
straddling the transplant and, in some areas, it was completely missing while inner retinas were 
generally well-preserved. The reduction of ONL was more prominent compared with our earlier 
work involving transplantation of full-thickness retinas into porcine eyes.  This suggests that the 
PGS-membrane contributed to host photoreceptor death [14]. However, the host ONL was still 
present in some areas, indicating that a membrane with a longer degradation time may be even 
more effective. This may be accomplished by the selection of different monomer precursors with 
altered hydrophobicity in order to reduce the rate of hydrolysis of ester bonds in the elastomer 
[22-23]. 
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Conclusion 
We show that a composite graft composed of retinal tissue fused with a PGS membrane can be 
transplanted into an adult porcine eye with minimal complications. The PGS component of the 
graft degrades without signs of inflammation after inducing selective elimination of host 
photoreceptors. The remaining grafted retina survives well but often displays an atypical retinal 
architecture in the form of rosettes which can already be observed prior to transplantation in 
vitro. In spite of the culturing procedure, inner retinal layers develop and persist in laminated 
areas of the graft which hampers proper integration of graft photoreceptors with the remaining 
inner retina of the host. Future work will be directed towards optimization of graft retinal 
architecture prior to transplantation. 
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Abstract 
The aim of this study was to employ an experimental protocol for in vivo evaluation of sols of 5 
wt.% poly(ethylene glycol) (PEG) in phosphate buffered saline (PBS) as artificial vitreous 
substitutes. A 20 gauge pars plana vitrectomy and posterior vitreous detachment were performed 
in the right eye of 8 pigmented rabbits. Approximately 1 mL of the viscoelastic PEG sols were 
then injected into the vitreous space of 6 eyes. PEG with an average molecular weight of 300,000 
g mol
-1
 and 400,000 g mol
-1
 was used in 2 and 4 eyes respectively. 2 eyes received balanced salt 
soultion (BSS) and served as controls. Full-field electroretinography (ERG) and intraocular 
pressure (IOP, palpation) was measured pre-and post-operatively at regular intervals up to 41 
days. The rabbits were sacrificed and the eyes were examined by retinal photography, gross 
macroscopic examination and histology. The viscoelastic sols were successfully injected and 
remained translucent throughout the postoperative period, with some inferior formation of 
precipitates. None of the eyes displayed IOP elevation postoperatively, but in 3 of the PEG sol 
injected eyes, transient hypotony was noted. One eye sustained a retinal detachment during 
surgery and another 2 in the postoperative period. ERG recordings confirmed preservation of 
retinal function in 3 out of 4 eyes injected with 400,000 g mol
-1
 PEG. Histological examination 
revealed upregulation of glial acidic fibrillary protein (GFAP) in Müller cells in PEG sol injected 
eyes, but normal overall morphology in eyes with attached retinas.  The viscosity of the sol was 
not retained throughout the postoperative period, indicating the demand for polymer crosslinking 
to increase residence time.  The results provide promising preliminary results of the use of PEG 
hydrogels as a vitreous substitute. 
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Introduction 
Synthetic vitreous replacement is an important part of vitreoretinal surgery, for use as a 
tamponade in retinal detachment, diabetic retinopathy, trauma or possibly as a depot for long-
term drug delivery.  Currently gases, perfluorocarbon liquids or silicone oil are most 
predominately applied clinically to separate water from the retinal rupture to prevent subretinal 
fluid accumulation leading to further retinal detachment. However, these agents have several 
disadvantages, including cataracts and elevation of intraocular pressure (IOP), and they are 
unsuitable as long term vitreous substitutes [1-2].  The vitreous is a hydrogel composed of 
collagen and hyaluronic acid, with reported values of 98-99% water. pH 7.0-7.4, with and elastic 
modulus of 4.2-4.7 Pa and a loss modulus of 1.9-3.7 Pa and a refractive index of 1.3345-1.3348 
[3].  Synthetic hydrogels are a promising form of vitreous substitute that could tamponade water 
influx through a rupture and simultaneously provide a normal vitreous biochemistry.  Material 
requirements include optical translucence and homogeneity, atoxicity and physiological 
isotonicity.  The material must also permit transport of salts, nutrients and water and be stable to 
enzymatic or hydrolytic degradation as well as being immunologically inert.  In addition, it 
should be able to be administrated through a 20 gauge needle without inducing structural damage 
to the gel.  Therefore, an injectable hydrogel that cross-links in situ is theoretically an ideal 
solution.  A wide variety of synthetic polymers, in solution or as cross-linked hydrogels, have 
been tested experimentally and shown to satisfy a wide range of necessary properties.  However, 
to date, no material has been successfully translated for clinical use that can meet all desired 
properties for an ideal vitreous substitute [4-15].Problems have included gel fragmentation, 
opacification, retinotoxicity and IOP elevation.  In a prior study, a polymer using in 
reconstructive surgery, poly(alkyl-imide) (Bio-Alcamid™), was tested as a potential substitute 
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[16-17].  However, this material caused central retinal edema one day after surgery, accompanied 
by pathological electroretinography (ERG) [18].  Poly(ethylene glycol) (PEG) is a synthetic 
water soluble polymer that has been FDA approved for use in a wide range of biomedical 
applications, including injectable hydrogels [19].  It has also been tested in formulations for 
intravitreal drug delivery, repair of scleral incisions and sealing retinal detachments [20-22].  In 
this study, we investigated the injection of viscoelastic sols of high molecular weight (> 200 
kDa) PEG in phosphate buffered saline (PBS) into the vitreous bodies of rabbit eyes following 
vitrectomy.  The molecular weights and concentration of PEG were chosen to approximate the 
mechanical properties of the natural vitreous.  The aim of the study was to ascertain whether the 
PEG sols preserve normal intraocular pressure (IOP), retinal function and attachment as vitreous 
substitutes after experimental vitrectomy. 
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Materials and methods 
Characterization of PEG sols 
Sols of 5 wt.% poly(ethylene glycol) (PEG, Sigma Aldrich, St. Louis, MO) were prepared in 
sterile phosphate buffered saline (PBS, pH 7.4, Invitrogen, Carlsbad, CA), with molecular 
weights of 200, 300 and 400 kDa.  The sols are referred to as S200, S300 and S400 respectively 
in subsequent sections.  pH was measured using a digital pH probe (Russell RL060P, Thermo 
Scientific, Waltham, MA).  Dynamic rheology was performed using an AR G-2 with a 40 mm 
diameter 2 cone and plate set-up (TA Instruments, New Castle, DE) at 10 rad s-1 oscillation and 
5 % strain.  Refractive indices were measured using a handheld Brix refractometer (PAL-1, 
Atago, Tokyo, Japan).  Sols were sterilized by ultraviolet irradiation for 12 hours prior to 
surgery. 
Animal selection and study protocol 
The study was approved by The Regional Ethics Committee for Animal Experiments in Lund 
and it also conformed to the ARVO Resolution on the Use of Animals in Vision and Ophthalmic 
Research. 
Eight pigmented rabbits, aged 4 months were used in the experiment. The right eye was operated 
upon and injected with 0.8-1 mL solutions following vitrectomy (3 with S300, 3 with with S400, 
2 with balanced salt solution (BSS)) while the left eye served as a control.  Examination 
including ophthalmoscopy and IOP measurement (palpation) was performed at postoperative day 
6, 20 and 41. The rabbits were sacrificed at day 41, at which time the eyes were gross examined, 
photographed and prepared for histological examination with routine microscopy. 
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Surgery 
All procedures were performed by clinically well experienced vitreoretinal surgeons. General 
anesthesia was provided with a combination of ketamine (35 mg/kg) and xylazine (5 mg/kg) 
intramuscularly. The right eye was instilled with cyclopentolate (1%) and phenylephrine (10%) 
30 minutes before surgery. Topical tetracaine (0.5%) was applied just before surgery. The 
conjunctiva was incised limbally 270° from 9 to 6 o’clock with a vertical incision at 12 o’clock, 
creating two flaps. A 20G infusion cannula was sutured to the sclera in the 4 o’clock position 1 
mm posterior to the limbus and a balanced salt solution (BSS, Endosol, Allergan Medical Optics) 
was started. Two 20G sclerotomies were made in the 10 and 2 o’clock positions. A BIOM 90-D 
lens (Oculus) was used to visualize the fundus, and an Accurus surgical system machine (Alcon, 
Fort Worth, TX) was used for surgery. A standard endo-illuminating light probe (Alcon) was 
introduced through the 10 o’clock sclerotomy (illumination level 80%), and a vitreous cutter 
(Innovit, Alcon) was inserted through the 2 o’clock sclerotomy. Posterior vitreous detachment 
(PVD) was created by positioning the vitrectomy probe at the margin of the disk and applying 
suction (100 mmHg) while pulling on the probe. PVD was confirmed visually as the posterior 
vitreous cortex separated from the posterior pole. All vitreous in the central fundus 
(approximately 50% of the total volume) was removed while peripheral parts were left because 
of the risk of instrument touch to the comparatively large lens. In one case (#1 S300) a retinal 
touch with the vitrector occurred causing a retinal rupture and anterior chamber bleeding.  After 
vitreous removal, a fluid-air exchange was performed after which PEG sol was injected under 
visual control through a 19 gauge needle. The amount of sol injected varied from 0.8 to 1.5 mL 
(Table 2).  In one case, there was backflow during gel injection and a volume of 1.5 mL sol was 
administered (#6 S400).  The sclerotomies and conjunctiva were sutured and 25 mg gentamicin 
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and 2 mg betamethasone were injected subconjunctivally. No postoperative treatment was given.  
The eyes were examined externally daily and with an external ophthalmoscope at days 6 and 20. 
Images of the retinas were taken at day 20 (RetCam, Clarity Medical Systems, Pleasanton, CA). 
Two eyes, used as controls, underwent the above surgery but were injected with balanced salt 
solution (BSS) instead of PEG sol. 
Full-Field ERG 
A standardized full-field electroretinography (ERG) was recorded 7 days before surgery and 41 
days postoperatively on the right eye using a Nicolet Viking analysis system (Nicolet Biomedical 
Instruments, Madison Wisconsin) as previously described [23]. During examination the rabbits 
were sedated with Hypnorm, (fentanyl 0.2 mg/ml and fluanisone 10 mg/ml) 0.1 ml/kg, 
intramuscularly and the pupils were dilated with Cyclogyl (cyclopentolate hydrochloride 1%) to 
a pupil diameter of 8–9 mm. After 30 minutes of dark adaptation a Burian-Allen bipolar ERG 
contact lens electrode was applied on the topically anesthetized cornea together with a 
subcutaneous ground electrode on the neck. The lens was lubricated with methylcellulose (2%). 
Responses were obtained with a wide band filter (-3 dB at 1 Hz and 500 Hz), stimulating with 
single full-field flashes (30 µs) with dim blue light (Wratten filters # 47, 47A and 47B) and of 
white light (0.8 cd.s/m2). Cone responses were obtained with 30 Hz flickering white light (0.8 cd 
s/m2) averaged from 20 sweeps with and without a background light of 10 fL. The luminances of 
the three different light stimuli refer to the light reflected from the Ganzfeld sphere. 
Tissue preparation 
At day 41, the rabbits were sacrificed and the eyes were dissected, gross examined and fixed for 
1 h in 4% formalin, pH 7.3 in a 0.1 M Sørensen’s phosphate buffer (PB). After fixation, the 
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specimens were washed with 0.1 M Sørensen’s PB, and then washed again using the same 
solution containing sucrose of rising concentrations (5-25%). The specimens were sectioned at 
12 µm on a cryostat, and each 10th slide was stained with hematoxylin and eosin according to 
standard procedures. For glial fibrillary acidic protein (GFAP) immunolabeling, sections were 
washed in 0.1 M of sodium phosphate-buffered saline pH 7.2 (PBS) with 0.25% Triton X-100 
(PBS/Triton) and incubated with the primary antibody (anti-GFAP, clone G-A-5; Boehringer 
Mannheim Scandinavia, Bromma, Sweden, diluted 1:4 with PBS/Triton with 1% bovine serum 
albumin) overnight at +4°C. After incubation, the slides were rinsed in PBS/Triton, incubated 
with fluorescein isothiocyanate (FITC)-conjugated antibodies for 45 min, rinsed, and mounted in 
custom-made anti-fading mounting media. Unoperated eyes served as controls. For negative 
controls, the same labeling procedure without the primary antibody was performed on both the 
normal left and the operated right eye of the animals. 
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Results 
Sol physical properties 
Table 1 shows the physical properties measured for the sols.  The addition of PEG to pH 7.4 PBS 
resulted in a decrease in pH, which remained above 7 in all cases.  Both the elastic and loss 
moduli increased with increasing molecular weight at constant PEG concentration in PBS of 5 
wt.%.  Refractive indices decreased slightly with increasing molecular weight and were 
approximately nD of 1.339 at 25ºC converted from Brix % in all sols.  The sols were not as clear 
as pure water, but permitted transmission of meaningful visual information (Fig. 1A).  
Transparency appeared unchanged when heating the sols from 4 ºC to 37 ºC.  S200 could be 
drawn in via a 23 gauge cannula and S300 and S400 via a 19 gauge cannula and this appeared 
unchanged at 37 ºC.  A small amount of PEG remained insoluble, observed by addition of a blue 
hydrophilic dye to the sols. This fraction is larger in S400 compared with S200 and S300 (Fig. 
1B). 
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Table 1. Sol physical properties 
Sol name 
PEG molecular 
weight (kDa) 
pH 
Elastic 
modulus G’ 
(Pa) 
Loss modulus 
G” (Pa) 
Refractive index 
at 25 ºC (Brix %) 
S200 200 7.04 0.05 1.05 5.2 
S300 300 7.13 0.74 4.68 5.1 
S400 400 7.06 7.59 20.56 5.0 
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Figure 1. Poly(ethylene glycol) (PEG) sols. A. Transparency of PEG sol (left) compared to 
distilled water (right). B. Addition of hydrophilic blue dye to PEG sols showed a hydrophobic 
precipitate.  The hydrophobic region was larger, the higher the molecular weight of PEG. S400 
(left), S300 (middle), S200 (right). 
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Post-operative evaluation 
Results are summarized in Table 2.  During surgery, one eye had a retinal rupture and bleeding 
in the anterior chamber due to contact with a surgical instrument (#1 S300).  After 6 days post-
operatively, two eyes injected with the PEG solutions displayed hypotony, with an intra-ocular 
pressure (IOP) approximately 0 mmHg (#1 S300, #8 S400), while the remaining 4 had an IOP of 
approximately 10-15 mmHg.  Hypotonic eyes had a slight cataract superiorly but the majority of 
the lens was clear.  No outer signs of inflammation were observed.  One retina had a retinal 
detachment of approximately 40% due to the surgery (#1 S300). The remaining eyes displayed a 
normal retina without signs of edema. The vitreous was clear in the central and superior part.  
However, all eyes containing PEG displayed small white aggregates in the inferior vitreous body 
(Fig. 2).  After 20 days post-operatively the precipitate was greatly reduced compared to 6 days 
post-operatively in most PEG injected eyes.  No precipitate was present in BSS eyes.  One eye 
had a total retinal detachment (#1 S300) (Fig. 3 A, B).  Two eyes had peripheral retinal 
detachments (#2 S400, #6 S400), possibly due to ruptures at the sclerotomy sites.  No 
inflammation was observed externally or internally (Fig. 3 C, E).  The lens was partly opaque in 
one eye (#2 S400), but remained clear in all others.  IOP was not elevated in any eye but 2 eyes 
with detachment were hypotonic, between 0-5 mmHg (#1 S300, #6 S400).  Upon termination, 
after 41 days post-operatively, the vitreous was clear in all animals (Fig. 3 B, D, F).  The IOP 
was normal in all eyes.  Minimal cataract was noted in some eyes, but appeared to be reduced.  
Precipitates were found in the inferior vitreous in a few eyes (#6 S400, #8 S400), but was 
reduced compared to earlier examination time points.  The retina was completely detached in 
two eyes (#1 S300, #6 S400) and some folding was also noted (#4 BSS, #5 S300, #6 S400) (Fig. 
3 F).  The sols in all eyes were completely resorbed.
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Table 2. Pre-, per-, and post-operative data. 
Case # 
and 
vitreous 
substitut
e 
Injection 
volume. 
Surgical 
notes 
Day 6 Day 20 Day 41 Dissection H&E GFAP 
#1 S300 0.8 mL 
Surgery: 
Retinal 
rupture 
and 
anterior 
chamber 
bleeding. 
Clear, 
Conjunctiva 
ok. 
Temporal 
detachment, 
otherwise 
attached. 
Some 
precipitate 
centrally. 
IOP 0 
No injection. 
Cornea 
clear. No 
cataract. 
Clear 
vitreous. 
Total 
funnelshape
d RD. IOP 0 
(palp) 
No external 
inflammation
. Minimal 
cataract 
nasally. Clear 
vitreous. 
Total retinal 
detachment. 
IOP normal. 
Total RD, 
highest 
inferiorly. 
Seems 
inflamed 
here 
Total retinal 
detachment 
with 
destruction 
of the retina.  
Choroidal 
inflammation 
and dissolved 
RPE 
Upregulated
, Müller 
disorganize
d 
#2 S400 0.9 mL Minimal 
conj. 
injection. 
IOP approx. 
20. Cornea 
clear. 
Moderate 
cataract. 
Minimal 
vitreous 
haemorrhag
e No 
precipitate 
No injection, 
cornea clear. 
Lens clear 
anteriorly, 
posterior 
cataract. RD 
in the 
periphery 
inferiorly, 
centrally ok. 
Some 
precipitate 
on the 
posterior 
lens capsule. 
IOP 10. 
Minimal 
cataract. 
Vitreous 
clear. Retina 
attached and 
normal. IOP 
ok 
Normal 
dissection 
Retina 
appears 
normal. Epi 
and 
intraretinal 
clusters of 
brownish 
large cells 
(leucocytes?)
. 
Upregulated 
generally, 
Normal 
Müller 
Morphology 
#3 BSS  Not 
examined 
No injection. 
Cornea 
clear. Lens 
and vitreous 
clear. IOP 
10 (palp). 
Clear, retina 
ok, IOP ok 
OK Normal Minimal 
upregulation 
#4 BSS  Not 
examined 
No injection. 
Cornea 
clear. Mild 
cataract 
corresp. To 
the right 
sclerotomy. 
Vitreous 
clear IOP 10 
(palp). 
Clear, retina 
ok, IOP ok 
Minimal 
retinal 
folds, 
artefact? 
Normal Minimal 
upregulation 
#5 S300 1.3 mL Minimal 
injection. 
Precipitate 
in the 
vitreous 
No injection. 
Cornea 
clear. Mild 
cataract. 
Vitreous 
Minimal 
cataract, 
vitreous clear 
without 
precipitate. 
Some 
retinal 
folding. 
No gel 
Minimal 
central 
detachment 
(fold?). 
Retina looks 
Some 
elongation 
of Müller 
cell nuclei 
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inferiorly 
IOP approx. 
10. Minimal 
cataract. 
clear. Some 
precipitate 
inferiorly. 
Retina ok. 
IOP 10 
(palp). 
Retina ok, 
IOP ok 
ok, but 
inflammatory 
cells 
subretinally 
and large 
cells in the 
ONL are 
present on 
some 
sections 
#6 S400 1.5 mL 
(backflow
) 
Minimal 
injection. 
Precipitate 
in the 
inferior 
vitreous. 
Photo taken. 
IOP approx. 
15. Minimal 
cataract. 
No injection. 
Lens clear. 
Some 
precipitate 
inferiorly. 
RD 
superiorly 
by the 
myelinated 
streak and 
inferiorly. 
Centrally ok. 
IOP 0-5 
No cataract. 
Vitreous 
clear but 
slightly 
brownish 
with 
precipitate 
inferiorly. 
One retinald 
fold 
superiorly, 
otherwise ok.  
IOP ok 
Total RD, 
artefact 
from 
dissection
? No gel, 
Retina 
missing 
superiorly 
Total RD, 
swollen 
choroid. 
Outer/Inner 
segments 
missing. 
developed a 
low 
detachment 
in the 
postoperative 
period 
Upregulated 
generally, 
Normal 
Müller 
Morphology  
#7 S400 1.2 mL Minimal 
injection. 
Precipitate 
in the 
vitreous 
inferiorly 
IOP approx. 
10. Minimal 
cataract. 
No injection. 
Cornea 
clear. No 
cataract. 
Clear 
vitreous. 
Retina ok. 
Some 
precipitate 
inferiorly. 
IOP 10. 
Clear, retina 
ok, IOP ok 
Normal, 
no gel 
Normal Upregulated 
generally, 
Normal 
Müller 
Morphology 
#8 S400 1.0 mL Minimal 
injection. 
Precipitate 
in the 
inferior 
vitreous. 
Photo taken. 
IOP approx. 
0. Minimal 
cataract. 
No injection. 
Cornea 
clear. No 
cataract. 
Clear 
vitreous. 
Retina ok. 
Some 
precipitate 
inferiorly. 
IOP 10. 
No cataract, 
vitreous with 
minimal 
precipitate 
inferiorly, 
retina ok, 
IOP ok. 
Some 
precipitate 
inferiorly, 
otherwise 
normal. 
No gel 
Normal. Upregulated 
generally, 
Normal 
Müller 
Morphology 
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Figure 2. Ophthalmoscopic examination 6 days postoperatively.  PEG injected eyes displayed 
white precipitate in the inferior vitreous body. DPO = days postoperatively. 
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Figure 3. Images of retinas 20 days postoperatively (A, C, E) and eyes at dissection 41 days 
postoperatively (B, D, F). A-B. #1 S300. Total retinal detachment caused during surgery (A) 
with no sol remaining (B). C-D. #7 S400. Eye injected with PEG sol was normal with retina 
attached (C) and no sol remaining (D). E-F. #4 BSS. Eye injected with balanced saline solution 
displayed attached retina (E) and minimal retinal folds (F). DPO = days postoperatively. 
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Histology 
#1 S300 developed a retinal detachment during surgery displayed a pathological retina in 
hematoxylin and eosin (H&E) stained sections, confirming total detachment destruction of the 
retina, choroidal inflammation and dissolved retinal pigment epithelium (RPE) (Fig. 4A).  #6 
S400 developed a retinal detachment post-operatively.  This eye displayed total retinal 
detachment, swollen choroid and missing outer and inner photoreceptor segments.  #5 S300 had 
a minimal central detachment, large inflammatory cells in the outer nuclear layer (ONL) and 
subretinal space (Fig. 4D).  The macroscopically observed precipitates seen in #2 S400 were 
observed in histological sections as brown clumps on the retinal surface, and also in an area 
within the inner retinal layers, with presence of macrophages (Fig. 4 E, F).  The remaining eyes 
had normal retinal morphology (Fig. B, C). 
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Figure 4. Hematoxylin and eosin (H&E) stained sections. A. #1S300. Total destruction of the 
retina with choroidal inflammation and dissolved retinal pigment epithelium (RPE). B-C. #7 
S400 (B) and #4 BSS (C) displayed normal retinal morphology. D. #5 S300. The retina of had 
some elongation of Müller cell nuclei, large cells in the ONL and subretinal inflammatory cells. 
E-F. #2 S400. Brown precipitate and macrophage invasion on retinal surface (E) and inner 
retinal layers (F). Scale bar = 200 microns (A), 50 microns (B-F). DPO = days postoperatively. 
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Immunofluorescence labeling 
All eyes injected with PEG sols displayed upregulation of glial fibrillary acidic protein (GFAP), 
as a sign of Müller cell activation (Fig. 5).  The eye with surgically induced total retinal 
detachment displayed disorganized Müller cells (#1 S300).  Another eye, which had a minimal 
central detachment, had elongated Müller cell nuclei (#5 S300).  In BSS injected eyes GFAP 
labeling was comparable with normal unoperated controls with discrete labeling of Müller cells 
seen only in the periphery. 
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Figure 5. Glial fibrillary acidic protein (GFAP) immunofluoresence stained section. #2 S400. 
Eye injected with PEG sol displayed upregulation of GFAP in Müller cells. Scale bar = 50 
microns. DPO = days postoperatively. 
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Electroretinography 
Full-field electroretinography (ERG) measurements were obtained pre- and post-operatively in 
all 8 eyes (Table 3).  All but one case followed the histological results.  The two eyes with total 
retinal detachment displayed no residual response could be measured (#1 S300, #6 S400).  
Another eye, with a minimal central detachment, also displayed no response (#5 S300).  All 
other eyes displayed only minor changes compared to pre-operative baseline recordings. 
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Table 3. Pre- and post-operative (day 41) ERG data.  Values are given of the wave amplitudes 
(μV) for rod ERG (blue light), combined ERG (white light), and dark-adapted single-flash cone 
ERG (30 Hz flicker). 
Eye # and 
vitreous 
substitute 
Blue light White light 30 Hz flicker 
Summary 
Pre-op 
Post-
op 
Pre-op 
Post-
op 
Pre-op 
Post-
op 
#1 S300 
89.8 0 61.2 0 20.8 0 All modalities 
reduced to 0 
#2 S400 
72.9 78.1 50.8 69 10.4 8.16 
No change 
#3 BSS 
76.8 53.4 50.1 50.1 20.8 12.3 Reduced rods 
and cones 
#4 BSS 
39.1 89.8 27.3 31.3 10 3.94 Reduced cones, 
increased rods 
#5 S300 
56 0 59.9 0 26.3 0 All modalities 
reduced to 0 
#6 S400 
91.1 0 65.8 0 19.7 0 All modalities 
reduced to 0 
#7 S400 
40.4 147 46.9 84.6 12.7 12.2 Increased rods 
and combined 
#8 S400 
56 52.1 65.8 57.3 12.5 15.4 
No change 
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Discussion 
The vitreous is a hydrogel composed of collagen and hyaluronic acid, with reported values of 98-
99% water. pH 7.0-7.4, with and elastic modulus of 4.2-4.7 Pa and a loss modulus of 1.9-3.7 Pa 
and a refractive index of 1.3345-1.3348 [3].  5 wt.% PEG sols with average molecular weights 
between 200,000 and 400,000 g mol
-1
 approximated the viscoelastic properties of the natural 
retina, with a high polymer content.  Using phosphate buffered saline (PBS), the pH values of the 
resulting sols were slightly above 7, and all sols had similar refractive indices (1.339 at 25ºC) to 
the natural vitreous.  PEG sols presented an attractive vitreous substitute to test in an 
experimental vitrectomy model, especially given promising results indicating ocular 
biocompatibility of PEG hydrogels [20-22]. 
Both eyes injected with S300 had retinal detachment and loss of electrical function (#1, #5).  In 
one eye, the retinal detachment was caused during surgery (#1 S300).  In the other, a minimal 
central detachment and subretinal and ONL inflammation was observed upon histological 
examination (#5 S300).  It is uncertain why this eye had no postoperative ERG responses after 
41 days.  In 3 out of 4 eyes with S400, the PEG sol had no apparent effect on retinal morphology 
and electrical function.  One eye with S400 developed a postoperative retinal detachment (#6 
S400).   However, all eyes injected with PEG sols exhibited elevated GFAP expression, 
indicative of retinal stress and Müller cell activation, which was not observed in BSS eyes.  BSS 
was well tolerated and resulted in minimal GFAP upregulation.  S400 affected the retina to a 
lesser degree than a previously tested material, poly(acryl-imide), which caused retinal edema 
[18].  The tolerability of S300 was inconclusive, limited by the small sample size.   
Following removal of the natural vitreous, metabolical and physiological changes occur within 
the eye, involving oxygen concentration, osmotic balance and molecular transport that may 
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affect both the lens and the retina [24, 25].  The normal morphology and ERG responses 
observed in the majority of eyes injected with S400 may indicate that the nutritional demands of 
the retina are met by the PEG sol.  Furthermore, the PEG sols did not result in IOP elevation, an 
important clinical consideration.  However, the PEG sols were not retained in the vitreous body 
throughout the post-operative period.  It takes about 3-7 days for the laser phototherapy to form 
permanent adhesions and in complex cases a tamponade may be required for several months 
[26].  Future work will focus on cross-linking PEG following injection, so that the resulting 
viscoelastic insoluble gel is retained for a longer period in the vitreous body.  This could be 
achieved, for example, through the use of PEG with thiol and acrylate functional groups to form 
cross-links in situ [27, 28]. 
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Executive Summary 
Market opportunities 
There is a common eye surgery that is called vitrectomy and tamponade (VT). We are proposing 
to commercialize a new surgical biomaterial to be used in VT surgery. Our initial estimate is 
there are approximately 150,000 VT surgeries every year in the United States alone. This surgery 
is also routine in Europe. These numbers are expected to grow with an aging population. 
Our new material meets an unmet medical need. For example, detachment of the retina is a 
medical emergency.  If untreated, the torn retina continues to peel off resulting in blindness. This 
VT surgery is required to reattach the retina.   
During surgery the jelly that fills the eye ball has to be removed.  This jelly is typically replaced 
with silicone oil or gas.  However, oil and gas only last for short periods of time in the eye and 
can cause complications such as glaucoma and cataracts. Our material is superior in every way to 
these options. 
Sales and marketing strategy 
Initially, our target customer is the expert ophthalmic surgeon. She is the thought leader who will 
make the decision on whether not the technology is clinically superior to existing materials. 
Without her buy-in, health insurers and patients are unlikely to support or demand the 
technology.  
Our early stage marketing strategy is to find prominent surgeons to participate in the clinical trial 
of the technology, who will then promote the use of the technology in their professional circles, 
based on quality data. After endorsement by the medical community, our sales and marketing 
strategy will evolve to target the other customers: health insurance companies and patients. 
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Product description 
Our team has worked with surgeons in to develop a special biomaterial that mimics the eye’s 
natural jelly and can be used in the eye long-term.  We propose to commercialize the gel as a 
medical device.  The pathway for filing a medical device has simpler regulatory hurdles and 
testing requirements than drugs or biologics. 
Financing needed and planned exit 
$4 million for pre-clinical trials (A round: $1m, B round: $3m) 
Potential double-down for investors at clinical stage.  There will be decision points to exit upon 
entering both the clinical or market phase, most likely to a strategic acquirer. 
Financial projections 
3 major phases of development with optionality at each transition for further investment or sale.  
In “MARKET” phase, gross margins are > 99%.  Total addressable market: $750m (US) > $2bn 
(US & Europe).  This makes us a $32 million company assuming an extremely conservative 5% 
penetration rate, or a $240 million company assuming a more realistic yet still conservative 50% 
penetration rate. 
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Figure 1. Cash flow projection for Hydrogel through 2025, reflecting three major phases of 
development with the option for double-down investment or strategic exit/sale at each transition. 
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Team 
Adrian Lu – Chief Executive Officer, technology marketing and sales experience 
Christopher Pritchard, PhD – Chief Technology Officer, expertise in hydrogels, former CSO of 
InVivo Therapeutics 
William Herbert – Chief Operating Officer, manufacturing and scale-up expertise 
Vision and Values 
 Our vision is to improve vision. 
 We are committed to improving the lives of patients suffering from long-term vision 
related disorders. 
 We believe in quality engineering. 
 We believe in creating superior technologies that can have a significant impact on 
patients’ lives recovering from surgery. 
 We believe in providing surgeons with the most innovative and clinically relevant 
technologies to make their ability to treat their patients easier. 
 We believe in reducing the burden of healthcare through technologies that prevent 
repetitive or chronic medical complications. 
 We listen to the challenges faced by surgeons and strive to address their most critical 
issues 
 We create healthcare solutions 
 We are a couple of good blokes who want to be superheroes.  We can do better than ‘do 
no evil’, we will ‘do good’. 
Doctoral Thesis A business plan towards clinical trials of biomaterials for the treatment of retinal detachment 
Page 215 of 256 
Market Analysis and Competitive Advantage 
Cost of the surgery 
The 2010 dollar price of a vitrectomy surgery is listed by several sources below- both for 
Medicare insurance and for industry averages with two different types of anesthesia. The average 
is just under $5000, with the cost to the hospital of performing the surgery on the order of $800. 
Therefore the hospital administration and surgeon charge a premium of roughly 85% over the 
cost of the surgery. 
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Table 1. Cost of vitrectomy (retinal re-attachment) surgery from major US Eye hospitals. 
Patient Charge Cost to Hospital No of Surgeries in 
2010 
Source 
$3467 $925 461 Mass Eye & Ear 
Medicare Claims * 
(ahd.com) 
$5025 $844 642 Miami Hospital 
Medicare Claims 
(ahd.com) 
$3508 $554 853 NY Eye & Ear 
Medicare Claims  
(ahd.com) [1] 
$7177±644 N/A N/A [2] 
$5469±514   [3] 
$4930 $774 N/A AVERAGE 
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Figure 2. COGS to the hospital of performing a vitrectomy surgery. Hydrogel will be sold at a 
premium, adding cost per surgery to the end user (the patient and his/her insurance firm), but 
also allowing the hospital and doctor to increase their revenue per surgery. This is important 
since the DMU is the ophthalmic surgeon. 
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Pricing 
Competition pricing 
Silicone oil: $100 per vial (such as Alcon Laboratories SILIKON 1000) 
Gas: Marginal cost of dispensing one extra unit of gas for the eye should be near zero 
Hydrogel pricing 
Our pricing strategy is to capture the value created by the significant reduction in expected cost 
of treatment to the patient. To that end, our product will have a $4900 premium over the 
competition and will cost $5000 for each unit of treatment. 
Table 2 below shows our gross margin, where it can be seen that our estimated marginal cost of 
producing each unit of our device is $5. The low cost of production is due in part to the fact to 
the simple method of producing the synthetic polymer that forms this medical device. The value 
is in the intellectual property covering the production method. 
Due to this low marginal cost, our gross margin, which is the margin on revenue before cost of 
sales, general and administrative expenses are taken into account, is a very healthy 99.90%. 
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Table 2. Gross margin on Hydrogel product 
Price per unit $5,000  
COGS per unit $5  
Gross margin 99.90% 
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The price premium for Hydrogel can be easily justified when the total cost of treatment is 
considered. Fig. 3 shows a simple calculation of the expected cost of treatment of our major 
competing product, silicone oil, versus the cost of Hydrogel treatment. The expected cost takes 
into account: 
 Odds of initial surgery success 
 Likelihood of repeat surgery required 
 Cost of follow-up treatment 
 Risk of complications causing cataracts 
Hydrogel outperforms silicone oil on all counts across these areas, giving an expected treatment 
cost of $11,300 which is a significant reduction over the expected cost of treatment of $12,500 
using silicone oil. Furthermore, there is the intangible value to the patient of less intrusive and 
debilitating treatment improving quality of life. We also have not taken into account risks of 
other potential complications with existing surgeries such as glaucoma, which would further 
increase the expected cost of existing treatments. 
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Figure 3. Comparison of expected total cost of treatment, taking into account Hydrogel’s 
improvements in reducing the need for repeat surgery, and also the risk of further cataract 
surgery. See Table 4 for statistics on Silicone Oil outcomes. 
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Total addressable market size with current products (US only)  
Total spent on surgery = 150,000 cases x $5000 = $750 M 
Total spent by hospitals providing this surgery (excluding labor) = $120 M 
of which spent on current commoditized “tamponade material” ≈ $100 per surgery 
 $15 M total market per annum (currently) 
This relatively small market size reflects the current low price paid for an eye jelly replacement 
material. We believe that as a more effective, commoditized product, Hydrogel can be priced at 
$5000 per surgery. Using this price, our product still reduces the overall surgical cost to the 
consumer, due to the greatly reduced risk of requiring repeat or further surgeries. This estimate is 
in line with advice from our expert ophthalmic surgeon, as well as our calculations on lifetime 
surgical costs outlined in the Pricing section. Given this premium we charge for Hydrogel, the 
US market is: 
  $750 M total market per annum in the US (with Hydrogel premium) 
 > $2 B total market per annum in the US and Europe (with Hydrogel premium) 
How the market size will change over time 
 Ageing population 
 Increase with development of healthcare in emerging countries 
 Our opportunity is mainly a function of product switching in addition to market growth 
How developments in the field are adopted 
Most new therapies are introduced at major ophthalmology meetings such as ARVO, AAO and 
Club jules Gonin. Surgeons then go home and try the therapies for themselves. 
Surgical products work differently compared with medical counterparts. The regulation 
surrounding surgery is much less strict depending on the material. For instance, heavy silicone 
oil was introduced in the early 2000´s without any official approval [4].  However, as far as 
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intravitreal drugs are concerned, they need to be approved (FDA or corresponding). 
Nevertheless, a lot of "off-label use" is carried out and presented at meetings, (e.g. Avastin for 
ROP [5]). 
Adopting new technologies is really up to each surgeon. Of course, this depends on local 
economic as well as hierarchical factors (a junior surgeon would not be able to use a very 
expensive new tool). 
Pricing varies heavily different depending on the organization of health care. For example, in 
Sweden, about 95% is government run, but the financial control is not very strict. This means a 
senior surgeon has a lot of say about what equipment and tools they need. 
Portrait of potential customers in the United States 
The patient 
Robert is a 67 year old retired lawyer from Boston. He is an avid bird watcher and golfer. 
Recently, Robert began experiencing flashing lights and was diagnosed with retinal 
detachment. 
His ophthalmic surgeon recommends emergency surgery. 
Robert understands the importance of this surgery, and what matters most is: 
• No medical complications 
• No repeat surgery 
• Convenient recovery 
The surgeon 
Stephen J. Ryan, MD is President, Doheny Eye Institute (USC), Distinguished Professor in 
Ophthalmology.  He received his MD from Johns Hopkins University 1965 and did internships 
at Bellevue Hospital and Cornell Medical Division from 1965 – 1966.  His residency was 
completed at Wilmer Eye Institute, Johns Hopkins University in Ophthalmology from 1966 – 
Doctoral Thesis A business plan towards clinical trials of biomaterials for the treatment of retinal detachment 
Page 224 of 256 
1970, and his fellowship at the Armed Forces Institute of Pathology in Ophthalmologic 
Pathology from 1970 – 1971.  His is board certified by the American Board of Ophthalmology 
and has professional society memberships in the American Academy of Ophthalmology, Institute 
of Medicine of the National Academy of Sciences, The Alliance for Eye and Vision Research. 
Implications for business model 
We have narrowed down the typical surgery cost to be about $5000 with an average cost to the 
hospital of $800. In terms of how we capture that value, our view is that we don't compete on 
cost terms to give hospitals a larger slice of the pie, but we compete on being the non-
commoditized premium product which is worth paying more for than existing procedures, so 
we're increasing the size of the pie. 
We plan to demonstrate to the insurers that the total cost of treatment (to make an analogy to 
Total Cost of Ownership) works out cheaper over the lifetime over the patient than existing 
methods. Reasons include eliminating the need for repeat surgery, decreased rate of further 
complications such as glaucoma and cataracts, which create further costs that the insurer needs to 
factor into the true cost of treatment. Litigation may be another potential cost saving. 
The incumbent technologies are both commoditized.  There are many producers of silicone oil 
and gas is even more commoditized - there's no magic to it at all and any industrial could get in 
the game for the existing products. The introduction of innovation and new materials to this 
space would set a precedent for biomaterials development in the eye, as well as drug delivery 
technologies.  It is likely that we would see a competitive response not from incumbents (who 
make silicone oil or gases), but from companies who make surgical biomaterials for other parts 
of the body (e.g. Covidien, Boston Scientific). 
With low costs of operations post clinical trials, there is a lot of money on the table for a small 
company or product division.  One potential option is to fund all of the development and trials 
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using SBIR grants and well as donations from eye research foundations to get past clinical trials 
and then either exit or run the company as a cash generator thereafter. 
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Product and Operations Section 
What the product is 
The product is an injectable hydrogel.  A hydrogel is a polymer gel that contains water.  A 
common example is a contact lens, which is a stiff gel and contains around 60% water. 
Hydrogels are made from polymers that can absorb water and also form a network of chains.  It 
is analogous to a three-dimensional tennis net, which is made up of strings tied together with 
knots.  Polymers are chains of molecules, so in the tennis net analogy they would be the strings 
and the chemical bonds that form the polymer gel would be the knots.  In a hydrogel, the knots 
are only nanometers apart. 
The hydrogel is ‘injectable’ because it can be squeezed through a very small diameter surgical 
needle as a liquid and only forms a gel in situ once injected (which happens when the chemical 
bonds form).  Most gels cannot be formed in this way.  One example of a gel that forms in situ is 
super glue, but super glue cannot absorb water. 
Our hydrogel is designed to be injected during surgery into the part of the eye called the vitreous 
body.  The vitreous body is the space between the lens and the retina.  The vitreous body is 
normally filled with a natural hydrogel called the vitreous humor.  The vitreous humor is often 
removed during retinal surgery, in a procedure called a vitrectomy.  Currently, there is no 
adequate replacement for the vitreous humor; retinal surgeons inject gases or silicone oil into the 
eye after vitrectomy. 
What is unique about it 
The product is unique in many ways: 
 It gels spontaneously in aqueous solution a few minutes after injection through a small 
diameter surgical needle  
o unlike gases or silicone oil which remain viscous 
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o unlike many hydrogels which must be gelled outside the body and therefore not 
injectable through surgical needle 
o unlike other injectable hydrogels that require UV light, basic conditions or 
additional chemicals to form gels 
o unlike other hydrogels that have to be formed in absence of water and 
subsequently hydrated 
 It has mechanical properties similar to the natural vitreous  
o unlike gases or silicone oil 
 It doesn’t need to be removed in a second surgery  
o as silicone oil does 
 It doesn’t require the patient to lie face down for 2 weeks after surgery 
o as gases do 
 It is transparent 
o unlike some hydrogels which are opaque 
 It is biocompatible with the retina 
o unlike some other tested vitreous substitutes 
o it is made from a family of polymers that is already FDA approved 
 It does not swell 
How it works 
The product works by preventing excess fluid from seeping behind the retina, which causes the 
retina to detach from the back of the eye (i.e. from the choroid).  The retina relies on the choroid 
for nutritional support and prolonged detachment will result in death of photoreceptors 
(responsible for vision).  This is why retinal detachment is a medical emergency. 
Intellectual property strategy 
We plan on generating IP within the company as we iterate on our initial designs for the product.  
Therefore we expect the company to own much of its IP in the form of trade secrets and key 
patents.  In addition, the company expects to license the technology  
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Associated technical risks 
There are significant technical risks associated with development of a medical device.  These can 
be classed according to safety and efficacy. 
Safety risks include problems associated with biocompatibility, toxicity and sterility of the 
product.  Further safety risks include mechanical damage attributed to deployment and 
placement of the technology in the human body.  Other risks include anticipated side effects, 
such as abnormal intraocular pressure, glaucoma, failure to promote reattachment of the retina, 
cause of re-detachment of the retina, cataract formation, and ischemia, hypoxia or hemorrhage of 
the retina resulting from application of the technology.  We hope to provide a better safety 
profile than currently available technologies, particularly with respect to cataract formation, 
intraocular pressure and glaucoma. 
Efficacy risks are associated with how successfully the technology keeps fluid away from a 
retinal tear.  The technology may not perform as desired and may be sensitive to surgical 
technique.  Even if we show much improved efficacy, existing technologies may be more 
robust/predictable and better understood by clinicians, so that adoption/adjustment to new a 
risk/benefit profile may be a challenge. 
We believe that the preclinical models and outcome measures will enable us to determine safety 
and efficacy potential to a large degree prior to commencing clinical trials, and will provide a 
‘proceed or surrender’ signal.  This will have a significant impact on the flexibility of financing 
the company, and the reduction of costs through the optionality and segregation of funding 
cycles. 
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Competitive Advantage 
Competing companies 
“The Big Guys”  
Bausch & Lomb manufacture Oxane HD ™ 
 Founded 1853, headquartered in Rochester, New York 
 13,000 employees in 36 countries 
 2007 revenue $2.51 Billion USD 
 Divisions include contact lenses and medical devices for ophthalmic surgery 
 Owned by private equity house Warburg Pincus since 2005 
 Last SEC 10K filing when the company was public (FY2005) gives net sales in the 
different divisions including “cataract & vitreoretinal”: 
Doctoral Thesis A business plan towards clinical trials of biomaterials for the treatment of retinal detachment 
Page 230 of 256 
Table 3. Bausch and Lomb net sales in 2005 in USD millions. Source: SEC Edgar Filings. 
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“The Small Fish”  
Fluoron GmbH manufactures Densiron 68™ 
 Subsidiary of Geuder AG 
 Founded in 1996 by Prof Meinert 
 Small, focused biotech company making innovative silicone oil tamponades (to remain in 
the eye for longer & longer periods) as well as new materials like perfluorocarbohydrates 
and semifluorinated alkanes for intraoperative use 
 “The Italian Job” 
Alchimia make a range of silicone oils and intraocular gas tamponades 
 Based in Padova, Italy 
 Founded by a team of research chemists in 1993 
 Publish 5-10 papers per year in peer-reviewed journals, mostly presented at conferences 
 Active in R&D: focus is on heavier-than-water silicone oils 
Competing technologies 
Silicone oil 
Companies making silicone oil include Alcon Laboratories and Bausch + Lomb Surgical. 
Following is a brief profile of each of these major competitors. 
Alcon Laboratories 
Product: SILIKON® 1000 (purified polydimethylsiloxane) Surgical Oil 
Product advantages: Reasonably high effectiveness outcomes, 84% effectiveness for preserved 
vision and 70% for complete after six months (source: Alcon) 
Product disadvantages: High incidence of cataracts (63%), hypotony (19%) and corneal 
opacity/abrasion (26%) measured six months post-surgery (source: Alcon) 
Price: $100 per 10mL vial (source: The Aesthetic Guide Primary Care Edition Autumn 2009) 
Company: Alcon Retina is a research division of Alcon, founded in 1945, a global medical 
company specializing in eye care products and now a subsidiary of Novartis. In 2010, Alcon had 
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sales of USD$7.2B and net income of USD$2.2B, offering a range of pharmaceutical, surgical 
and consumer eye care products. 
Bausch + Lomb 
Product: ADATO® SIL-OIL 5000 Silicone Oil 
Usage: As a prolonged retinal tamponade in selected cases of complicated retinal detachments 
Product advantages: Sold as pre-filled silicone oil disposable syringes (rather than vials) for 
ease-of-use in terms of sterility and administering 
Product disadvantages: Use as a long-term tamponade has not been studied. Like other silicone 
oils, it carries high risk of cataracts, anterior chamber oil migration, keratopathy, and glaucoma. 
Pricing: AU$1,140 for a packet of six (source: Bausch Australia) 
Company: Bausch + Lomb is a private company founded in 1853 in the U.S. and is one of the 
world’s leading suppliers of eye health products. Its three categories of products are Vision Care, 
Pharmaceuticals, and Cataract and Vitreoretinal Surgery. The company had USD $2.4B in sales 
and net income of USD$52M in 2007. 
Surgical Gas 
Following is an example of a company supplying ophthalmic gases to surgeons. 
Air Products 
Products: A range of medical device gases for ophthalmic surgery including hexafluorohethane, 
octafluoropropane, and sulphur hexafluoride 
Usage: The gas is injected into the vitreous of the eye and expands over several days, sealing the 
retinal tear and the area surrounding the tear as the pressure of the gas bubble pushes against it. 
Product disadvantages: The treatment is very inconvenient to the patient, who must lie face 
down for two weeks to maintain the position of the gas bubble against the retinal tear. Deviating 
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from this requirement may re-introduce complications or prevent proper recovery of the 
treatment. 
Company: Air Products is a global supplier of gases, performance materials, equipment and 
services. It comprises three main divisions: (1) Merchant Gases, (2) Tonnage Gases, Equipment 
and Energy, (3) Electronics and Performance Materials. Gases for healthcare and medical 
(including ophthalmic gases) is a part of the Merchant Gases division. This division alone had 
sales of USD$3.7B in 2010. 
Feature comparison matrix 
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Table 4. Comparison of competitors’ effectiveness and features. Source: Alcon Technologies 
Feature Silicone Oil Gases New Technology Inferior/Super
ior 
Effectivene
ss in 
sealing 
retinal tear 
84% 
effectiveness for 
preserved vision 
and 70% for 
complete after 
six months 
Effective in 
sealing a 
retinal tear as 
the gas 
bubble keeps 
water away 
from it 
We anticipate equal 
ability to seal 
retinal tears, but 
more versatility to 
seal tears in any 
part of the eye 
without special 
head positions 
Equal 
Time 
period in 
the eye 
Must be 
removed a 
Two weeks Years – the 
material is 
biocompatible 
Superior 
Complicati
ons 
High incidence 
of cataracts 
(63%), 
hypotony (19%) 
and corneal 
opacity/abrasion 
(26%) measured 
six months post-
surgery (source: 
Alcon) 
 We anticipate better 
oxygen transport 
and pressure 
regulation which 
would reduce 
cataracts 
Superior 
Convenien
ce for 
surgeon 
Comes in 
prefilled 
syringes 
 Can be packaged in 
prefilled syringes 
but requires more 
careful handling 
Equal/Inferior 
Convenien
ce for 
patient 
Requires a 
second surgery 
to remove 
silicone oil 
Requires 
patient to lie 
face down for 
two weeks.  
Deviation 
may re-
introduce 
complications 
No second surgery 
or special 
positioning 
required 
Superior 
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Other Competitors 
 For example, Covidien, Boston Scientific 
 Other biomaterials companies 
 Eye laser companies for retinal surgeries 
 Researchers inventing and testing new biomaterials 
 Organizations that help to prevent retinal problems e.g. nutritional products, smoking 
cessation 
Marketing Strategy  
Our marketing philosophy is that our product offers a better quality of life to patients of 
vitrectomy surgeries and reduces the risk of complications, which benefits not only the sufferer 
but also the ophthalmic surgeon, the hospital, and the medical insurance company. 
Our approach is a marketing strategy that will facilitate a public awareness of the benefits of our 
medical device, which is far superior to existing forms of technology for vitrectomy surgeries. 
The marketing communication will convey: 
 Improved efficacy 
 Reduced risk of complications 
 Reduced risk of repeat surgeries 
 Lower total cost of treatment (analogous to TCO) 
 Better quality of life 
As this is a medical device currently still subject to clinical trials, we need to take some unique 
approaches to our marketing strategy. This can be viewed in two sequential stages, each 
requiring a different approach to marketing and distribution. 
Doctoral Thesis A business plan towards clinical trials of biomaterials for the treatment of retinal detachment 
Page 236 of 256 
Stage 1: Clinical trials 
In this stage we will not establish any channels of distribution given the product cannot yet be 
sold the general market. By far, the key players in the value chain are our chief ophthalmic 
surgeons participating in the clinical trials. Marketing is achieved in the following manner: 
 Establishing credibility for the device as it progresses through clinical trials 
 Creating awareness of the new technology through publications and medical conferences, 
where the chief surgeon will be the advocate for the product. Her reputation in the 
medical community is therefore essential. 
During this stage, our strategy is to target only the professional community of ophthalmic 
surgeons. 
Stage 2: After completion of trials and FDA approval 
Once the product is ready for launch, we expect to employ a direct sales team for customer 
acquisition and distribution. The reasons for this approach are: 
 It is a concentrated market in terms of potential sales volume per surgeon 
 As a medical device, the product requires highly trained professionals to market 
 Establishing relationships with the medical surgeon 
The geographic areas we will initially target are the United States and Europe, where we have 
potentially lower clinical hurdles. In the U.S. we will initially target the Boston area, represented 
by one of the leading hospitals in the country, Massachusetts Eye and Ear Hospital. Expansion to 
the rest of the country will take place once the device achieves regulatory approval. Such a rapid 
expansion target makes sense because our customers are concentrated to a small population 
around the country, which lends itself to sales by our direct sales force being achieved rapidly. 
Since retinal detachment is a medical emergency, there is no seasonality to our business and we 
do not need to consider any off-season sales. 
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Sales and distribution 
As earlier discussed, our method of sales and distribution will initially be through publicizing by 
word-of-mouth in the medical community, journal publications, and medical conferences. A 
large part of this will be driven by our chief ophthalmic surgeon who will be a proponent of this 
technology; simultaneously boosting his own professional reputation is a pioneer in this area of 
ophthalmic surgery. 
The longer range method of sales is to deploy a direct sales force of highly trained professionals. 
Core to sales professional’s responsibilities are: 
 Fostering a long-term client relationship with the ophthalmic surgeon 
 Maintaining order flow and delivery of Hydrogel to clients 
 Provide training on product usage and assistance during vitrectomy surgeries 
 Being the first point of call for support or issues raised about the product 
 Building new client relationships and seek opportunities to grow orders and revenues 
As this is a synthetic pre-sterilized product that will be packaged into very small units, 
distribution by the direct sales force is achievable considering the concentrated number of 
potential customers.  
Our sales force expansion plan is to extend our sales team into major metropolitan cities in the 
United States as a follow-the-customer strategy, as this is where the major medical hospitals and 
ophthalmic surgeons tend to be located. Table 2 shows our expected sales schedule for each sales 
person. 
Doctoral Thesis A business plan towards clinical trials of biomaterials for the treatment of retinal detachment 
Page 238 of 256 
Table 5. Sales schedule of expected cost per Sales Professional 
Retainer $60,000 
Average number of clients 20 
Annual surgeries per client 150 
Price per unit $5,000 
Revenue per sales person $15,000,000 
Commission rate 2% 
Total commission $300,000 
General expenses (travel, etc.) $50,000 
Cost per Sales Professional $410,000 
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Advertising and Promotion 
We expect that once we are able to achieve a minimum penetration rate for our product (say 
20%), we can begin directly marketing to potential patients in the general public to raise our 
brand awareness, similar to the marketing strategy employed by LASIK for laser eye surgery. 
This will be supplementary to our direct sales force and not a substitute for them. 
The objective of direct advertising is to try and create some customer pull, so that patients will 
ask their doctors and surgeons for Hydrogel treatment. Although the surgeon’s own 
recommendations will still have by far the greatest influence on the patient’s decision, creating 
public brand awareness will be helpful to: 
 Persuade ophthalmic surgeons who do not use Hydrogel to consider using it, reducing the 
acquisition cost for our direct sales team 
 Create brand value to raise barriers to entry for potential competing products in future 
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Operations 
The company needs $4 million to complete the preclinical phase, which represents a major 
milestone and decision point; a potential ‘double-down’ for investors as well as an opportunity 
for a strategic acquisition. 
Phases of development and resources needed ($1000s) 
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Table 6. Expected resources needed for pre-clinical and clinical trials. 
Phase Pre-clinical Clinical Market 
Year 1 2 3 4 5 6 7 8 9 10 
SG&A 100 200 200 200 900 1,000 1,100 1,200 1,300 2,600 
Pre-clinical studies 60 250 300 300       
R&D 200 500 500 500       
CAPEX 320         50 
Clinical trial through FDA approval     1,000 1,000 2,000 2,500 3,000  
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Selling, general & administrative (SG&A) 
Initially, SG&A will consist mainly of costs associated with running the business, including 
costs of fundraising, legal costs of incorporation, patent filing and licensing, and hiring 
employees, advisors and consultants.  During the clinical and market phase, there will be selling 
expenses as the company generates knowledge about its products, mainly through professional 
organizations and scientific presentations, as well as increased G&A associated with operating a 
company in sales mode. Upon product launch, there will be also expenses incurred for the 
manufacturing, packaging and distribution of the hydrogel. These costs will become better 
defined as we refine our strategies on production (e.g. whether to outsource manufacturing) and 
distribution (e.g. channel partners and supply chain). 
Pre-clinical studies 
Pre-clinical studies will be conducted in collaboration with vitreoretinal surgeons who maintain 
world-class preclinical research facilities.  The preclinical studies mirror the eye physiology, 
surgical procedures and outcome measures performed in the clinic.  The hospital already has the 
staff, equipment and resources to conduct these studies, and is largely supported by grants.  We 
anticipate being able to conduct a significant amount of preclinical research using grants. 
Research & Development (R&D) 
During the pre-clinical phase, we will iterate on the materials used to make the hydrogel, to 
improve it and generate new IP in design as well as manufacturing and surgical methods.  R&D 
costs will include the costs of a chemical engineer, a polymer scientist and a lab technicians, as 
well as chemical supplies. 
We will also face costs associated with filing for FDA approval, and will need to hire a Quality 
and Regulatory Affairs specialist as we move towards clinical studies. 
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Capital Expenditures (CAPEX) 
The company will open a small laboratory for R&D and incur capital expenditures associates 
with purchase of polymer synthesis equipment and chemical and physical analytical equipment 
for a wet chemical lab. We anticipate further capital expenditure in setting up corporate 
infrastructure including office space upon completion of clinical trials and commencement of 
marketing. Further capital expenditure will be required if we choose to manufacture the product 
in-house. Given the high fixed costs of running a production facility, we may choose to delay 
this approach until we have reached sufficient scale in production volume. 
Clinical studies 
We expect to conduct clinical studies at a major research hospital, such as Massachusetts Eye 
and Ear Institute, under direction of a Clinical Research Organization. 
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Finance Section 
Financial Summary 
Hydrogel’s proprietary technology – a gel for the replacement of intraocular jelly following 
intrusive ophthalmic surgery – is still under development and requires two rigorous testing 
phases before general release into the surgical devices market: i.e. both pre-clinical and clinical 
trials. These phases are expected to last approximately 4 and 5 years respectively, at a total cost 
of around $4-5 million for preclinical and upwards of $10 million for clinical trials.  
Therefore we present here an extended, yearly income statement for the period 2012-2025, 
comprising three different phases corresponding to the preclinical, clinical and mass market 
stages of the company’s growth. We focus primarily on the company’s financials through the 
foreseeable future in a 4-year timeframe, during which the technology will be pushed through the 
pre-clinical phase. By partnering with a third-party, experienced medical professional with full 
access to resources and independent funding grants, we expect to generate revenue through the 
sale of our gel as a high-margin developmental (academic) product. Following this strategy, we 
expect to reach breakeven in net income sometime in the first quarter of 2015. Similarly, the gel 
will be sold as a medical research product during the clinical phase, and we expect the company 
to break even in net income during the first year of clinical trials. 
Meanwhile we will pursue a fundraising strategy focused on seed funding through government 
and other medical grants coupled with a bridge loan from a private investor. Following that, the 
company will seek to raise $1M in a funding round in year 3 and a further $3M in year 5. This 
will help build the company’s commercial, manufacturing and research capabilities in 
Cambridge, MA and address costs associated with FDA approved (pre-) clinical trials in the US. 
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Marketing and sales costs will be low during the first three years, during which there are no 
projected sales to the general surgical devices market. 
Extended Projected Income Statement for Hydrogel 
In the preclinical stage, we are looking to partner with a specific research leader  to leverage the 
existing hospital and laboratory resources efficiently. The company will initially generate 
revenue through the sale of developmental 100 ml sachets of its product, at a price of $500 each. 
This price is a 90% discounted rate of our $5000 product selling cost based on our previous 
calculations of expected lifetime surgery cost reductions: using current technologies, the cost to 
the patient (insurer) is on average > $12,000 for this type of ophthalmic surgery. By using our 
product we expect this figure to drop below $6,000.  
Main Assumptions 
 COGS is initially higher during the developmental stages when the product will go 
through many iterations and modifications based on researcher feedback; it then drops to 
0.1% of selling price, reflecting the extremely low manufacturing cost of our product. 
 Our hiring strategy is to start with the founders managing the overall project and leading 
two full-time R&D professionals to build the manufacturing base and supply the pre-
clinical medical research requirements. We do not hire management staff until mid-way 
through the clinical period as we ramp up production and begin a more dedicated sales 
and marketing strategy. Finally, we hire 2 sales staff in the final stages of clinical trials to 
build a customer base for product launch in 2020. 
 We purchase $300,000 worth of equipment and wet laboratory space for the pre-clinical 
trial period, which depreciates at a fixed rate of 10% p.a. thereafter. For the clinical 
period we anticipate capital costs of $0.5M for technical equipment, and subsequently 
$1M to ramp up production for market launch. 
 We assume a tax rate of 35% and tax deferred assets are not used. 
Long-term free cash flow projections for Hydrogel (in $ ‘000’s) 
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Table 7. Projected income statement for Hydrogel 2012-2025 in ‘000s of USD. 
 
Phase
Year (End) 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Price / trial product 0.5 0.5 0.5 0.5 1 1 1 1 1 - - - - -
Trial sales 100 200 400 1000 2000 2000 3000 5000 5000 - - - - -
Price / surgery - - - - - - - - - 5.0 5.0 5.0 5.0 5.0
Market Share 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 5.0% 10.0% 20.0% 35.0% 50.0%
Sales Revenue 50$             100$          200$             500$           2,000$         2,000$         3,000$         5,000$         5,000$         37,500$        75,000$         150,000$         262,500$         375,000$         
COGS 0.5 1.0 1.0 2.5 10.0 10.0 10.0 10.0 10.0 0.4 0.8 1.5 2.6 3.8
Gross Profit 50$             99$             199$             498$           1,990$         1,990$         2,990$         4,990$         4,990$         37,500$        75,000$         150,000$         262,500$         375,000$         
Gross Margin % 99.0% 99.0% 99.5% 99.5% 99.5% 99.5% 99.7% 99.8% 99.8% > 99.9% > 99.9% > 99.9% > 99.9% > 99.9%
OPEX
Founder Salaries 20$             30$             60$               75$             250$             250$             250$             250$             250$             400$              500$               600$                  750$                  750$                  
R&D Staff 2$               2$               4$                 4$               5$                 6$                 8$                 8$                 8$                 3$                   3$                    3$                      3$                      3$                      
R&D Staff Salaries 200$          200$          400$             400$           500$             600$             800$             800$             800$             300$              300$               300$                  300$                  300$                  
Management Staff -$           -$           -$             -$           -$             -$             1$                 2$                 2$                 4$                   4$                    4$                      4$                      4$                      
Management Staff Salaries -$           -$           -$             -$           -$             -$             150$             300$             300$             600$              600$               600$                  600$                  600$                  
Sales Staff -$           -$           -$             -$           -$             -$             -$             -$             1$                 5$                   10$                 20$                    30$                    50$                    
Sales Staff Salaries -$           -$           -$             -$           -$             -$             -$             -$             360$             1,800$           3,600$           7,200$              10,800$            18,000$            
Marketing and Travel -$           -$           -$             10$             10$               20$               20$               50$               50$               250$              500$               1,000$              1,500$              2,500$              
G&A (non-salary) 33$             35$             69$               71$             113$             128$             180$             203$             257$             465$              750$               1,305$              1,868$              2,948$              
Preclinical Trial Related Expenses 200$          200$          200$             200$           
Clinical Trial (FDA) Related Expenses 100$             100$             100$             100$             100$             
TOTAL OPEX 455$          467$          733$             760$           978$             1,104$         1,509$         1,713$         2,128$         3,827$           6,267$           11,032$            15,855$            25,155$            
CAPEX
Technical Equipment 200$          180$          160$             140$           620$             558$             496$             434$             372$             310$              248$               186$                  124$                  62$                    
Laboratory Rent 100$          100$          100$             100$           200$             200$             200$             200$             200$             - - - - -
Non-technical Equipment 20$             18$             16$               14$             10$               10$               10$               10$               10$               50$                 50$                 50$                    50$                    50$                    
TOTAL CAPEX 320$          298$          276$             254$           830$             768$             706$             644$             582$             360$              298$               236$                  174$                  112$                  
Earnings before Interest and Taxes (EBIT) (726)$         (666)$         (810)$           (517)$         183$             119$             775$             2,634$         2,281$         33,313$        68,435$         138,732$         246,471$         349,733$         
Pretax Income (726)$         (666)$         (810)$           (517)$         183$             119$             775$             2,634$         2,281$         33,313$        68,435$         138,732$         246,471$         349,733$         
Taxes - - - - 64$               41$               271$             922$             798$             11,660$        23,952$         48,556$            86,265$            122,407$         
Free Cash Flow (726)$         (666)$         (810)$           (517)$         119$             77$               504$             1,712$         1,482$         21,653$        44,483$         90,176$            160,206$         227,327$         
Pre-clinical Trials Clinical Trials Market
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Breakeven analysis: 
Based on these projections, the company is expected to become cash flow positive around the 
first quarter of 2016, or 58 months from incorporation at the beginning of 2012.  If the company 
succeeds in clinical trials, it will be able to self-fund the investment required to go to market. 
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Figure 4. Projected cash flow through 2025 in ‘000s of USD. 
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Capitalization and Ownership 
To fund the pre-clinical trial period with the anticipated $4-5 million required, we will pursue 
three complimentary strategies: 
I. Application for SBIR (Small Business Innovation Research) grants from the National 
Institute of Health (NIH). This government-sponsored grant is non-diluting and does not 
require repayment. A typical application cycle lasts 4-5 weeks and if successful results in 
two funding phases of $100,000 (6 month period) and $750,000 (over 2 years). 
II. Early capital raise from private investors (starting beginning 2012) to make up to $1 
million, along with grants, for year 1. This would preferably be a convertible bridge loan 
with a due date in mid-2013 and an optional discount of 20% on series A funding, but we 
can also offer preferred stock in the company. 
III. Two successive funding rounds of $1 million in 2013 and $3 million in 2015 from 
institutional investors. 
Ownership structure 
The three founding members will retain a 5% stake in the company each after the pre-clinical 
funding rounds. We also retain 10% as stock options for future employees to attract and retain 
talented management, R&D and sales staff. A breakdown of the equity share at each round of 
capital raising is below: 
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Table 8. Equity split for stakeholders following successive funding rounds. 
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Figure 5: Pie charts of equity split following three major investment rounds. 
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Balance Sheet (in $ ‘000’s) 
Hydrogel’s projected balance sheet for the pre-clinical period, through the end of 2015, is 
displayed below, reflecting the three rounds of capital injection. 
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Table 9. Projected balance sheet for Hydrogel for the pre-clinical trial period in ‘000 of USD. 
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Discounted Cash Flow Analysis of Hydrogel (in ‘000’s) 
Based on these assumptions and projections, we expect Hydrogel to have  a net present value of 
over $806 million. This valuation reflects our estimate that Hydrogel will achieve a 50% market 
penetration five years after clearing FDA approval and going to the general surgical market. 
After this initial period, the company can expect to sell the gel at extremely high margin (>99%) 
in a specialised and market sector with little to no competition, yielding multi-tens of million 
dollar rapidly after incorporation. 
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Table 10. DCF analysis of Hydrogel in ‘000s of USD. 
 
 
Phase
Year (End) 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Free Cash Flow (726)$          (666)$ (810)$ (517)$ 119$ 77$ 504$ 1,712$ 1,482$ 21,653$ 44,483$ 90,176$ 160,206$ 227,327$ 
Present value of free cash flow 10,787$      
Plus: Present value of terminal value 795,644$    
Less: Debt -$             
Equity Value 806,431$ 
Key Assumptions
Tax Rate 40%
Discount Rate 35%
Long-term growth rate 5%
Pre-clinical Trials Clinical Trials Market
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